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Abstract of a thesis submitted in partial fulfilment of the 
requirements for the Degree of PhD of Food Science. 
Abstract 
A comparative study of immunomodulatory activity  
of deer and cow milk proteins 
by 
Nelum Lawanya Opatha Vithana 
 
The aim of this study was to compare the immunomodulatory activity of peptides derived 
from deer and cow milk using in vitro lymphocyte proliferation assays and cytokine (IL-2 
and INFγ) production by human peripheral blood mononuclear cells (PBMC). Bioactive 
peptides were produced using in vitro digestion and lactic acid bacteria (LAB) fermentation. 
Deer and cow milk were fermented using Lactobacillus delbrueckiisubspbulgaricus, 
Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota at 37oC 
for 24 hours. Unfermented and fermented milk proteins were digested in two steps; imitating 
both the human stomach (Pepsin, pH 2.5, 30 min) and the duodenum (Corolase PP, pH 7.5, 
30 min) digestion. The production of peptides was quantified using the O-phthaldialdehyde 
assay and the degradation patterns of the milk proteins were analysed by SDS-PAGE. 
Immunomodulatory activity of each hydrolysate was carried out for 0.125, 0.25 and 0.5 
mg/ml protein concentrations. All unfermented and fermented deer and cow milk digestions 
were fractionated using Fast Protein Liquid Chromatography (FPLC) in order to separate and 
identify the most active fractions. Identification of peptides present in these 
immunostimulating fractions were carried out using Liquid Chromatography–Mass 
Spectrometry (LC-MS/MS) and database searching. 
 
Deer milk contained 8.8 ± 0.13% protein which was twice the level found in cow milk (4.1 ± 
0.02%). Peptide production was significantly higher in unfermented deer milk than 
unfermented cow milk (P< 0.05). The commercial proteolytic enzymes degraded milk 
proteins from deer more rapidly than those from cow. Deer milk fermentation gave higher 
peptide production than cow milk fermentation. Following in vitro digestion peptide 
production was significantly greater in deer milk ferment than cow milk ferment (P≤ 0.05). 
 v 
 
Lymphocyte proliferation, interleukin-2 (IL-2) and interferon-γ (INFγ) production were 
significantly greater in deer milk digestions than cow milk digestions (P ˂ 0.001)at the same 
concentration. LAB fermentation of both deer and cow milk prior to in vitro digestion 
increased (P < 0.001) lymphocyte proliferation. Fermentation with lactobacillus strains 
increased lymphocyte proliferation and cytokine IL-2 and IFNγ production (P < 0.05) more 
than with streptococcus. The immunostimulating effect was significantly greater (P ˂ 0.001) 
at 0.125 mg/ml protein concentration than at higher protein concentrations.  
 
The deer milk digests were more effective at increasing lymphocyte proliferation than the 
cow milk digests (P < 0.001) at the same protein concentration. Proliferation was higher (P < 
0.001) at 0.125 mg/mL protein than at higher protein concentrations. 
 
FPLC fractions (11, 22 and 30) with high immunostimulatory activity from deer digests 
(unfermented and fermented) showed higher lymphocyte proliferation and higher cytokine 
IL-2 and IFNγ production than the correspondening fractions of cow digests when measured 
in vitro with human PBMC. 
 
Mixtures of different peptides with different protein origin have been identified in the above 
FPLC fractions in both deer and cow milk digests which could be responsible for 
theimmunostimulating effect. The main protein source was β casein for both deer and cow 
fractions. Some differences in amino acid composition of β casein, α1 and α2 casein were 
identified between deer milk than cow milk. Few previously identified immunostimulating 
peptide sequences were found in tested FPLC fractions in cow digests. Some different 
peptides were detected in deer fractions compared to corresponding cow fractions.  No 
previously identified immunostimulating peptides were detected in deer digests. Further 
studies are required to further purify and identify unknown immunostimulating peptides. The 
activity could be confirmed with synthesised peptides. 
 
Keywords: deer milk, cow milk, milk proteins, peptides, in vitro digestion, fermentation, 
immunomodulatory activity, human PBMC, lymphocyte proliferation, cytokine production, 
FPLC, LC-MS/MS, database searching 
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     Chapter 1 
 
Introduction 
Milk has been described as nature’s most complete food (Park, 2009). It provides essential 
nutrients during neonatal development and plays an important protective role in development 
of the immune system of new-born mammals (Inglingstad et al., 2010; Korhonen and 
Pihlanto, 2006). Ruminant milk and milk products have also formed an integral part of 
human diets since the earliest domestication of livestock (Cross &Gill, 2000). The nutritional 
benefits of milk derived protein, vitamins and minerals have been promoted extensively by 
commercial dairy enterprises, and the vast range of milk based products now available are 
partly the result of the continued image held by consumers of milk as a ‘healthy’ product.  
Research has identified milk as a product with benefits beyond its nutritional value (Cross 
&Gill, 2000).  The concept of milk as a functional food with bioactive peptides and one 
which has direct and measurable influence on the health of its recipient, has increasingly 
gained scientific creditability (Meisel, 1997; Mclntosh et al., 1998; Meance et al., 2003; 
Korhonen, 2009). Bioactive peptides have been defined as specific protein fragments that 
have an impact on body functions or conditions and may ultimately influence health (Kitts & 
Weiler, 2003). Bioactive peptides exhibit opiate-like, mineral binding, immunomodulatory, 
antimicrobial, antioxidant, antithrombotic, hypocholesterolemic, and antihypertensive actions 
(Erdmann et al, 2008) and most contain 2–20 amino acid residues per molecule, although 
some are larger than 20 amino acids (Erdmann et al., 2008). Such peptides are inactive within 
the sequence of the parent protein and can be released by digestive enzymes during 
gastrointestinal transit or by fermentation or ripening during food processing (Korhonen & 
Pihlanto, 2003).  Immunomodulatory peptides have been identified from milk and milk 
products (Fabienne Parher, 1984; Laffineur et al., 1996; LeBlanc et al., 2002; Silva et al., 
2005; Erdmann et al., 2008; Korhonen, 2009; Nagpal et al., 2011; Perez Espitia et al., 2012). 
Currently milk proteins are the most important commercial source of bioactive peptides 
(Korhonen, 2009) and widely studied but information on peptides from milk of species other 
than cow is very limited.  
The proteins in milk from different species vary in concentration and amino acid 
composition. Cow milk has a protein content of approximately 3.3% (Park & Haenlein, 
 2 
2006), whereas red deer milk contains more protein, approximately 7.6% (Arman et al., 
1974). This suggests deer milk might produce more bioactive peptides than cow milk after 
fermentation and digestion. Along the borders between Russia, Mongolia, and China there is 
historical use of deer milk to cure digestive problems; heal wounds, frostbite and other 
injuries (Park &Haenlein, 2006), which suggest immunomodulating bioactive properties of 
deer milk. Extracts of deer velvet have been shown to induce proliferation of a variety of cell 
lines and trials to develop novel anti-cancer products and products to treat specific 
gastrointestinal conditions are underway (Gosh & Playford, 2003; Yang et al., 2009). In 
2010, Liu et al. reported that hydrolysed red deer plasma was rich in bioactives with AEC 
inhibitory activity (Angiotensin I-Converting Enzyme Inhibitors). There is an interest in 
bioactive peptides from deer products (velvet, antler) and deer milk which could be a good 
source of bioactive peptides and is not utilized presently. New Zealand has 1.2 million 
farmed deer which is half of the world’s farmed deer population.They are used to 
producemeat and velvet. Therefore, there is a large potential for isolation of 
immunomodulatory peptides from deer milk for pharmaceutical or nutraceutical purposes.   
 
Hypotheses 
• Deer milk proteins are a better source of immunomodulating bioactive peptides than 
cow milk proteins. 
• Lactic acid bacteria (LAB) fermentation of milk prior to digestion with commercial 
enzymes will improve the formation of bioactive peptides. 
Project Aims 
There are a number of studies and reviews on cow milk bioactives (Minervini et al., 2003; 
Gobbetti, 2007; Korhonen, 2009; Picariello et al., 2010) and a few on bioactives from other 
species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; Hernandez-
Ledesma et al., 2011), camel (El-Agamy, 2009), buffalo (Pandya and Haenlein, 2009) and 
yak (Mao et al., 2005). To the author’s knowledge there are no reported studies on red deer 
milk bioactives. This PhD thesis aimed at investigating immunomodulatory bioactive 
peptides from red deer milk and comparedthem to cow milk bioactivity.  
 3 
The first objective of this study was to investigate the in vitro digestion of deer and cow milk 
by commercial gastric and duodenal enzymes with the major focus being on comparison of 
the degradation of protein to evaluate the differences in digestibility and peptide production.  
Secondly deer and cow milks were fermented using three LAB cultures to compare peptide 
production before and after in vitro digestion and to compare deer and cow milk proteins 
digestibility. 
The LAB fermentation and in vitro digestion of both deer and cow milks were tested for 
immunomodulatory activity. Lymphocyte proliferation and cytokine production (IL-2 and 
IFNγ) were determined using human peripheral blood mononuclear cells (PBMC).    
The immunomodulatory activity of deer milk in vitro digests was compared with that of milk 
digests from three species (cow, sheep and goat). 
Finally immunomodulatory peptides of deer milk were fractionated by FPLC and their 
sequences were determined by mass spectrometry and compared with those of cow milk.   
 
Thesis Structure 
Including this introduction, this thesis contains nine chapters. Chapter 2 is the literature 
review which gives background information on which this project is based. Chapters 3 to 8 
are experimental chapters prepared as journal papers. Chapter 9 provides the overall 
conclusions from the project, future work and is followed by a complete list of references. 
Figure 1.1 details how the experimental chapters are related and data that contribute to more 
than one chapter.  
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Chapter 1: Introduction 
                                          (Importance, aims and structure of the project)  
 
Chapter 2: Literature review  
                                         (Background information necessary for project) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 9: General discussion, conclusion and future work    
Figure 1.1: Structure of chapters and research experiments of the thesis.Chapters shown in 
boxes are experimental chapters.   
Chapter 3 
 Peptide production & 
digestibility of deer and cow 
milk protein by in vitro 
digestion 
Chapter 4 
Peptide production after LAB 
Fermentation&in vitro 
digestion of deer and cow milk 
protein 
Chapter 5 
Immunomodulatory activity of 
unfermented & fermented deer and cow milk 
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     Chapter 2 
 
Literature Review 
2.1 Milk 
Milk is the substance that is produced to feed the mammalian infant. All mammals, from 
mice to whales, produce milk for this purpose. Milk has been described as the most perfect 
food in nature and it is balanced for most nutrients and often has a high caloric value (Park, 
&Haenlein, 2006). It contains lactose, protein, lipid and minerals which all are required for 
optimal health and growth. The components of milk provide critical nutritive elements, 
immunological protection, and biologically active substances to both neonates and adults 
(Shah, 2000).  
Milk and milk products are consumed everywhere and in 2010 the world total milk 
production was 713.6 million tonnes (FAO, 
http://www.fao.org/docrep/012/ak341e/ak341e10.htm).  Cowshave been the major source of 
milk and dairy products in developed countries, especially in the Western world (Haenlein, 
2001) but milks from other mammals such as goat, sheep, reindeer, buffalo, camel and yak 
are also consumed  (Park, 2009). 
2.2 Milk Bioactives 
Research over the last twenty years has identified milk as a product that has a commercial 
value beyond its traditional nutritional value (Cross & Gill, 2000). In their native form, milk 
proteins exert an appreciable range of physiological activities. The major role of milk 
proteins is to supply amino acids and nitrogen to young mammals and constitute an important 
part of dietary proteins for the adult. Intact milk proteins also have specific functions such as 
micelle formation (Nagpal et al., 2011). Specific immunoglobulins in milk provide the first 
line of defence to suckling neonates through passively acquired immunity. Also milk is good 
source of several hormones and growth factors (Grosvenor et al., 1993). Other non-specific 
antimicrobial milk factors including the iron-binding protein, lactoferrin, and several 
enzymes such as lactoperoxidase and lysozyme prevent microbial proliferation (Florisa et al., 
2003). 
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Although the protein fraction of milk has been the most widely studied in terms of bioactive 
compounds, there are other compounds that have shown physiological significance in milk 
such as some milk sugars (lactose, oligosaccharides), calcium and lipid-based bioactive 
compounds (Shah, 2000). Lactose has been reported to enhance calcium absorption and 
lactulose which is a product of lactose, is used as a promoter of probiotic bacteria and its use 
is now widespread in infant formula (Shah, 2000). Calcium plays a role in the regulation of 
blood pressure and calcium phosphate binds bile salts in order to prevent their toxic effect, 
thereby reducing the risk of colon cancer (Der Meer et al., 1991). The lipid-based bioactive 
compounds in milk include fatty acids and the role of conjugated linoleic acid for inhibition 
of cancer and atherosclerosis has been studied (Pariza et al., 2001).    
2.3 Bioactive Peptides from Milk 
In recent years, intense research interest has been focused on identifying biologically active 
components in cow milk and characterising the mode by which mammalian physiological 
functionsare modulated by these compounds (Fait et al., 1993; Korhonen, 2009). At present, 
milk proteins are considered the most important source of bioactive peptides (Korhonen, 
2009). Bioactive peptides have been defined as specific protein fragments that have a positive 
impact on body functions or conditions and may ultimately influence health (Kitts & Weiler, 
2003). They usually contain 2–20 amino acid residues per molecule, but in some cases they 
may consist of more than 20 amino acids (Erdmann et al., 2008). Such peptides are inactive 
within the sequence of the parent protein and become active only when they are released 
from the precursor protein (Fig. 2.1.).  
Different mechanisms can release the encrypted bioactive peptides from the precursor 
proteins (Korhonen & Pihlanto, 2003): 
a.) In vivo, during gastrointestinal digestion through the action of digestive enzymes or of 
microbial enzymes of the intestinal flora; 
b.) During milk processing (e.g. milk fermentation, cheese production) through the action of 
microbial enzymes expressed by the microorganisms used as starter; 
c.) During milk processing through the action of a single purified enzyme or a combination of 
selected enzymes; 
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In many studies, combinations of (a) and (b) or (a) and (c), have proven to be effective in 
generation of short functional peptides (Korhonen & Pihlanto, 2003). 
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Fig 2.1. Summarizing scheme of the possible mechanisms by which bioactive peptides can be 
released from the precursor proteins by microbial fermentation and/or gastrointestinal 
digestion, from Möller at al.(2008). 
The production and properties of milk protein-derived bioactive peptides have been reviewed 
in many articles (Samacchi & Goggetti, 2000; Silva & Malcata, 2005; Korhonen & Pihlanto, 
2006; Korhonen, 2009).  Depending on the sequence of amino acids, these peptides can 
exhibit diverse activities, including opiate-like, mineral binding, immunomodulatory, 
antimicrobial, antioxidant, antithrombotic, hypocholesterolemic, and antihypertensive actions 
(Erdmann et al., 2008). Many bioactive peptides are multifunctional and can exert more than 
one of the effects (Fig. 2.2) mentioned (Korhonen, 2009; Pihlanto et al. 2011).   
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2.3.1 Immunomodulatory Bioactive Peptides from Milk 
Cow milk contains a number of potent peptides that affect the immune system via cellular 
functions including cell proliferation and downstream immunological responses (Werner et 
al., 1986; Coste & Tome, 1991; Fiat et al., 1993; Kayser & Meisel, 1996; Gill et al., 2000; 
Cross &Gill, 2000; Phelan et al., 2009). A large number of studies have demonstrated that 
hydrolysis of cow milk protein by digestive enzymes can produce biologically active peptides 
including immunomodulatory peptides (Gill et al., 2000; Korhonen and Pihlanto, 2009) and 
some of these are summarised in Table 2.1.  
Immunomodulation can be defined as adjustment of the immune response to a desired level, 
as in immunopotentiation, immunosuppression, or induction of immunologic tolerance. 
Pepsin, trypsin and chymotrypsin have been shown to release a number of 
immunomodulatory peptides both from caseins (α-, β-, and κ- casein) and whey proteins, e.g.  
α- lactalbumin, β-lactoglobulin and glycomacropeptide (Gauthier et al., 2003; Gobbetti et al., 
2004; Phelan et al., 2009).  
2.3.2 Immunomodulatory Bioactive Peptides from Fermented Milk 
A number of reports (Table 2.2) have demonstrated up- and down-regulation of the immune 
system by milk-derived immunomodulatory peptides from fermented milk products 
(Korhonen & Pihlanto, 2006). Growing evidence drawn from epidemiological studies, 
scientific reports and clinical data indicate that consumption of fermented dairy products 
reduces the risk of certain types of cancer; including tumours of breast, colon, lung and 
subcutaneously implanted fibrosarcomas (Matar et al., 2001; Matsuzaki et al., 1996; Biff et 
al., 1997). The peptidic profile of milk proteins is significantly different after microbial 
fermentation, suggesting that modification exerted by microbial proteolysis can be a potential 
source of bioactive peptides (Matar et al., 1996). It is now well established that 
physiologically active peptides are produced from milk protein during fermentation of milk 
with lactic acid bacteria (Korhonen & Pihlanto, 2006). Lactic acid bacteria (LAB) utilize 
milk proteins as their source of essential and growth-stimulating amino acids (Juillard et al., 
1998). These bacteria possess cell-envelope-located proteinases which degrade caseins into 
oligopeptides, peptide transport systems, which internalize the released oligopeptides; and 
intracellular peptidases, which hydrolyse the oligopeptides into smaller peptides or into 
amino acids, which can then be used by the cell (Juillard et al., 1998).  
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Table 2.1. Immunomodulatory peptides derived from milk proteins 
Peptide Source Hydrolysis  Immune effect Reference 
Val-Glu-Pro-Ile-
Pro-Tyr 
Human  
β casein 
Trypsin No effect on  antibody formation 
↑ Phagocytosis 
↓ Klebsiella pneumoniae infection 
 
 
Parker et al., 1984 
Gly-Leu-Phe Human casein Trypsin ↑ Phagocytosis 
↓ Klebsiella pneumoniae infection 
 
Berthou et al., 1987 
Leu-Leu-Tyr Cow casein Trypsin ↑ Phagocytosis 
No effect on Klebsiella pneumoniae 
infection 
↓ Antibody formation 
 
Berthou et al., 1987 
Tyr-Gly Cow κ - casein synthetic peptides 
corresponding to bioactive 
sequences 
↑ Human lymphocyte proliferation Kayser & Meisel, 1996 
Casein 
hydrolysates  
Cow casein Commercial enzyme 
hydrolysis 
↑ IL-2 production 
 
Phelan et at., 2009  
Casocidin-I Cow α2 - casein Acid  hydrolysis ↓ growth of E. coli&Staphylococcus 
carnosus  
Zucht et al., 1995 
Goat α2 – Casein 
fraction 
Goat casein No hydrolysis ↑ Antibody formation (indirect ELISA) 
 
Haza et al., 1995 
Casein 
hydrolysates 
Cow casein Human gastric and duodenal 
or commercial enzymes  
↓ Human lymphocyte proliferation Eriksen et al., 2008 
Beta-casomorphin Cow β-casein Trypsin ↑ lymphocytes proliferation, 
NK activity and neutrophil locomotion 
Migliore-Samour et al., 
1989 
Casecidin αs1casein 
f(1-23) 
Cow αs1-casein Chymosin Stimulation of phagocytosis 
and immune responses 
against bacterial infections 
Lahow and Regelson, 
1996 
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Isracidin Cow αs1-casein Chymosin Stimulation of phagocytosis 
and immune responses 
against bacterial infections 
Lahow and Regelson, 
1996 
Cow κ casein 
f(106-169) 
Cow κ casein Rennin Depression of mice lymphocytes 
proliferation 
Otani et al., 1992 
Cow whey protein 
hydrolysates 
Cow whey proteins Trypsin/ Chymotrypsin ↑ mice lymphocyte proliferation at 
lower concentration (0.5 - 500µg/ml) 
Mercier et al., 2004 
Lactoferrin 
hydrolysates 
Cow Lactoferrin Pepsin Stimulation of proliferation 
and antibody production in 
murine splenocytes and 
Miyauchi et al., 1997 
Cow & goat milk 
whey protein 
hydrolysates 
Cow & goat whey 
protein 
Human Gastric juice & 
Human duodenal juice  
↓ Human lymphocyte proliferation Eriksen et al., 2008 
Tyr-Gly-Gly Cow α-lactalbumin synthetic peptides 
corresponding to bioactive 
sequences 
↑ Human lymphocyte proliferation Kayser & Meisel, 1996 
Unsequenced 
acidic 
immunomodulatory 
peptides 
of less than 
1000kDa in size 
Cow β - Lactoglobulin Trypsin,  Chymotrypsing & 
Lactobacillus paracasei 
NCC2461 Peptidases 
↑ IL-10 production 
↓lymphocyte proliferation 
Prioult et al, 2004 
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Table 2.2. Immunomodulatory peptides derived from fermented milk  
Fermentative 
strain 
Peptide Fraction Immune effect Reference  
Lactobacillus 
helveticus R389 
Size-exclusion HPLC Fraction п Response following Escherichia coli O157:H7 infection 
↑Intestinal IgA+ B cells 
↑ Intestinal IgA secretion  
↑ total serum IgA secretion 
↑ Cytokine production (IL-4 & IFN-γ ) 
 
LeBlanc et al., 2004 
Lactobacillus 
helveticus R389 
Size-exclusion HPLC Fractions ↑Intestinal IgA+ B cells 
↓ Fibrosarcoma Tumor 
LeBlanc et al., 2004 
Lactobacillus 
helveticus L89 
(In vitro digestion) 
Reverse-phase HPLC 
 - low molecular      mass peptides 
 - YPVEPF 
 - HPHPHLSFM 
         _  Matar et al., 1996 
Lactobacillus 
helveticus 5089 
β Casein ferment  ↑ IFN-γ production  
↓  IL-2 production 
↑ lymphocyte proliferation 
 
Laffineur et al., 1996 
Lactobacillus 
helveticus R389 
Non-bacterial fraction  ↑ IL-6 production 
↑ IgA production 
Vinderola et al., 2006 
Lactobacillus 
helveticus R389 
Fermented milk ↑ IgA production 
-↑ Phagocytosis 
 
Martha et al., 2001 
Lactobacillus 
acidophilus 
DPC6026 
IKHQGLPQE, VLNENLLR, 
SDIPNPIGSENSEK 
-Antibacterial against Enterobacter sakazakii ATCC 12868 
&Escherichia coli DPC5063 
Hayes et al., 2006 
Lactic acid bacteria 
(LAB) 
Isolate from goat cheese Antibacterial against the Gram-positive bacteria Bacillus 
cereus, Clostridium sporogenes and Staphylococcus aureus; 
and against the Enterobacteriaceae, Shigella sonnei and 
Klebsiella pneumoniae. 
Hernandez et al., 2005 
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Lactobacillus 
helveticus PR4 
Human β casein f184-210   Antibacterial against Gram-positive and -negative bacteria, 
including species of potential clinical interest, such as 
Enterococcus faecium, Bacillus megaterium, Escherichia 
coli, Listeria innocua, Salmonella spp., Yersinia 
enterocolitica, and Staphylococcus aureus. 
Minervini et al., 2003 
Lactobacillus casei 
strain Shirota 
Dairy products ↑ IFN-γ production 
↑ IL-1β 
↑ TNF-α 
↓ Tumour growth in rodents 
↓ Bladder cancer in human 
Matsuzaki, 1998 
Lactobacillus 
helveticus 
Fermented milk ↓ Mammary tumour growth in mice 
↓ IL-6 production 
Richid et al., 2006 
Lactobacillus casei 
strain Shirota 
Fermented drink ↓ natural killer (NK) activity Takeda & Okumura, 
2007 
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The transport system of LAB enables them to internalize oligopeptides up to 18 amino acids 
in length, although rarely above 10 amino acids (LeBlanc et al., 2002). This allows the longer 
oligopeptides to be a source of bioactive peptides when further degraded by gastrointestinal 
enzymes or by intracellular peptidases of LAB. 
Lactobacillus helveticus fermented milk has demonstrated an immunomodulating effect on 
lymphocyte proliferation in vitro (Laffineur et al., 1996). This strain is known to have high 
proteolytic activity, causing the release of oligopeptides from milk proteins. Matar et al. 
(2001) identified immunostimulatory peptides generated through fermentation of milk protein 
using LAB, specifically Lactobacillus helveticus commonly used in the manufacture of 
Swiss-type cheese and other fermented milk products. The immunostimulatory and antitumor 
properties of peptidic fractions issued from milk fermented with Lactobacillus helveticus 
R389 were also reported by LeBlanc et al. (2002).  
 
2.4 Overview of the Immune System 
Although the immunomodulation mechanism of bioactive peptides remains uncertain, it was 
confirmed that immunomodulatory activity was related to lymphocyte proliferation, cytokine 
and antibody synthesis (Gauthier et al., 2006; Yang et al., 2009; Hou et al., 2012). Therefore, 
it is important to have an overview of the human immune system in order to gain a better 
understanding of the potential immunomodulation mechanisms of bioactive peptides.        
Immune system 
The mammalian immune system has evolved to provide protection against infectious agents 
called pathogens (Wood, 2006). Pathogens include infectious organisms, such as bacteria, 
viruses and eukaryotic parasites, and foreign inanimate materials, for example toxins. The 
immune system has historically been divided into innate and adaptive (specific) systems 
(Turvey et al., 2010).  
The human immune system can be simplistically viewed as consisting of three levels: (1) 
anatomical and physiological barriers; (2) innate immunity; and (3) adaptive immunity (Fig 
2.3). Failure in any of these systems will greatly increase susceptibility to infection (Turvey 
et al., 2010). 
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Fig 2.3. Integrated human immune system from Turvey et al. (2010). The human defence 
system can be simplistically viewed as consisting of 3 levels: (1) anatomical and 
physiological barriers; (2) innate immunity; and (3) adaptive immunity. In common with 
many classification systems, some elements are difficult to categorize. For example, natural 
killer (NK), T cells and dendritic cells could be classified as being on the cusp of innate and 
adaptive immunity rather than being firmly in one camp. 
 
 
Innate immune system 
The innate immune system includes: 
• Cells (e.g. macrophages, neutrophils, mast cells) 
• Soluble factors (e.g. the complement proteins, acute-phase proteins). 
The innate immune system used to be regarded as a primitive defence system of limited 
effectiveness, found in vertebrates and invertebrates. Cells and proteins of the innate immune 
system can recognize certain molecules on the surface of pathogens (pathogen-associated 
molecular patterns – PAMPs) as foreign. PAMPs are large molecules with a significant non-
protein component and examples include lipopolysaccharides, peptido-glycans, lipotechoic 
acids and mannans. They are found only on microbes and are essential for microbial survival; 
therefore they cannot stop manufacturing them as a way of avoiding recognition by the innate 
immune system. The cell receptors that recognize PAMPs are called pattern-recognition 
receptors and include toll-like receptors and lectins such as the mannose receptor. Soluble 
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factors recognizing PAMPs include mannose-binding lectin and C-reactive protein (Fig. 2.4) 
(Wood, 2006). 
There is a limit to the number of receptors that can evolve to recognize foreign PAMPs and, 
given the quicker replication of pathogens compared with mammals, some pathogens will 
evolve ways of escaping recognition by the innate immune system. For example, avirulent 
streptococci are recognized and eliminated by the innate immune system and therefore do not 
cause disease. However, virulent streptococci synthesize a waxy carbohydrate outer coat that 
is not recognized by the innate immune system and therefore to eliminate them a specific 
immune response is required(Wood, 2006). 
Adaptive immune systems 
The cellular components of the adaptive immune system are the lymphocytes (mainly T and 
B lymphocytes). Lymphocyte precursors originate from the bone marrow and some 
differentiate in the thymus into T lymphocytes which are responsible for cellular immunity. 
They have receptors for antigen on their surface (Fig. 2.4). Other lymphocyte precursors 
differentiate into B lymphocytes in the fetal liver and after birth in the bone marrow. B 
lymphocytes are responsible for humoral immunity (immunity that is mediated by secreted 
antibodies). They have antibody molecules on their surface (Fig. 2.4). After differentiation, 
the lymphocytes migrate to the lymph nodes and other lymphoid tissue. Although 
morphologically indistinguishable, the three types of lymphocyte perform different functions. 
One of the main features distinguishing specificor adaptive immunity from innate immunity 
is that specific immunity is not present before infection. Following initial infection with a 
pathogen it takes about 4 days to produce antibodies against it. 
The specific immune system is found only in vertebrates and was thought to be the main 
defence mechanism. It is now known that the innate immune system does more than provide 
the first line of defence and plays an important role in determining the type of specific 
immune response that is mounted against infectious agents (Wood, 2006). 
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Fig 2.4. Recognition by the immune system from Wood, (2006) 
 
The simplified working procedure of our immune system is illustrated in Fig. 2.5. Specialized 
antigen presenting cells (APCs) called macrophages circulate throughout the body and if they 
encounter an antigen, they ingest and fragment them into antigenic peptides (I). The pieces of 
these peptides are displayed on the cell surface by major histocompatibility complex (MHC) 
molecules existing in the digesting APC. The presented MHC–peptide combination on the 
cell surface is recognised by the T-cells causing them to be activated (II). Activated T-cells 
secrete some chemicals as alert signals to other units in response to this recognition (III). B-
cells, one of the units that respond to these signals, become activated with the recognition of 
antigen by their antibodies occurring at the same time (IV). When activated, B-cells turn into 
plasma cells that secrete antibodies which are bound on their surfaces (V). Secreted 
antibodies bind the existing antigens and neutralize them signalling other components of 
immune system to destroy the antigen–antibody complex (VI) (Polat et al., 2006).  
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Fig 2.5. Immune response from Perelson & Oster (1979). 
 
Lymphocytes 
The three major types of lymphocytes are T lymphocytes (or T cells), B lymphocytes (or B 
cells) and natural killer cells (NK cells). T and B lymphocytes are the main self-defence 
weapons of the adaptive immune system (Turvey et al., 2010). The T cells coordinate the 
entire immune response and eliminate viruses hiding in infected cells and contribute to the 
immune defences in a cell-mediated way and can be sub-grouped as follow. T helper cells 
(Th cells) assist other white blood cells in immunologic processes, including maturation of B 
cells into plasma cells and activation of cytotoxic T cells and macrophages, among other 
functions. Cytotoxic T cells (TC cells, or CTLs) destroy virally infected cells and tumour 
cells, and are also implicated in transplant rejection. After the infection has resolved, another 
subset of antigen-specific T cells persist and they are called Memory T cells. They quickly 
expand to large numbers of effector T cells upon re-exposure to their cognate antigen, thus 
providing the immune system with "memory" against past infections. Memory T cells 
comprise two subtypes: central memory T cells (TCM cells) and effector memory T cells 
(TEM cells). Finally, regulatory T cells (Treg cells), formerly known as suppressor T cells, 
are crucial for the maintenance of immunological tolerance. Their major role is to shut down 
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T cell-mediated immunity toward the end of an immune reaction and to suppress auto-
reactive T cells that escaped the process of negative selection in the thymus (Wood, 2006). 
 Natural killer cells (NK cells) are a type of cytotoxic lymphocyte. NK cells play a major role 
in the rejection of tumours and cells infected by viruses. The cells kill by releasing the 
proteins called perforin and granzyme that cause the target cell to die by apoptosis.  Most of 
the production of lymphocytes occurs during fetal and neonatal life, but there is a slow 
continuous production of new lymphocytes from stem cells in adults (Turvey et al., 2010). 
Lymphocytes reside in different organs of the human body. They circulate through the 
primary lymphoid organs (thymus and bone marrow), the secondary lymphoid organs 
(spleen, lymph nodes (LN), tonsils and Peyers patches (PP)) as well as non-lymphoid organs 
such as blood, lung and liver (Fig. 2.6.). Especially in lymphoid organs, lymphocyte subsets 
migrate and home to different compartments (Blum & Pabst, 2007). 
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Fig. 2.6. Distribution of lymphocytes to the different organs from Blum and Pabst, (2007)  
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Cytokines 
The components of the immune system act cooperatively to eliminate the infection. The 
“communication” between the different parts is mediated by specialized chemical mediators, 
called cytokines (Belardelli & Ferrantini, 2002). Cytokines are diverse and potent chemical 
messengers secreted by the cells of the immune system. Over 80 cytokines have been 
described and they play an important role in coordinating embryonic development, cell 
growth and maturation, new blood vessel formation, wound repair and healing, the immune 
response including acute phase reactions and septic shock, and destroying targeted cells 
including cancer cells (Dunlop et al., 2000). Expression of cytokines and their receptors after 
stimulation is an important indicator of mononuclear cell activation (Garibay-Escobar et al., 
2003) 
Lymphocytes, including both T cells and B cells, secrete cytokines called lymphokines, while 
the cytokines of monocytes and macrophages are called monokines. Many of these cytokines 
are also known as interleukins because they serve as a messenger between leukocytes. 
Binding to specific receptors on target cells, cytokines recruit many different subsets of the 
immune system. Moreover, it is common for different cell types to secrete the same cytokine 
or for a single cytokine to act on several cell types. Cytokines are redundant in their activity, 
meaning that the same function can be stimulated by different cytokines. 
Cytokines include several categories such as interleukins (IL-1, IL-2, IL-6, IL-10), 
interferons (IFNα, IFNβ, IFNγ), tumor necrosis factor (TNFα), colony-stimulating factors 
(CSF), growth factors and others (Dunlop et al., 2000). They may be grouped into various 
sub-families (Table 2.3), although the nomenclature is somewhat arbitrary, having arisen in 
different branches of biology. 
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Table 2.3. Cytokine families 
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Reference: Hopkins, (2003) 
 
A complex network of cytokines, simplistically outlined in Fig. 2.7, critically affects the 
nature of the lymphocyte response. 
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Fig. 2.7.Regulation of adaptive immunity by cytokines from Hopkins, (2003). Cytokine 
production (solid arrows) regulates adaptive immunity at the level of antigen presentation (1), 
clonal expansion (2), differentiation along alternate T-cell regulatory pathways (3), regulation 
of B cell differentiation (4) and effector actions of T cells at the tissue level (5).   
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In particular, two important cytokines involved in the proliferation and activation of 
lymphocytes are IL-2 and INFγ (Belardelli and Ferrantini, 2002). IL-2 is a T cell growth 
factor produced by T helper 1 (Th1) and NK cells. As an autocrine and paracrine growth 
factor, IL-2 induces proliferation and differentiation of T and B cells (Belardelli and 
Ferrantini, 2002). IL-2 is responsible for stimulation of B cells for antibody synthesis. IL-2 
stimulates the growth of NK cells and enhances the cytolytic function of these cells, 
producing lymphokine-activated killer cells. IL-2 can also induce interferon INFγ secretion 
by NK cells (Smyth et al., 2001).IL-2 is a major autocrine and/or paracrine T-cell growth 
factor, produced primarily by CD4+ T cells and used for the treatment of some human 
malignancies and priming of immune activity (Belardelli & Ferrantini, 2002). IFN-γ has 
marked effects on cells of innate immunity, including macrophages, the activation state of 
which is regulated mainly by INF-γ (Belardelli, 1995). The fact that IFN-γ is produced 
typically during a Th1 immune response has led this cytokine to be considered as 
characteristic of adaptive immunity. However, recent studies have reported IFN-γ production 
by cells of the innate immune system, such as macrophages (Gessani & Belardelli, 1998) and 
T cells (Frucht et al., 2001), suggesting that IFN-γ plays a role in bridging the innate and 
adaptive branches of the immune response. IFN-γ is important in host defense against 
intracellular pathogens, viruses, natural surveillance against cancer and IFN-γ can induce 
marked antitumor effects in mouse models (Belardelli & Ferrantini, 2002).  
 
 
In vitro lymphocyte proliferation assay as an immunomodulatory parameter  
 
After activation by encounter with an antigen (or foreign protein), B and T lymphocytes start 
to proliferate and rapidly expand their numbers, so that there are many lymphocytes available 
which can recognize and fight the invading antigens (Zilman et al., 2010). Measurement of 
lymphocyte proliferation is frequently used in clinical and experimental immunology as a 
means of assessing lymphocyte activation and response to a variety of stimuli including 
nonspecific mitogens, specific antigen, cytokines, and allergenic stimulation in mixed 
lymphocyte reactions (De Fries & Mitsuhashi, 1995). 
The lymphocyte proliferation assay measures the ability of lymphocytes placed in short-term 
tissue culture to undergo a clonal proliferation when stimulated in vitro by a foreign 
molecule, antigen or mitogen (Zhi-Jun et al., 1997; Wanger et al., 1999; Zilman et al., 2010).   
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Proliferation of lymphocytes in response to various stimuli has been assessed by several 
means. Traditionally the most commonly used method assessed the incorporation of 
radiolabeled nucleotides (3H-thymidine) into cells during cell division (Khan et al., 1986; 
Fries & Mitsuhashi, 1995; Metcalf & Wiadrowski, 1966 and Eriksen et al., 2008). The 
primary drawbacks of the 3H-thymidine incorporation assay are that it requires specialized 
equipment, as well as the use of radioisotopes which present a hazard in the laboratory and 
which pose increasing difficulties in their disposal (Fries & Mitsuhashi, 1995). 
 
 A number of alternative methodologies for measurement of lymphocyte proliferation have 
been reported. Assays which measure total cell number by detecting reduction of tetrazolium 
compounds, such as MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
by microbial enzymes, have been evaluated (Weichert et al., 1991). Methods which measure 
incorporation of fluorescent dye into cellular DNA (Blaheta et al., 1991) and incorporation of 
BrdU (5-bromodeoxyuridine) and subsequent detection by ELISA assay (Houng et al., 1991) 
have also been reported.  
The Alamar Blue assay was developed by Alamar Bioscience Inc (Fries and Mitsuhashi, 
1995), as a reliable and sensitive alternative assay for determining lymphocyte proliferation 
which is convenient, simple to perform and does not require the use of radioactive materials 
(Ansar Ahmad et al., 1994; Zhi-Jun et al., 1997; Al-Nasiry et al., 2007; Jacquot et al., 2010). 
An oxidized form of the Alamar Blue reagent is added to cells and this is reduced by 
mitochondrial enzyme activity of the cells being tested. Reduction causes a change in colour 
as well as a shift in fluorescence profile which can be quantitatively detected colorimetrically 
or fluorimetrically (Zhi-Jun et al., 1997). Fries and Mitsuhashi, (1995) have demonstrated the 
reliability of Alamar Blue assay in measuring human peripheral blood mononuclear cell 
(PBMC) proliferation.   
 
Cytokine production as immunomodulatory parameter   
It has been well established that cytokine levels correlate with the severity of diseases and/or 
clinical outcomes (Kurzrock et al., 1993; Tartour et al., 1994). Commercially available 
ELISA kits (based on a sandwich technique using antibodies) make it convenient to measure 
cytokines in biological samples and cell culture supernatants (Leduret al., 1995).  The same 
ELISA procedure has been used to test immunomoduatory activity of milk proteins 
previously with human lymphocytes (Laffineur et al., 1996; Phelan et al., 2009) and murine 
splenocytes (Saint-Sauveur et al., 2007).    
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2.5. Deer milk, usage and potential of immunomodulating 
bioactives  
Most of the studies and reviews on bioactive peptides are on cow milk (Minervini et al.,  
2003; Gobbetti, 2007; Korhonen, 2009; Picariello et al., 2010) while only a few on milk from 
different species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; 
Hernandez-Ledesma et al., 2011) are found In the mass production of bioactive peptides cow 
milk is used as an ingredient for the manufacture of functional foods by chromatographic 
purification (Choi et al., 2012). There is no reported study on deer milk bioactives which may 
have this potential.  
Knowledge of milk and milk bioactives of ruminants is mainly related to studies on bovids. 
These are often taken to be typical of the sub-order as a whole, but it is interesting to extend 
our knowledge to the milks of other families to see their value. Of these families, the cervids 
are the largest and appear to have evolved earlier than the bovids. The cervids, especially the 
reindeer (Rangifer tarandus L.) are herded but their milk and milk proteins have not been 
studied in any detail (McDougall & Stewart, 1975). Reindeer pastoralism, where milking was 
an integrated part of the farming activity, evolved at least two thousand years ago in the 
Taiga region of eastern Siberia around Lake Baikal and spread to nearby ethnic groups 
(Fondahl, 1989). The most intensive milking regime was developed along the borders 
between Russia, Mongolia and China. The animal provided milk both for immediate fresh 
consumption and processing. The milk was dried and processed into cheese, butter, and sour 
cream, (Table 2.4.) as well as used medicinally. The milk was curdled and often mixed with 
herbs such as Oxyria spp. and Angelica spp. (Park & Haenlein, 2006). Reindeer milk and its 
products were highly priced and also used as a medical remedy to cure digestive problems 
(the milk has antidiarrheic properties) and to heal wounds (Park & Haenlein, 2006). Fat 
exuded by heat from reindeer cheese was also used to cure nursing pains, frostbites, and other 
injuries. In addition, colostrum was used for children’s ailments (Fondahl, 1989). 
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Table2.4. Traditional Products and Uses of Reindeer milk (Park & Haenlein, 2006) 
Removed due to copy right  
 
Park, Y. W., & Haenlein, G. F. W. (Eds.). (2006). Handbook of Milk of Non-Bovine 
Mammals. Iowa: Blackwell Publishing. 
 
 
 
 
 
 
 
 
 
Red deer (Cervus elaphus L.) has become an experimental animal and increasing attention is 
being given to methods of farming it (Gómez et al., 2002). Intensive farmed red deer 
production for meat increased in France following the success of Scotland and New Zealand 
where the first commercial flocks were created 20 years ago and deer hinds produce 120 to 
200kg milk in 100 days depending on pasture quality and the milk contains on average 10 % 
fat and 8 % protein which is twice the levels found in cow milk (Theriez, 1988). Milk 
composition of Red deer and some domesticated mammals and human milk are shown in 
Table 2.5. 
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Table 2.5.  Gross Composition (%) of milk of human & some domesticated mammals 
Species Fat Protein Total solids 
Human 4.1 1.3 12.3 
Cow 3.6 3.3 12.3 
Goat  3.8 3.5 12.2 
Sheep 5.3 5.5 16.3 
Deer (Red Deer) 10.3 7.8 23.9 
Data from Emmett & Rogers, (1997) and Park & Haenlein, (2006) 
Since milk protein is the precursor of several bioactive peptides, this may indicate that deer 
milk might be rich in bioactives compared to bovine milk. So far there are no studies on deer 
milk bioactives. Furthermore, the evidence of historical use of deer milk as a medical remedy 
suggests there is potential to capture immunomodulatory bioactive peptides in deer milk and 
utilize them more efficiently for certain age groups that require support for the immune 
system. 
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     Chapter 3 
(Paper published in International Food Research Journal 2012,19 (4): 409-416 
 
In vitro Digestion of Red Deer (Cervus elaphus) and Cow 
(Bos taurus)milk 
 
 
3.1. Introduction 
The proteins in milk from different species vary in concentration and amino acid 
composition. The protein content in milk from bovine species is approximately 3.3%, 
whereas reindeer milk contains more protein, approximately 7.8% (Park & Haenlein, 2006). 
Casein is the main protein component of bovine milk constituting about 80% of the total milk 
proteins (Shah, 2000). The casein fraction consists of αs1-, αs2-, β- and κ-casein. The main 
proteins in the whey fraction are β-lactoglobulin (β-lg), α-lactalbumin (α-la), serum albumin 
(SA), immunoglobulins (Igs), lactoferrin (LF) and lysozyme (LZ) (Inglingstad et al., 2010). 
The amino acid composition of casein and whey protein fractions varies in different species 
and will affect their digestibility (Almaas et al., 2006).      
Protein digestion starts in the stomach by the action of acid and pepsin and is followed by 
intestinal digestion by trypsin, chymotrypsin and various carboxypeptidases and 
aminopeptidases. Milk protein represents an important dietary source for humans, providing 
that they are digested suitably.The high digestibility of milk protein (~ 95%), combined with 
a superior amino acid composition for human requirements, makes milk a “high quality 
protein” source (Bos et al., 1999).  In vivo results of Dangin et al. (2002, 2003) led to the 
concept of “slow” digested caseins and “fast” digested whey protein. In vivo studies with 
either milk or purified milk proteins in healthy human showed that whey proteins were taken 
up more rapidly in the upper jejunum than the casein (Mahe et al., 1995, 1996).  However, 
studies by Almaas et al., (2006) using human gastric and duodenal juices for the in vitro 
digestion of cow and caprine milk proteins revealed that the whey proteins, α-lactalbumin 
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and β-lactoglobulin were very resistant to hydrolysis and that the caseins were degraded 
faster.  
This study investigates the in vitro digestion of deer and cow milk by commercial gastric and 
duodenal enzymes with the major focus being on comparison of the degradation of protein to 
evaluate the differences in digestibility and peptide production. No information on the 
digestion of red deer milk, which is unique from other species in its composition (Landete-
Castillejoset al., 2000), is available and only basic composition of red deer milk has been 
reported. This information could potentially be useful in understanding functional roles in 
animal nutrition and evaluating its potential for human use.  
3.2. Materials & Methods 
3.2.1. Materials 
Oxytocin was purchased from Pharm Distributors (Auckland, New Zealand). Pepsin (66 units 
/ mg solid) from porcine stomach mucosa, OPA (O-phthaldialdehyde), Leucine and TCA 
(trichloroacetic acid) were purchased from Sigma (St. Louis, MO, USA) and Corolase PP 
(CPP) (350 proteolyticU/mg) from pig pancreas was from AB Enzymes (Darmstadt, 
Germany). Corolase PP is a mixture of trypsin, chymotrypsin and several amino and 
carboxypeptidases. NuPAGE 4-12% Bis-Trisprecast gels were purchased from Invitrogen 
USA. Bio-Rad Precision Plus Protein TM standard was used as a high molecular weight 
marker.  
 
3.2.2. Preparation of Milk Samples 
Pooled deer milk was obtained from the Lincoln University deer farm at Lincoln (New 
Zealand). Calves were weaned from twenty hinds which were then milked twice-daily. 
Immediately prior to milking, each hind received an injection of 1 ml oxytocin (10 IU/ml) to 
enable the ‘let down’ of milk. The hinds were milked in a side-loading crush, using a 
commercial machine designed for milking sheep and goats. Approval for this work was given 
by Lincoln University Animal Ethics Committee (# 377).Pooled cow milk was obtained from 
Lincoln University Dairy Farm. Fat was removed by centrifugation at 4000 ×g for 30 min at 
4°C. Defatted milk was freeze dried and stored at room temperature in airtight containers 
until analysis.  
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3.2.3. Protein content 
Total nitrogen (TN), non-protein N (NPN) and non-casein nitrogen (NCN) were measured 
using the Kjeldahl method (Barbano et al., 1991). NPN was estimated after precipitation of 
protein with 24% trichloracetic acid followed by centrifugation at 27,000 x g for 60 min. The 
supernatant was filtered using Whatman No 1 filter paper and the filtrate was used for 
Kjeldahl analysis. NCN was measured after precipitation of casein by adjusting the milk to 
pH 4.6 with slow addition of 1M HCL while stirring and centrifugation at 10,000 ×g for 15 
min at 200C. The supernatant was filtered and protein content was determined using the 
Kjeldahl method. Total protein [(TN-NPN) x 6.38], casein protein   [(TN-NCN) x 6.38] and 
whey protein [(NCN-NPN) x 6.38] concentrations were calculated. 
 
3.2.4. Dry matter content 
Weights of deer and cow milk were taken before and after freeze drying of milk. Dried 
weight was calculated as percentage of total milk weight.  
 
3.2.5. In vitro Digestion 
Defatted deer and cow milk samples (20 ml) were prepared in triplicate by rehydrating freeze 
dried defatted milk in 26% and 12% rehydration ratio respectively. In vitro protein digestion 
was performed using pepsin and CPP according to Eriksen et al. (2008). The procedure 
mimics “normal digestion” in the human gastro-intestinal tract. The first incubation, which 
mimics digestion in the stomach, was adjusted to pH 2.5 with 1M HCl, and used pepsin 
(4mg/g milk protein) at 37°C for 30 min. The second incubation used CPP (4 mg/g milk 
protein) at 37°C for 60 min after the pH was adjusted to 7.5 with 1M NaOH. Continuous 
shaking (150 rpm) was maintained during digestion. The digestion of milk protein was 
monitored by measuring pH, the production of amino-terminals by O-phthaldialdehyde 
(OPA) assay andsodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Small samples were drawn for OPA assay (250 µl) and SDS-PAGE (1 ml) every 10 min of 
digestion.     
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3.2.6. ProteolysisAssessment using OPA assay 
The OPA assay followed the method of Church et al. (1983). The OPA reagent contained 2.5 
ml of 20% (w/v) SDS, 25 ml of 100 mM sodium tetraborate, 40 mg OPA (previously 
dissolved in 1 ml methanol), 100 µl of 2-mercaptoethanol and distilled water up to 50 ml. 
Samples were incubated with 0.75 M TCA at a sample:TCA ratio of 1:3 (250 µl: 750 µl) at 
4°C for 30 min and then centrifuged (4000 ×g for 10 min)to eliminate any interference of the 
undigested protein fractions as suggested by Church et al. (1983). A 10 µl aliquot of the 
supernatant was diluted by adding 140 µl H2O, 1 ml of OPA reagent was added and then the 
tube was incubated at room temperature for 2 min. Absorbance at 340 nm was measured 
using UNICAM 8625 UV/VISspectrophotometer. Leucine (Leu) was used for the 
construction of a standard curve and the proteolytic activity was expressed as mM Leu 
equivalent. 
3.2.7. SDS -polyacrylamide gel electrophoresis (SDS-PAGE) 
Electrophoresis was used to analyse the protein samples taken at different hydrolysis times 
during digestion. SDS-PAGE was performed according to a standard protocol (Laemmli, 
1970) using NuPAGE 4-12% Bis-Trisgels. Bio-Rad Precision Plus Protein TM standard was 
used as a molecular weight marker. Samples were diluted to 2 mg /ml protein with 6x sample 
buffer (30 µl)  containing 0.35 M Tris-HCl, 10.28% SDS, 30% glycerol, 0.012% 
bromophenol blue and 5% mercaptoethanol. The volume was adjusted to 180 µl with water 
and the sample was heated at 95°C for 4min. Samples (15 µl) and 10 µl of protein marker 
were loaded into the wells. Electrophoresis was performed at a constant voltage of 200V for 
40 min. Gels were fixed in 50% methanol and 7% acetic acid for 15 min with rocking and 
then washed 3 times for 15 min with water. Gels were stained with Coomassie Brilliant Blue 
(Gel Code Blue) and destained with continuous shaking in water overnight.      
3.2.8. Quantification of protein bands 
The intensities of protein bands in the gels were quantified (Inglingstad et al., 2010) by 
ImageJ software (version 1.42 http://rsbweb.nih.gov/ij/). Gels were scanned using Coral 
Photo Paint 12. Image rectangle was applied for background subtraction, and rolling ball 
radius was fixed to 30 pixels. Bands of interest were marked in each lane to be able to 
investigate the degradation pattern of the different proteins. In order to measure degradation, 
the amount of intact protein remaining in the digested samples was calculated as a percentage 
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of its undigested counterpart. Three gels from each sample were quantified, and the results 
are given as a mean value.  
3.2.9.Statistical analysis 
All experiments were carried out in triplicate and values are mean ± standard deviation. The 
data were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to 
determine the significant differences between samples at P < 0.05 level using Minitab 
statistical software(version 16, Minitab Inc., USA). 
3.3. Results and Discussion  
Milk composition 
The dry matter content and protein composition of deer and cow milk are shown in Table 3.1. 
Dry matter content of deer milk was 25.7% while cow milk has 12.1% dry matter. Hence 
deer milk had more than twice the dry matter of cow milk. Similarly total protein content in 
deer milk is 8.8% which is more than twice that of cow milk (4.1%). In accordance with this 
finding Arman et al.,(1973) showed total protein content of red deer has between 7.1 to 8.6 
%.Total protein is the combination of casein and whey proteins. Deer milk has 8.7% casein 
while cow milk has only 4.0% casein. Both deer and cow milk have very low amounts of 
whey proteins which are 0.64% and 0.57% respectively. Therefore both milks have high 
casein to whey protein ratio. The difference between total proteins detected and sum of casein 
and whey proteinmay be due to experiment error.  
Table 3.1.  Dry matter & protein content of red deer and cow milk 
Milk Type Dry matter (%) Total Protein (%) Casein (%) Whey protein (%) 
Deer Milk 25.7 ± 0.76b 8.8 ± 0.13b 8.7 ± 0.13b 0.64 ± 0.002 
Cow Milk 12.1 ± 0.01a 4.1 ± 0.02a 4.0 ± 0.02a 0.57 ± 0.004 
Values are mean ± standard deviation (n= 3).  
Means within the same column that have different letters (a-b) are statistically different (P < 
0.05) as determined by Tukey’s test. 
 
The milk from ruminants is characterized by high casein: whey protein ratio when compared 
with other groups of mammals (McDougall and Stewart, 1975; Vincenzetti et al, 2008). 
Among ruminants, most domesticated species are bovids and their milk is readily available 
and economically important. Hence our knowledge of the milk proteins of ruminants is 
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mainly confined to bovids, but it would be useful to investigate the milk of other ruminant 
families. The cervids are the largest of these families and appear to have evolved earlier than 
the bovids (Young, 1962). Consistent with data of Arman et al.,  (1974) our results showed 
that deer milk casein and whey contents (Table3.1) had a similar ratio to that found in other 
ruminants.  
In vitro Digestion 
In humans, pepsin digestion and acid hydrolysis at pH of 1.5 – 2.5 are the first steps in the 
gastrointestinal degradation of protein, followed by stomach emptying and further digestion 
in the duodenum by pancreatic enzymes at pH ~ 7. To mimic in vivodigestion the present 
work has used invitrodigestion of defatted deer and cow milk by commercial pepsin and the 
duodenal enzymes trypsin and chymotrypsin. Pepsin is an aspartic protease which prefers to 
cleave peptides at bonds with Phe, Tyr, Trp and Leu in position P1’ (Fujimoto et al., 2004). 
Trypsin cleaves peptide bonds following a positively charged amino acid and chymotrypsin 
cleaves peptides bonds following bulky hydrophobic amino acid residues (Antal et al., 2001). 
Therefore digestion pattern with these enzymes will vary depending on the protein structure 
of cow and deer milks and this could lead to differences in digestibility and digestive 
products with different bioactivity.  
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Figure 3.1.  pH during in vitro digestion of deer ( ) and cow (  ) milk.0 to 30 min 
digestion is simulated stomach. At 30 min pH was adjusted to7.5. 30 to 90 min digestion is 
simulated duodenum. Data are mean ± S.D.  (n = 3). 
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The pH affects the activity of enzymes during in vivo digestion. The pH of stomach increases 
rapidly from 2 (pH of gastric juice) to pH of the diet immediately following the consumption 
of meal and then decreases progressively toward its initial value (Savalle et al., 1989). At the 
beginning of digestion the pH was adjusted to 2.5 with 1 M HCl for the pepsin digestion. The 
pH increase during digestion was greater (Fig 3.1) in cow milk than deer milk which could 
indicate a higher buffering effect of deer milk.  Milk acts as a complex buffer because it 
contains carbon dioxide, protein, phosphate, citrate and a number of minor constituents 
(Ismail et al., 1973). Goat milk has a higher buffering capacity due to its higher content of 
major buffering components including minerals (Park, 1992). Deer milk had 1.1 ± 0.05 % ash 
while cow milk had only 0.70 ± 0.04 % (n = 6). This finding was in accordance with mineral 
composition analysis reported by Arman et al. (1974) which showed a 1.11 % ash content in 
deer milk (average of 6 hinds in mid lactation). Our results showed (investigated further in 
Chapter 6 Fig. 6.2) that deer milk had higher buffering effect than cow milk. This could be 
due to high protein and mineral content and this high buffering quality of deer milk could 
enhance its value for subject suffering from peptic ulcers and other gastric ailments. At 40 
min (10 min into the second stage of digestion) deer milk showed only 0.8 unit pH drop 
whereas the pH of cow milk decreased by 1.3 (Figure 3.1). Again the buffering effect of deer 
milk could contribute to the observed differences. In deer milk, the pH change during the 
start of second stage of digestion was higher than that for the first stage of digestion. It could 
be a result of the higher digestibility of deer protein in simulated duodenum by trypsin and 
chymotrypsin than pepsin. Cow milk caseins were more susceptible to hydrolysis by trypsin 
than camel caseins, whereas camel caseins were more prone to hydrolysis by chymotrypsin 
than cow casein (Salami et al., 2008). To examine the differences in digestibility of deer and 
cow protein, peptide production and protein profile were evaluated using OPA assay and SDS 
– PAGE using quantification by ImageJ software.   
Proteolysis Assessment Using OPA Assay 
In this study, the hydrolysis of milk protein was measured using a rapid, sensitive and simple 
OPA-based spectrophotometric assay (Pescuma et al., 2008; Salami et al., 2008; Salami et 
al., 2009). The peptide production from the in vitro digestion of milk proteins is shown in 
figure 3.2. Deer milk produced more hydrolysed products (peptides and amino acids) than 
cow milk which is consistent with deer milk containing twice the protein available in cow 
milk. However, peptide production was not two times greater than cow milk. This could be 
due to differences in protein structures and hence enzyme target sites in deer and cow milk 
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that may lead to formation of different peptides with different lengths. Kopf-Bolanz et al. 
(2012) demonstrated the formation of different number of peptides with different length 
during in vitro digestion of cow milk.  Therefore the number of N terminals produced by deer 
milk digestion might not be twice that of cow milk digestion.     
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Figure 3.2.  Peptide production during in vitro digestion of deer ( ) and cow (  ) 
milk (up to 30 min: simulated stomach and then simulated duodenum). Peptide production 
was measured using OPA assay after TCA precipitation. Data are mean ± S.D.  (n = 3). 
 
There was a gradual increase of peptide production during digestion with pepsin in the 
simulated stomach for both milks and then a rapid increase in the simulated duodenum. This 
was faster in deer milk than cow milk (Fig3.2). Peptide production of simulated duodenum 
was significantly (P<0.05) higher than simulated stomach for both milks. The analysis of 
hydrolysis of deer and cow milk (Fig 3.2) revealed greater production (P<0.05) of peptides 
from deer milk than cow milk in simulated duodenum. Therefore hydrolytic activity was 
higher in simulated duodenum in deer milk compare to cow milk. After 60min of digestion, 
peptide production had plateaued. No new peptides were produced by extending the reaction 
time. Therefore, for gel band quantification only 30min was used for simulated duodenum 
digestion (stage 2).  
SDS – polyacrylamide gel electrophoresis (SDS – PAGE) 
SDS – polyacrylamidegels (4-12%) were used to analyse the milk proteins and digested 
proteins based on a preliminary study of various concentrations (Appendix A). Inglingstad et 
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al.,(2010) used 12.5 % gel to separate milk protein and digests of cow, goat, horse and human 
milk. The protein patterns on SDS – PAGE (Figs 3.3 and 3.4), illustrated the protein profile 
of red deer (lane D of Fig 3.3) and cow (lane C of Fig 3.4) milk and these milks during 
invitro digestion at 10 min intervals. Protein bands of deer milk were identified based on cow 
proteins (Preliminary studies inAppendix A). The intensity of casein like bands reduced from 
0 min to 30 min in digests of both milks. Deer casein like protein was totally digested after 40 
min of digestion (10 min after second stage of digestion) whereas traces of casein (14%) were 
still present in cow milk (Fig 3.3, 3.4 and 3.5 a). The casein band in cow milk was completely 
digested after 50 min (Fig 3.4 and 3.5a). This result confirms that deer casein like protein was 
digested more rapidly than cow casein. The gel results supported the higher hydrolysis 
activity of deer milk than cow milk in simulated duodenum which was suggested by OPA 
results. About half (49%) of intact major milk protein (casein) started to degrade at the 
beginning of simulated duodenum digestion in deer milk while only about a quarter (27%) of 
intact casein was digested during simulated duodenum in cow milk under the same conditions 
of time, temperature and pH (Fig 3.3 and 3.4, Fig 3.5 a). The major protein components of 
milk, the αs1- and β- caseins, contain covalently attached phosphate groups bound to residues 
of serine and threonine (Medina et al., 1992). The bound phosphate groups influence many 
functional properties of these proteins, including their digestibility, bioavailability of divalent 
cations and immunogenicity (Tezcucano Molina et al., 2007).             
 
M  D  D10  D20    D30 D40 D50  D60  D90 
Figure 3.3.  SDS- PAGE (4-12%) of skimmed deer milk & deer milk digested with pepsin 
and CPP.  Major bands; Immunoglobulins heavy chain (IgHC), lactoferrin (LF), serum 
albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). High molecular 
weight markeris shown on left-hand side of the gel. The lanes are: Protein molecular 
marker(M), Deer milk(D), Digest after10 min (D10), 20 min (D20), 30 min (D30) in 
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simulated stomach digestion and digest after 40 min (D40), 50 min(D50), 60 min(D60), 90 
min(D90)  (simulated duodenum digestion). Each contained had 2 mg/ µl protein. 
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Figure 3.4. SDS- PAGE (4-12%) of skimmed cowmilk & cowmilk digested with pepsin and 
CPP. The wells contain; Immunoglobulins heavy chain (IgNC), lactoferrin (LF), serum 
albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). High molecular 
weight markeris shown on left-hand side of the gel. The lanes are: High molecular 
marker(M), Cow milk(C), Digest after10min (C10), 20min (C20), 30min (C30) in simulated 
stomach and digest after 40min (C40),50min(C50), 60min(C60), 90min(C90) (simulated 
duodenum). Each lane contained 2 mg/ µl protein.     
The specific protein pattern and in particular the physico-chemical and biological properties 
of milk proteins may influence their digestibility (Salami et al., 2008). There is limited 
information on red deer milk proteins. McDougall (1976) reported  amino acid analysis of 
deer milk β-lactoglobulin, adjusted to lysine = 15 residues (the number of residues is given 
relative to 15 residues of lysine) showed that it contains one more residue of aspartic acid, 
alanine and methionine and one less glutamic acid residue and two less leucine residues than 
cow β-lactoglobulin. From this McDougall (1976) concluded there was only a small 
difference in amino acid composition of β-lactoglobulin in deer milk compared to cow milk 
and demonstrated the similarity by gel chromatography and electrophoretic methods. This 
similarity of β-lactoglobulin in the two species could lead to similarities in digestibility of 
this protein in milk. β-lactoglobulin is considered the dominant cow milk allergen and its 
rigid spatial conformation exhibits high resistance to gastric digestion, which in part explain 
its allergenicity (Prioult et al.,  2005).  
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Figure 3.5.In vitro digestion of casein (a), α-lactalbumin (b), immunoglobulin (c)  in raw 
milk from deer ( ) and cow (  ) by pepsin at pH 2.5 / 37°C (1 step of digestion up 
to 30 min) and CPP at pH 7.5 / 37°C (step 2 until 60 min). Values were obtained using 
ImageJ of SDS-PAGE. Data are means ± S.D.  (n = 3). 
 
Our results confirmed that the digestibility of β-lactoglobulin is low in milk from both 
species. After completein vitro digestion 54% and 55% of intact β-lactoglobulin was still 
intact in deer and cow milk respectively.  With respect to digestion of whey proteins, 
Inglingstad et al. (2010) reported that β-lactoglobulin and α-lactalbumin of cow and goat 
were very resistant to human gastric and duodenal enzyme digestion, while horse milk 
showed rapid duodenal degradation of β-lactoglobulin. Cow milk α-lactalbumin possesses 26 
potential chymotrypsin-specific target sites and 13 trypsin-specific target sites in its primary 
structure (Salami et al.,  2008).The digestibility of α-lactalbumin like protein was 
significantly ( P<0.05) higher in deer milk than cow milk after total digestion (Table3.2). At 
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40 min of digestion there was only 14% α-lactalbumin like protein remaining undigested in 
deer milk, where as 62% remained in cow milk (Fig. 3.5b).  Present results are in accordance 
with those of Pintado and Malcata (2000) who also found that cow milk α-lactalbumin was 
resistant to hydrolysis by trypsin. β-lactoglobulin and α-lactalbumin are the major milk 
allergen whey proteins (El-Ghaish et al.,  2011; Wal, 1998). Significantly (P<0.05) lower α-
lactalbumin like proteinconcentration in deer milk digest than cow milk digest (Table 3.2) 
may suggest less allergenic effect of deer milk than cow milk.  
 
Table 3.2.  Protein content (%) remaining in raw milk before digestion (start), after 
stage 1 digested with pepsin at pH 2.5 for 30 min / 37 °C and after stage 2 digested with 
CPP at pH 7.5 for 30 min / 37 °C. Values are obtained from SDS-PAGE using ImageJ 
(n=3) 
    Deer       Cow   
  Start Stage 1 Stage 2  Start Stage 1 Stage 2 
IgHC 100 10 ± 5* 1 ± 2*   100 53 ± 9*  21 ± 5*  
LF 100 25 ± 2  0 ± 1   100 32 ± 4  1 ± 1  
SA 100 11 ± 6*  0 ± 0   100 25 ± 3*  1 ± 1  
CN 100 49 ± 9*  0 ± 0  100 27 ± 3*  1 ± 1  
β-lg 100 94 ± 3 54 ± 5   100 91 ± 4 55 ± 8  
α-la 100 79 ± 8  11 ± 2*    100 82 ± 10  27 ± 5*  
S1 (stage 1) = simulated stomach  SA: serum albumin 
S2 (stage 2) = simulated duodenum  CN: casein  
IgCN:  immunoglobulin heavy chain  β-lg: β-lactoglobulin  
LF: lactoferrin     α-la: α-lactalbumin 
* statistically different between deer & cow (P < 0.05) as determined by Tukey’s test              
 
The other whey proteins such as lactoferrin and serum albumin were highly degraded by the 
gastrointestinal enzymes. In this study, lactoferrin and serum albumin bands disappeared after 
digestion of both milk samples (Fig 3.3 and 3.4). But for serum albumin like protein this was 
significantly faster in deer milk than in cow milk, with only 11% intact serum albumin like 
protein remaining after simulated stomach in deer while cow milk had 25% (Table3.2). Our 
results showed that deer immunoglobulin is more susceptible to digestion by commercial 
enzymes than cow milk. Deer immunoglobulin like protein was almost completely digested 
(1% intact) after simulated stomach and duodenal digestion while 21% of cow milk 
immunoglobulins remained (Fig 3.5c). Many in vitro studies have shown that cow 
immunoglobulins are resistant to proteolysis by digestive enzymes and are not inactivated by 
gastric acid (Korhonen et al., 2000; Hurley &Theil, 2011). 
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The results reveal that less intact protein is present after simulated stomach and duodenal 
digestion of deer milk than cow milk (Table 3.2). The rate of hydrolysis was different 
between proteins and between the two species as shown in Figures 3.3-3.5. Commercial 
proteolytic enzymes degraded milk proteins from deer more rapidly than those from cow. 
This suggests deer milk may also be more digestible in vivo than cow milk.  
 
3.4. Conclusion  
In vitro digestion using commercial proteolytic enzymes has provided new knowledge of deer 
milk protein digestion. Commercial proteolytic enzymes degraded milk proteins from deer 
milk more rapidly than those from cow. Most noticeable was the difference observed in 
casein, α-lactalbumin and immunoglobulin. Deer and cow milk β-lactoglobulins were 
resistant to both gastric digestion (simulated stomach) and simulated duodenal digestion. This 
study provides better knowledge about the digestion of deer milk, compared with cow milk 
and may reveal important issues with regard to the proteins in nutrition. The results obtained 
may be relevant for development of easily digestable products for consumer groups with 
special needs, such as infants, athletes and the elderly. However, as this is an in vitromodel 
system, clinical studies are needed in order to confirm results.   
Deer milk produced more peptides than cow milk after in vitro digestion using commercial 
enzymes. This may mean that deer milk will have more bioactive peptides. The bioactivity of 
the peptides produced is currently under investigation.      
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     Chapter 4 
 
(Paper from part of this work was accepted in Proceedings of the Nutrition Society of New 
Zealand, 2011, Volume 35) (Appendix B) 
Fermentation of Deer and Cow Milk 
4.1. Introduction 
Fermented milk products, in addition to providing energy and nutrients, also have biological 
functions that may improve health upon ingestion. The health benefits of fermented milk 
have been recognized and documented for centuries (Hitchins &McDonough., 1989). 
Empirical observations and scientific demonstrations have concurred, strengthening this 
evidence. The beneficial health effects of fermented dairy products may be the result of 
bacterial metabolites, such as cell wall components (Furushiro et al., 1993), bacteriocins 
(Hernandez et al., 2005) and the hydrolytic action of cell-free extracts containing proteinase / 
peptidase activities on milk protein substrates (Pan et al., 2005). Casein and whey protein 
derived peptides can be released from milk proteins during fermentation by various bacterial 
strains. Moreover, the health benefits of fermented dairy products have been related to the 
living microorganisms contained in the fermented products (Perdigon et al., 1991; Saucier et 
al., 1992).  
Chapter 3results showed that deer milk has 8.8 % protein which is twice as much as in the 
cow milk. This could be a good substrate for proteolytic activity of LAB strains and may 
produce more peptides which might have biological functions beneficial to health. LAB 
utilize the lactose as their first food source producing lactic acid. They then hydrolyse 
protein). The lactose content is not different between these milks.LAB can withstand the 
increased acidity from organic acid production (Kandler, 1983 
The aim of this study was to compare deer and cow milk during fermentation using three 
LAB cultures in terms of peptide production before and after in vitro digestion and to 
compare deer and cow milk protein digestibility. TheLactobacillus delbrueckiisubsp 
bulgaricus and Streptococcus salivarius subsp thermophilus stains used in this study are 
commonly used in commercial yogurt making (Tharmaraj and Shah, 2003) while 
Lactobacillus casei strain Shirota is a probiotic strain (Yuki et al., 1999). 
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 This is the first study to investigate the fermentation of red deer milk followed by in vitro 
digestion. The information from the present work is potentially useful in understanding the 
release of peptides in animal nutrition and to evaluate the potential use of deer milk products 
as functional foods for human.  
 
 
 
4.2. Material & Methods 
4.2.1. Materials 
Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp 
thermophilus (Sst) cultures were the kind gifts from Dr. Michelle McConnell, Department of 
Microbiology and Immunology, Otago University (New Zealand) and  Lactobacillus casei 
strain Shirota (Lcs) was propagated from Yokuth (Australian dairy product).All other 
materials were those stated in 3.2.1. 
 
4.2.2. Milk Fermentatiom 
Cultures (Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp 
thermophilus (Sst) and Lactobacilluscasei strain Shirota (Lcs) were propagated by weekly 
transfers in skimmed cow milk(heated at 850C for 30 min to killed endogenous bacteria and 
enzyme activity (Wang et al., 2009))and stored at 4°C after growing for 17 hr at 37°C in 
closed containers (Matar et al., 1996; Pescuma et al., 2008).  
Deer and cow milk samples (50 ml) were prepared in triplicate by rehydrating freeze dried 
defatted milk in 26% and 12% rehydration ratios, respectively. Samples were heated at 850C 
for 30 min (Wang et al., 2009). Prepared milk samples were inoculated withLactobacillus 
delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and 
Lactobacilluscasei strain Shirota with 2% (vol/vol) inoculums separately and incubated at 
37°C for 24 hr (Matar et al., 1996). Fermentation was carried out under aerobic conditions 
(conical flask closed with aluminium foil) without pH control.A control milk sample without 
any inoculum added to it was maintained in same condition.Lactobacillus delbrueckiisubsp 
bulgaricus and Lactobacillus casei strain Shirota growth was determined by plating serial 
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dilutions on Lactobacilli MRS agar, incubating anaerobically at 37°C for 72 hr in Oxoid jars 
and counting colony-forming units (cfu). Similarly Streptococcus salivarius subsp 
thermophilus were plated in sheep blood agar anaerobically at 37°C for 48 hr. The fermented 
milk solutions were used for in vitro digestion.  
 
4.2.3. In vitro Digestion 
The in vitro protein digestion was performed for unfermented and fermented milk in two 
steps using Pepsin and CPP as described in chapter 3.  
4.2.4 Proteolysis Assessment using OPA assay 
Proteolytic activity was measured after fermentation and after in vitro digestion of 
fermentations as described in chapter 3. TCA precipitation was done prior to OPA assay.  
4.2.5. SDS -polyacrylamide gel electrophoresis (SDS-PAGE) 
The sodium dodecyl sulphate-polyacrylamide gel electrophoresis was performed to 
monitorthe protein degradation of deer and cow milks during fermentation and in vitro 
digestion. SDS-PAGE of unfermented and fermented milk and digest of fermented milk 
samples were done according to a standard protocol (Laemmli, 1970) using NuPAGE 4-12% 
Bis-Trisgels.  
The protein bands in the gels were quantified by ImageJ software (version 1.42) as described 
in chapter 3.2.8.  
 
4.2.6. Statistical analysis 
All experiments were carried out in triplicate and the reported values are mean ± standard 
deviation. The data were subjected to one way analysis of variance (ANOVA), followed by 
Tukey’s test to determine the significant difference between means at P ˂0.05 level using 
Minitab (version 16).   
 
 
 
4.3. Results 
Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus 
were able to grow in both milks at 37°C.Their growth plateaued after 12 hours (Fig. 4.1). 
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There was no growth shown in the control milk sample.In cow milk Streptococcus salivarius 
subsp thermophilus population reached 107 CFU/ml, whereas it was 106 CFU/ml in deer milk. 
The growth of Lactobacillus delbrueckiisubsp bulgaricus was also slightly lower in deer milk 
than cow milk. Lactobacillus caei strain Shirota showed a similar growth pattern in both 
milks (Fig.4.2). Lactobacillus casei strain Shirota grew slower than the other two organisms 
reaching its highest level of 108 CFU/ml level after 24 hours fermentation.   
 
 
Figure 4.1. Growth of Lactobacillus delbrueckiisubspbulgaricus (Ldb), Streptococcus 
salivarius subsp thermophilus (Sst) in deer and cow milk at 37°C for 24 hr. Data are mean of 
three independent fermentations ± S.D.   
 
Figure 4.2. Growth of Lactobacillus casei strain Shirota (Lcs) in deerand cow milk at 37°C 
for 72hr. Data are mean of three independent fermentations ± S.D.   
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The pH of deer milk was 6.1 whereas it was 6.5 for cow milk.  Cow milk fermented by 
Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius 
subspthermophilusshowed a slight pH reduction from the beginning of fermentation and 
started to decrease more rapidly after 6 hr of fermentation (Fig. 4.3 a and b). In deer milk, pH 
declined only after 6 hr of fermentation for those two strains and the pH decrease was less 
than in cow milk fermentation. After 24 hr of fermentation, the pH of cow milk was 
significantly (P ˃ 0.05) lower than deer milk for all 3 stains. The pH fell below 4.6 for cow 
milk at which pH the casein precipitated. Although the deer milk fermentation started at a 
lower pH than cow milk, it did not fall below 4.6 for any of the three LAB fermentations 
(Fig. 4.3). The pH drop for Lactobacillus casei strain Shirota fermentation was observed after 
12hr of fermentation and reached a plateau after 44 hr for both milks whilst pH reached a 
plateau after 17 hr for   Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus 
salivarius subsp thermophilus.  
 
The proteolytic activity of the studied strains was significantly higher (P < 0.05) in deer milk 
than cow milk for Lactobacillus casei strain Shirota and Lactobacillus delbrueckiisubsp 
bulgaricus stains. There was no significant difference (P > 0.05) between deer and cow 
ferments using Streptococcus salivarius subsp thermophilus. The highest production of 
peptides was shown by Lactobacillus casei strain Shirota (Fig. 4.4) after 24 hr of 
fermentation at 37°C. 
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Figure 4.3.  pH drop during fermentation  of deer and cow milk at 37°C with (a) 
Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (b) Streptococcus salivarius subsp 
thermophilus (Sst), (c) Lactobacillus casei strain Shirota (Lcs). Data are means of three 
independent fermentations ± S.D (SD values are too small to view). 
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Figure 4.4. Peptide production measured by OPA assay during fermentation of deer and cow 
milk at 37°C with (a)Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (b) Streptococcus 
salivarius subsp thermophilus (Sst), (c) Lactobacillus casei strain Shirota (Lcs).Data are 
means± S.D.  (n = 3) 
Once ferments were digested in in vitro system, significantly higher (P < 0.05) peptide 
production was observed in deer milk than in cow milk for all 3 stains.  The highest peptide 
production was shown in digests of Lactobacillus casei strain Shirota fermented deer milk 
(Fig 4.5).      
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Figure 4.5.  Peptide production during in vitro digestion of 24hr fermented (Lactobacillus 
delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus 
casei strain Shirota) deer and cow milk - up to 30 min: simulated stomach (step 1) and 30 – 
90 min simulated duodenum (step 2). Peptide production was measured after TCA 
precipitation prior to OPA assay. Data are means of 3.  SD not shown for clarity of graph. 
 
Comparison of peptide production of fermented milk digests with milk digests and fermented 
milk prior to digestion is shown in Figure 4.6.  Digestion (with or without fermentation) 
always produced significantly higher (P < 0.05) peptide levels compared to the level 
produced from fermentation only for all 3 LAB strains in both deer and cow milk. Digests of 
fermented milk always had higher concentrations of peptides than digests of raw milk. This 
was significantly higher for Lactobacillus casei strain Shirota fermented deer milk and 
ferments using all 3 stains in cow milk than the raw milk digestion. This means the 
fermentation process of milk favoured an increase in the peptide production during digestion 
(Fig. 4.6). This was clearer for Lactobacillus casei strain Shirota fermentation than other 
strains and this showed higher level for deer milk than cow milk (Fig 4.6 c). There was no 
significant difference (P > 0.05) in peptide production between the three strains fermentations 
after in vitro digestion for both deer and cow milk.    
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Figure 4.6.  Peptide production after in vitro digestion of raw milk (30min simulated stomach 
+ 30min simulated duodenum) , 24hr fermented milk and fermented digests for deer (  ) and 
cow(  ) milk (a)Lactobacillus delbrueckiisubspbulgaricus (b)Streptococcus salivarius subsp 
thermophilus (c)Lactobacilluscasei strain Shirota) -peptide production was measured after 
TCA precipitation prior to OPA assay. Data are means± S.D.  (n = 3) 
 
 
 
The protein degradation of fermented milk by all 3 strains was monitored by SDS-PAGE and 
compared to unfermented deer and cow milk (Fig. 4.7). After 24 hr of fermentation, casein 
degradation was visible as indicated by the fading (Cf and Df lanes) of the original bands (C 
and D lanes) on the electrophoresis gel (Fig. 4.7). After in vitro digestion, most of the milk 
protein bands completely disappeared and new lower molecular mass bands could be seen on 
the gel (Cfd and Dfd lanes).  
 
 
 
 
 
 
 
 
 
48 
 
 
(a)                                           (b)                                                    (c) 
 
   C   Cf     Cfd                        D    Df   Dfd       C   Cf     Cfd                        D      Df    Dfd           M        C   Cf    Cfd                D    Df   Dfd 
 
Figure 4.7. SDS-PAGE (4-12%) of fermented cow and deer milks by (a)Lactobacillus 
delbrueckiisubsp bulgaricus, (b)Streptococcus salivarius subsp thermophilus and 
(c)Lactobacillus casei strain Shirota at 37°C for 24 hr  and in vitro digestion  (30min 
simulated stomach + 30min simulated duodenum). The lanes are (C) cow milk, (Cf) cow milk 
ferment, (Cfd) cow milk ferment digest, (D) deer milk, (Df) deer milk ferment, (Dfd) deer milk 
ferment digest, (M) high molecular marker.Each contained 2 mg/ µl protein. 
Protein band intensities were quantified using ImageJ software to illustrate degradation of 
protein after fermentation and in vitro digestion of ferment (Table 4.1). All the main proteins 
started to degrade after fermentation for both milk. After 24 hr of fermentation, cow milk had 
significantly higher (P<0.05) intact lactoferrin (LF) than deer milk. LF of cow milk was more 
resistant to fermentation than that of deer milk for all 3 strains. Specifically in the 
Lactobacillus casei strain Shirota ferment LF was still intact in cow milk while only 47% 
remained for deer milk. Digestibility of β-lactoglobulin (β-lg) and α-lactalbumin (α-la) like 
protein of deer milk was improved by fermentation. The results showed 55% intact β-lg and 
11% intact α–la like protein after in vitro digestion of raw deer milk. Fifty one % of β-lg 
remained intact for Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius 
subsp thermophilus fermented digest. At the same time Lactobacillus delbrueckiisubsp 
bulgaricus ferment digest only had 1% intact α –la like protein in deer milk. Digestibility of 
cow α –la also improved after fermentation and showed only 13% intact protein in 
Lactobacillus delbrueckiisubsp bulgaricus ferment digest when it was 27% for unfermented 
milk digest. There was a dramatic difference observed in digestion of immunoglobulin (Igs) 
of cow milk. Intact protein level was 21% after in vitro digestion of unfermented milk and 
decreased to 0 (no intact protein) after in vitro digestion of fermented milk for all 3 strains. 
Intact β-lg in cow milk was higher (68%) inStreptococcus salivarius subsp thermophilus 
ferment digest than unfermented milk digests (58%). These improvements or reductions of 
digestibility of different protein may lead to formation of novel peptides during digestion of 
fermented milk.       
CN 
β-lg 
α-la 
IgHC 
LF 
SA 
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Table 4.1.  Remaining protein content (%) in in vitrodigests of milk;before and after in vitro digestion of Lactobacillus 
delbrueckiisubspbulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) fermented (24 
hr at 37°C) milk (30min simulated stomach + 30min simulated duodenum). Values are obtained by ImageJ. 
        Lactobacillus delbrueckiisubsp bulgaricus Streptococcus salivarius subspthermophilus Lactobacillus caei strain Shirota 
 Milk Digest  Ferment  
Ferment 
Digest  Ferments 
Ferment 
Digest   Ferment  
Ferment 
Digest 
  Deer Cow  Deer Cow Deer Cow   Deer Cow Deer Cow   Deer Cow Deer Cow  
IgHC 1± 2 21±5   71±4 74±3 ND 8±1  73±3 77±3 ND ND  62±1 64±2 ND ND 
LF ND 1±1   42±5 63±4 ND 2±1  48±2 69±5 ND ND  47±3 101±1 1±1 2±1 
SA ND 1±1   62±7 63±6 ND 1±1  70±1 67±6 ND ND  77±1 68±1 ND 1±0 
CN ND 1±1   76±8 82±4 1±0 1±1  85±2 84±1 2±0 2±0  83±2 85±1 ND ND 
β-lg 54±5  55±8   85±2 91±7 51±1 57±4  83±4 78±2 51±1 68±1  87±1 86±1 52±1 57±1 
α -la 11±2  27±5    87±2 90±3 1±1 13±4   85±3 91±2 15±3 23±4   92±2 90±1 8±4 17±1 
Data are means ± S.D. (n=3) 
Not detected (ND) 
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4.4. Discussion  
Lactobacillus delbrueckiisubsp bulgaricus,Streptococcus salivarius subsp thermophilus and 
Lactobacillus casei strain Shirotaare widely used LAB in the dairy industry. Lactobacillus 
delbrueckii subsp. bulgaricus is commonly used alongside Streptococcus salivarius subsp 
thermophilus as a starter for yoghurt making and is also found in other naturally fermented 
products. Lactobacillus casei strain Shirotahas been extensively studied and it is widely 
available as functional food (e.g.Yakult, http://www.yakult.com.au/index.html).  
The lower growth of fermentative organisms in deer milk may suggest some kind of 
inhibitory effect of deer milk. There was a historical use of reindeer milk as a medical 
remedy to heal wound, frostbites and other injuries (Park & Haenlein, 2006). Milk contains 
several antimicrobial compounds, including lactoferrin, lactoperoxidase, and lysozyme, 
which may be involved in protecting against bacterial growth. Milks of different species 
contain different amounts of the various antimicrobial factors (Aimutis, 2004). Cow milk has 
high lactoperoxidase, but low lactoferrin and lysozyme, while human breast milk has high 
lactoferrin and lysozyme, but low lactoperoxidase (Aimutis, 2004). The antibacterial 
properties of milk may be due to synergistic activity of naturally occurring proteins and 
peptides, in addition to peptides generated from inactive protein precursors (Clare & 
Swaisgood, 2000). Minervini et al. (2003) found an antibacterial peptide from hydrolysis of 
human β casein, which had a wide spectrum of antibacterial activity, including activity 
against Gram-positive and Gram-negative species. This peptide (β-CN f184-210) inhibited 
the growth of Lactobacillus delbrueckiisubspbulgaricusB15. However the identity of the 
factors responsible for these low microbial growths is unknown and further studies should be 
done on the antibacterial effect of deer milk. 
Deer milk is slightly more acidic (6.1 pH) than cow milk (6.5 pH).  Differences in pH and 
buffering capacity of fresh milk reflect compositional variation (McCarthy, 2002). After 24 
hr of fermentation, deer milk showed significantly higher (P < 0.05) pH than cow milk for all 
three strains and after fermentation, cow milk pH decreased below the isoelectric point of 
casein resulting in precipitation of casein (Fig. 4.3). LAB growth in milk is low at higher pH 
closer to 7 (Dat et al., 2011) than lower pH. The higher pH during later part of fermentation 
in deer milk than cow milk may be a reason for the low growth in cultures in deer milk 
compared to cow milk during fermentation.  Lower pH drop of deer milk may be due to 
several factors such as low bacterial growth resulting in low lactic acid formation or higher 
buffering capacity of deer milk than cow milk. The ultimate pH of cheese results from the 
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lactic acid produced (from starter culture breaking down lactose) and is moderated by the 
buffering capacity of the milk (Pendey et al., 2003). Buffering action of milk is due to the 
presence of acid buffers (weak acid–conjugate base pairs) and base buffers (weak base–
conjugate acid pairs) (McCarthy, 2002). Milk contains many acidic and alkaline groups that 
result in buffering action over a wide pH range. Principal buffer components in milk are 
soluble phosphate, colloidal calcium phosphate, citrate, bicarbonate, casein, salt and a 
number of minor constituents (Ismail et al., 1973; McCarthy, 2002). Goat milk has high 
buffering capacity due to its high content of major buffering components including minerals 
(Park, 1992). The mineral content of red deer milk is about two times that of cow milk 
(Arman et al., 1974). Also deer milk has twice as much as casein as cow milk (Chapter 3).  
This high casein and mineral content may lead to high buffering quality of deer milk and 
could reduce the pH drop during fermentation compared to cow milk. However, further 
studies should be carried out to confirm the buffering effect of deer milk. 
 Nielsen et al. (2009) reported that the total amount of peptides produced was significantly 
affected by final fermentation pH using 4 species of LAB in cow milk. In that study more 
peptides were produced at a final pH of 4.3 than 4.6. In the present study pH did not affect 
the same way (more peptide from lower pH)since; milks are from two species of animals. In 
this study high pH milk ferment from deer milk yielded more peptides than low pH cow milk 
ferment. Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus caei strain Shirota 
ferment of deer milk produced significantly (P < 0.05) higher peptide concentrations than in 
cow milk ferments. Deer milk fermented with Lactobacillus casei strain Shirota produced 
significantly (P < 0.05) higher peptide levels followed by Lactobacillusdelbrueckiisubsp 
bulgaricus. Gobbetti et al. (2000) showed that during milk fermentation, probiotic strains 
may produce several oligopeptides which generate bioactive peptides only after subsequent 
digestion by pepsin and trypsin. Peptide bonds that are hidden within the native protein 
structure might be exposed by the action of LAB enzymes, thereby allowing the release of 
new peptides. In terms of peptide level there is no significant difference (P < 0.05) between 
three strains for both milk type after in vitro digestion of ferments (Fig. 4.5).  
Bioactive peptides are inactive within the sequence of the parent protein and can be released 
by enzymatic hydrolysis by digestive enzymes and fermentation of milk. In many studies use 
of both fermentation and digestion has proven more effective in generating biofunctional 
peptides than fermentation or digestion alone (Korhonen & Pihlanto, 2007). Both milk 
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digestions (with or without fermentation) produced significantly higher (P < 0.05) peptide 
level than fermentation alone for all three strains.  This proved that more peptides are 
produced by digestion than fermentation. Mata et al., (1996) reported that cow milk 
fermentation by Lactobacillus helveticus resulted in a very low degree of proteolysis. They 
concluded that proteolysis during fermentation enhanced the release of peptides and may lead 
to the formation of novel peptides during gastrointestinal digestion. A large number of studies 
have demonstrated that hydrolysis of milk proteins by digestive enzymes, prominently 
pepsin, trypsin and chymotrypsin, can produce biologically active peptides (Korhonen & 
Pihlanto, 2006). When comparing the digestions with and without fermentation, deer and cow 
milk acted in different ways. In deer milk only Lactobacillus casei strain Shirota produced 
significantly higher (P < 0.05) peptide levels after digestion compared to unfermented digest, 
whereas in cow milk ferment digest for all 3 strains produce significantly higher (P <0.05) 
peptide levels than unfermented digest (Fig. 4.6). In contrast digestion of deer milk produces 
more peptides than cow milk and was further improved by fermentation prior to digestion. 
Highest peptide concentrations were observed in deer milk digest followed by fermentation 
and there were no significant difference between LAB strains.  
Proteolysis is considered to be one of the most important biochemical processes involved in 
the manufacture of many fermented dairy products, irrespective of the contribution of the 
proteolytic/peptidolytic enzymes of LAB to organoleptic properties of the final milk 
products. The ability to produce extracellular proteinases is a very important feature of LAB. 
They catalyse milk proteins, providing the amino acids essential for growth of LAB (Fira et 
al., 2001). Proteolysis by microbial enzymes in yogurt is a desirable process for  improving 
milk digestibility and enhancing the nutritional quality of yogurt. It is accepted that the 
proteolytic system of LAB degrades proteins and hence, changes the texture, the taste and the 
aroma of fermented products (El-Ghaish et al., 2011). In this study, LAB fermentation 
improved the digestibility of β-lg like protein of deer milk more than that of cow milk (Table 
4.1). There was 54% intact β-lg like protein in deer milk digest without fermentation. It 
decreased to 51% in digest of Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus 
salivarius subsp thermophilus deer ferment. β-lg is the main cause of milk allergies causing 
about 80% of all cases in children and infants. β-lg is the major whey protein in milk and 
dairy products and it is of particular interest since it is the only whey protein of cow milk 
absent in human milk (El-Ghaish et al., 2011).  The lower β-lg like protein level in ferment 
digest in deer milk than cow ferment digest may lead to less allergenicity. Kleber et al.(2006) 
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studied the ability of some LAB strains to reduce the antigenicity of β-lg using skim milk and 
sweet whey by indirect competitive ELISA, using polyclonal antibodies. They observed a 
reduction of antigenicity of skim milk by 90% and sweet whey by 70% compared to the 
initial value. α-lactalbumin (α –la) is another whey protein which has lesser extent of 
allergenicity compared to β-lg (Wal, 1998). Intact α –la like protein of deer milk reduced to 
1% in digests of  Lactobacillus delbrueckiisubspbulgaricus ferment and to 8% in 
Lactobacillus casei strain Shirota ferment from 11% intact  α–la of unfermented digest (Table 
4.1).  The digestibility of α–la in cow milk was also improved by fermentation with the above 
two strains. There was always significantly low intact α–la like protein level in deer ferment 
digest than cow ferment digests for all three LAB strains.  Bu et al. (2010) found combined 
strains of LAB reduced the antigenicity of cow skim milk α –la and β-lg. Therefore, our 
results suggest fermented deer milk digest may have less allergenicity than fermented cow 
milk digest. There was a significant improvement of digestibility of cow Igs after 
fermentation by all tested LAB strains (Table 3). Intact Igslevel of cow unfermented digests 
was 21% and this went down to 8% in Lactobacillus delbrueckiisubsp bulgaricus ferment 
digest and 0% with other 2 strains. The milk Igsare relatively resistant to digestive enzymes 
in the gastrointestinal tract but can be sensitive to a group of microbial enzymes (Marnila & 
Korhone, 2011).  
  In this study lactoferrrin (LF) in cow milk was significantly (P < 0.05) more resistant to 
fermentation than that in deer milk for all 3 strains. Lactoferrin is an 80 kDa iron-binding 
glycoprotein of the transferrin family that is expressed in most biological fluids and is a 
major component of the mammalian innate immune system (Gonzalez-Chavez et al., 2009). 
By characterising the various peptides generated by hydrolysis of LF, the antimicrobial 
activity of the peptides that have minimal variations in the amino acid sequence change was 
found. For example, LFampin 268–284 and LFampin 265–284, differ in only three amino 
acids (265Asp-Leu-267Ile) but exhibit different strength of antibacterial activity  (Kraan et 
al., 2006). Therefore different levels of hydrolysis in deer and cow milk fermentation may 
form different peptides with different biological activity. Similar to present cow milk 
fermentation results of Franco et al., (2010) indicated that LF structure does not seem to be 
altered by the activity of commercial (yogurt) LAB bacteria. Hence, their study demonstrated 
that yogurt is an excellent product for supplementation with LF though it should be added 
after milk pasteurization because heat treatment could make LF more susceptible to 
proteolysis by LAB. This work results suggest deer milk will be a better option than cow 
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milk for this purpose. In summary, digestibility of deer milk was higher than cow milk and 
this was further improved by LAB fermentation prior to digestion.        
4.5. Conclusion 
Fermentation prior to digestion increased the production of peptides from and the digestibility 
of major milk proteins from both deer and cow milk. Digestion of fermented deer milk 
produced more peptides than digestion of fermented cow milk. There was no significant 
difference in peptide level produced after digestion among three LAB strains used in this 
experiment.  Digestibility of major milk proteins was higher in deer ferment than cow 
ferment. The study demonstrates unique characteristics of deer milk which may prove useful 
in understanding the potential use in human or animal nutrition and generate new information 
which will help in understanding fawn nutrition.  Immunomodulation activity of deer and 
cow peptides will be examined in the following chapters. 
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Chapter 5 
(Paper was prepared for submission toFood and Bioprocess Technology Journal) 
Immunomodulatory Activity of Fresh and Fermented Red Deer and 
Cow Milks 
 
 
 
5.1. Introduction 
Milk provides essential nutrients during neonatal development and plays an important 
protective role in the development of the immune system of newborns (Inglingstad et al., 
2010). While milk contains components such as immunoglobulin that can modulate the 
immune system, an increasing number of studies suggest that milk proteins, may also contain 
biologically active peptides with immunomodulating properties within their primary 
sequences (Kayser & Meisel 1996; Eriksen et al., 2008; Korhonen, 2009; Phelan et al., 
2009). The concept of developing nutraceuticals based on peptide-enriched fractions from 
milk to target the immune system is attractive and is an area of active research (Bhat & Bhat, 
2011).  
The goal of this study was to investigate the in vitro immunomodulatory activity of 
hydrolysed deer and cow milk protein obtained by in vitro digestion using pepsin and CPP, 
with and without prior fermentation using three LAB strains [Lactobacillus delbrueckii subsp 
bulgaricus (Ldb), Streptococcus salivarius subspthermophilus (Sst) and Lactobacillus casei 
strain Shirota (Lcs)]. The effects of hydrolysates on lymphocyte proliferation and cytokine 
production (IL2 and IFNγ) were determined.  
 
5.2. Material & Methods 
5.2.1. Materials 
Oxytocin was purchased from Pharm Distributors (Auckland, New Zealand). Pepsin from 
porcine stomach mucosa (66 units / mg solid), O-phthaldialdehyde (OPA), Leucine and 
trichloroacetic acid (TCA) were purchased from Sigma (St. Louis, MO, USA) and Corolase 
PP (CPP) (350 proteolyticU/mg) from pig pancreas was from AB Enzymes (Darmstadt, 
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Germany). Corolase PP is a mixture of trypsin, chymotrypsin and several amino- and 
carboxypeptidases.  
Ficoll-Paque PLUS was from GE Healthcare (Sweden) and Concanavalin A (Con A) and 
Trypan blue were from GIBCO (Invitrogen, Grand Island, NY, USA). Complete RPMI 
(RPMI media was developed by Royal Park Memorial Institute) was prepared from; L-
glutamine supplemented RPMI 1640, 9 mL/L non-essential amino acid, 9 mL/L sodium 
pyruvate, 10 mL/L Penstrep (GIBCO, Invitrogen, Grand Island, NY, USA ) and 10% heat 
inactivated foetal calf serum (Bio International, New Zealand ). All cell culture plates were 
sterilized individually packed, flat bottom 96-well cell culture plates from Costar (Corning, 
NY, USA). Bovine serum albumin (BSA) was obtained from Sigma, New Zealand. Human 
IL-2 and Human IFNγ enzyme-link immunosorbent assay (ELISA) Ready-SET-Go kits were 
purchased from eBioscience (USA).    
All incubations of cells were performed at 37°C in a humidified 5% CO2 incubator (Function 
line BB15, BioLab Scientific LTD, Heraeus). 
5.2.2. Collection and Preparation of Milk Samples 
Pooled deer milk was obtained from the Lincoln University Deer Farm (Lincoln, New 
Zealand) as described in previous work (Chapter 3.2.2). Approval for this work was given by 
Lincoln University Animal Ethics Committee (# 377). Pooled cow milk was obtained from 
Lincoln University Dairy Farm. Fat was removed after centrifugation at 4000 ×g for 30 min 
at 4°C. Defatted milk was freeze dried and stored at room temperature in airtight containers 
until analysis. 
5.2.3. Fermentation 
Cultures (Lactobacillus delbrueckii subsp bulgaricus (Ldb), Streptococcus salivarius subsp 
thermophilus (Sst) and Lactobacillus casei strain Shirota (Lcs)  were propagated by weekly 
transfers in skimmed cow milk and stored at 4°C after growing for 17h at 37°Cin closed 
container (as per chapter 4.2.2.)(Matar et al., 1996; Pescuma et al., 2008).      
Deer and cow milk samples (50 ml) were prepared to the original concentration by 
rehydrating freeze dried defatted milk in 26% and 12% rehydration ratio, respectively. 
Samples were heated at 850C for 30 min (Wang et al., 2009). Prepared milk samples were 
inoculated in triplicate with Ldb, Sst or Lcs strains with 2% (vol/vol) inoculums separately 
and incubated at 37°C for 24 hr (Matar et al., 1996). Fermentation was carried out under 
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aerobic conditions without pH control and the resultant ferment was used for in vitro 
digestion.  
 
5.2.4. in vitro Digestion 
Unfermented and fermented deer and cow milk samples (15 ml) were digested in triplicate. In 
vitroprotein digestion was performed using pepsin and CPP according to Eriksen et al. 
(2008). The procedure mimics “normal digestion” in the human gastro intestinal tract. In the 
first incubation, which mimics digestion in the stomach, the sample was adjusted to pH 2.5 
with 1M HCl and incubated with pepsin (~4mg/g milk protein) at 37°C for 30 min. The 
second incubation, mimicking digestion in the small intestine, used CPP (~4 mg/g milk 
protein) at 37°C for 60 min after the pH of the sample was adjusted to 7.5 with 1M NaOH. 
Continuous shaking (150 rpm) was maintained during digestion. The hydolysates were used 
for further analysis. 
5.2.5. BCA Protein Assay 
Protein concentration in each sample was determined using Bicinchoninic acid reagent 
(Pierce, Rockford, Il., USA) according to the manufacturer’s instructions. Samples (10 µl) 
were assayed in triplicate and compared to a standard curve generated using dilutions of 2 
mg/mL Albumin Standard (Pierce, Rockford, Illinois, USA), to provide concentrations 
ranging from 0.0625 mg/ml to 1 mg/ml. Samples were diluted before BCA assay whenever 
needed. 
5.2.6. Isolation of human peripheral blood mononuclear cells (PBMC) 
Human peripheral blood mononuclear cells (PBMC) were isolated from whole blood 
collected from a healthy donor (Lincoln University Human Ethics Committee approval # 
2011-2) using Ficoll-Paque PLUS as per manufacturer’s instructions. The isolated PBMC 
were adjusted to the appropriate cell concentration in complete RPMI.  
5.2.7. In vitro lymphocyte proliferation assay 
Lymphocyte proliferation assays followed the method of De Fries & Mitsuhashi,(1995) and 
Zhi-Jun et al. (1997).Digested fresh and fermented milks were tested for their effects on 
lymphocyte proliferation. The protein concentration of each sample was diluted to 
0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml in complete RPMI. The positive control had no milk 
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proteins while the negative control contained BSA as in Eriksen et al. 2008 which used the 
same condition with human PBMC.   
A 100 µL cell suspension (105 cells/ml) was added to each well in a 96-well cell culture plate.  
10 µL Con A (10 µg/ml) (Eriksen et al. 2008) was added to the wells to stimulate cells. 
Triplicate 100 µl aliquots of each concentration of the milk protein samples were added to 
wells. The plates were incubated at 37°C in a humidified 5% CO2 incubator for 48 hr. Alamar 
Blue (20 µl) (Invitrogen, Camarillo, CA 93012) was added to each well and plates were 
incubated at 37°C and measured after 24 hr. Fluorescence readings were determined at 
wavelengths of 544 nm excitation and 590nm emission using a FLUOstar Omega (BMG 
LABTECH) plate reader. Proliferation was expressed as the percentage increase of 
fluorescence compared to the fluorescence of the positive control.  
 
% Change in proliferation= Sample fluorescence reading – Positive control fluorescence reading x100 
                                                                       Positive control fluorescence reading  
 
The effects of Con A and protein concentration on lymphocyte proliferation were also tested 
using this assay procedure with and without Con A and by using different concentrations of 
protein (10 to 640 µg/ml). Deer and cow milk hydrolysates with and without 
Lactobacillusdelbrueckiisubsp bulgaricus fermentation were tested.  
5.2.8. Cell viability test 
The viability test was carried out according to Eriksen et al. (2008). Aliquots (100 µl) of 
0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml deer and cow milk digestions and ferment digests 
were added to 100 µl lymphocytes (105 cells/ml) in complete RPMI and incubated for up to 4 
days. A 20 µl sample from each incubation was then mixed with 20 µl Trypan blue and 
allowed to stand for 5 min at room temperature. A haemocytometer was used to count living 
(unstained) and dead (stained) cells using a light microscope. Living (viable) cells were 
expressed as a percentage of total cell number.  
5.2.9.  Cytokine production 
Cytokine production by PBMC was stimulated by Con A (Laffineur et al., 1996, Phelan et 
al., 2009). PBMC (105 cells/ml) were supplemented with 10 µg/ml Con A in the presence or 
absence of milk protein hydrolysates and incubated for 24 hr in 96-well plates with final 
volume of 200 µl. The production of IL-2 and IFNγ were assessed using ELISA kits as per 
the manufacturer’s instructions (Burrells et al., 1999).  Absorbance was read at 450 nm 
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wavelength and cytokine concentrations were quantified using the standard curve (IL-2 and 
IFNγ standard solutions in the kit).  
5.2.10. Statistical analysis  
Data were presented as the mean ± standard deviation of three independent experiments with 
triplicate measurements (n = 3). The lymphocyte proliferation and cytokine production data 
were subjected to factorial analysis of variance using GenStat 12.2 (GenStat Release 12.2, 
VSN International Ltd, UK). Animal species (deer and cow), treatment (digests of 
unfermented and fermented with three LAB strains) and protein concentrations (0.125, 0.25 
and 0.5 mg/ml) were used as variable factors and interaction of all factors were tested. 
Significant differences between means were determined by Tukey’s test and the level of 
statistical significance was taken as P < 0.05. Cell viability and production of cytokines with 
and without Con A data were subjected to one way analysis of variance (ANOVA), followed 
by Tukey’s test to determine the significant differences between samples at P < 0.05 level 
using Minitab statistical software (16 version, Minitab Inc., USA). 
 
 
5.3. Results and discussion 
Effect of milk protein samples on in vitro lymphocyte proliferation  
The immunomodulatory activity of in vitro digestions of deer and cow milk and digests of 
these milks after fermentation with three lactic acid bacteria commonly used in fermented 
dairy products was investigated. Previous researchers have revealed both suppressive and 
stimulating effects of cow milk proteins on in vitro lymphocyte proliferation (Cross &Gill, 
2000; Gauthier et al., 2006). The degradation rate of milk protein and production of peptides 
by LAB fermentation and subsequent in vitro digestion of deer and cow milk were previously 
reported (Chapter 4, Opatha Vithana et al., 2011). The aims of the present study were to 
investigate whether these digests exhibited immunomodulatory activity and whether 
differences in such activity exist due to the milk source.    
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Figure 5.1. Percent change of lymphocyte proliferation of 10 µg/ml Con A stimulated human 
PBMC at a) 0.125mg/ml, b) 0.25mg/ml and c) 0.5mg/ml protein level  for in vitro digestions 
of deer  and cow milk, Lactobacillus delbrueckiisubsp bulgaricus (Ldb fer di), Streptococcus 
salivarius subsp thermophilus (Sst fer di), Lactobacillus casei strain Shirota (Lcs fer di) 
fermented milk. BSA (negative control) values for a,b & c were -1.5%, -5.7% & -10.8% 
respectively. Data are means± S.D.  (n = 3) 
٭ Deer significantly higher than cow P<0.01   
٭٭ Deer significantly higher than cow P<0.001   
 
To test the effect on in vitro lymphocyte proliferation, three different concentrations (0.125, 
0.25, 0.5 mg/ml) of milk protein digests were added to cultures of PBMCs which were 
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stimulated with 10 µg/ml Con A. De Fries & Mitsuhashi (1995) has shown use of Con A 
stimulated human PBMC with Almar Blue assay as a reliable method to assess proliferation. 
Results were evaluated as percentage change of proliferation compared to the control without 
milk proteins. Positive values indicate proliferation had increased and negative values 
indicate proliferation had decreased compared to the control. All samples caused significant 
proliferation of lymphocytes (P < 0.05) except for unfermented cow milk digestions at 0.25 
and 0.5 mg/ml protein concentration (Fig. 5.1) and BSA which was the negative control. BSA 
significantly (P < 0.01) suppressed the proliferation at 0.5 mg/ml protein concentration. This 
is in agreement with Eriksen et al., (2008) who showed a suppressive effect for BSA on 
human PBMC proliferation. Also, in agreement with Eriksen et al., (2008), the highest 
proliferation activity was found with 0.125 mg/ml protein concentration and the proliferation 
activity was decreased with an increase in protein concentration (Fig. 5.1). Our results for 
cow milk are consistent with the substantial body of evidence that indicates cow milk 
contains a number of potent immunoregulatory peptides (Cross & Gill, 2000; Gauthier et al, 
2006) while there are no published studies on deer milk immunomodulatory activity.  
Lymphocyte proliferation was higher (P < 0.001) for deer milk protein than cow milk protein 
(Table5.1). At 0.125 mg/ml protein concentration, deer milk digest stimulated the production 
of significantly more lymphocytes (P < 0.01) than cow milk digest (Fig. 5.1). This suggests 
that deer milk protein has higher immunomodulatory activity than cow milk protein at the 
same protein concentration (Figure 5.1a, b and c). Reindeer milk has a long history in 
Mongolian traditional medicine for curing digestive problems and healing wounds (Park 
&Haenlein, 2006). Our findings suggest that the efficacy of deer milk as a medical remedy 
may be the result of the immunomodulatory effects of peptides derived from deer milk 
proteins. This result taken with previous results of a higher protein content of 8.8 %, which is 
twice the level in cow milk (Chapter 3, Opatha Vithana et al., 2012), suggests deer milk 
could be a good source to purify bioactive peptides. 
Fermentation of the milk prior to digestion significantly increased effectiveness (P < 0.001) 
at inducing lymphocyte proliferation than without fermentation (Table5.1) for both deer and 
cow milks. This suggests fermentation prior to digestion increases the release of 
immunomodulatory peptides from both deer and cow milk. There was no significant 
difference (P > 0.05) between digested deer and cow ferments at the lower protein 
concentration (0.125 mg/ml), although there was a significant difference in lymphocyte 
proliferation between deer and cow milk digests without fermentation at the same 
concentration (Fig. 5.1a and Fig. 5.2). Cow milk digests at higher protein concentrations 
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(0.25 and 0.5 mg/mL) did not significantly (P>0.05) enhance the lymphocyte proliferation; 
however once it had been fermented with LAB (specifically with Sst) and digested, there was 
significantly higher (P < 0.05) proliferation with all three concentrations (Fig. 5.1). This 
suggests LAB fermentation of cow milk might generate more immunostimulative peptides 
which counteract the immunosuppressive peptides generated by digestion. The type of 
microorganism seems to be important in the net activity.  
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Figure 5.2. Percent change of lymphocyte proliferation of digest deer ( ) and cow 
(  ) milk at 0.125, 0.25 and 0.5 mg/ml protein concentrations. Data are means± S.D.  (n = 
3) 
٭ Significantly enhance proliferation compared to control (P < 0.001). 
 
The results from the extended protein concentration trial (10 to 640 µg/ml) which was carried 
out in the presence and absence of Con A for digests of unfermented milk and Lactobacillus 
delbrueckii subsp bulgaricus fermented deer and cow milk supported the above conclusion of 
improvement of immunostimulation effect by LAB fermentation (Fig. 5.3). When PBMCs 
were not treated with Con A, there was no significant increase of proliferation by cow milk 
digest. Once cow milk was fermented with Lactobacillus delbrueckiisubsp bulgaricus and 
digested, it showed significantly higher (P< 0.05) proliferation without Con A at 40 and 80 
µg/ml (Fig. 5.3) than unfermented. This evidence of the release of immunostimulatory 
peptides during LAB fermentation of cow milk is in accordance with previous published 
work (Matsuziki, 1998; LeBlanc et al., 2002 and 2004; Vinderola et al., 2007; Korhonen, 
2009). This study represents the first documented evidence that peptides derived from deer 
milk after digestion and LAB fermentation has potentially enhancethe proliferation of 
lymphocytes.    
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Figure 5.3. Percent change of lymphocyte proliferation with ConA (  ) and without 
ConA( ) for different protein concentrations of digested a)Deer and b) Cow.  Data are 
means± S.D.  (n = 3). 
٭Significantly enhance proliferation compared to control (P < 0.05). 
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Figure 5.4. Percent change of lymphocyte proliferation with ConA (  ) and without 
ConA( ) for different protein concentrations of digests of Lactobacillus 
delbrueckiisubsp bulgaricus ferments of a) Deer (DL)and  b) Cow (CL). Data are means± S.D.  (n 
= 3). 
 
٭Significantly enhance proliferation compared to control (P < 0.05). 
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 Fermentation with lactobacillus strains appeared more effective at producing 
immunomodulatory peptides than with streptococcus.  At 0.125 mg/ml protein concentration 
digest of  Lactobacillus casei strain Shirota  ferment, deer milk showed significantly higher 
(P < 0.05) proliferation compared with Streptococcus salivarius subps thermophilus but was 
not significantly (P > 0.05) different from Lactobacillus delbrueckiisubsp bulgaricus 
ferments(Fig. 5.1a).Lactobacillus casei strain Shirota ferment of cow milk produced 
significantly higher lymphocyte proliferation than milk fermented with Streptococcus 
salivarius subsp thermophilus (P< 0.05)and Lactobacillus delbrueckiisubsp bulgaricus (P < 
0.001).   
 
Table 5.1.ANOVA for percent change in lymphocyte proliferation for deer and cow 
unfermented and fermented (Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus 
salivarius subspthermophilus, Lactobacillus casei strain Shirota) milk digests at three protein 
concentrations (0.125 mg/ml, 0.25 mg/ml and 0.5 mg/ml). 
 
Variable d.f. ms F pr 
Species (deer vs cow) 1 3344.84 < 0.001 
Unfermented vs fermented 1 4789.65 < 0.001 
Protein concentration 2 4118.11 < 0.001 
Species x fermentation 1 382 0.034 
Species x protein concentration  2 79.37 0.389 
Fermentation x protein concentration 6 162.34 0.076 
Species x fermentation x protein concentration 6 169.8 0.063 
Values are degrees of freedom (df), mean squares (ms), and significance (F pr) from variance analysis.  
(P < 0.05) significantly different 
 
There was a significant (P < 0.001) inverse effect of protein concentration on proliferation of 
lymphocytes (Table5.1). The highest proliferation was shown at the lowest protein 
concentration (0.125 mg/ml) and gradually decreased with increased protein concentration 
(Fig. 5.1 and 5.2) for all treatments as can be clearly seen in Figure 2 for deer and cow 
unfermented digests. This could be due to cytotoxic effect of milk proteins at high 
concentration (Phelan et al., 2009). The viability test confirmed there was a significant (P < 
0.05) reduction in the viable cell percentage at the highest protein concentration after 72 hr of 
incubation. Phelan et al., (2009) reported exposure to increased concentrations of hydrolysed 
milk protein (0 – 50 %, v/v) resulted in a gradual decline in cell viability by affecting cell 
membrane integrity.    
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In the second trial the effect of protein concentration in presence and absence of Con A was 
considered for unfermented (Fig. 5.3) and Lactobacillus delbrueckiisubsp bulgaricus 
fermented digests (Fig. 5.4) on the proliferation of human PBMC.  The proliferation activity 
with presence of Con A was initially increased with increased concentration of protein and 
reached a maximum between 60 - 120 µg/ml for all unfermented and fermented deer and cow 
digests. Then the proliferation decreased with increased protein concentration. Sizemore et al. 
(1991) studied the effects of cow milk-derived immunomodulatory bioactive peptides YG 
(Tyr-Gly) and YGG (Tyr-Gly-Gly) on Con A induced regulatory T cell activity on cell 
proliferation. They also observed a biphasic effect as YGG stimulated proliferation at low 
concentrations (10-13 – 10-14 mol/l) and inhibited proliferation at higher concentrations. 
Kayser and Meisel (1996) also studied the effect of YGG on human peripheral blood 
lymphocytes previously activated with Con A and estimated cell proliferation by BrdU 
incorporation. The maximum increase in lymphocyte proliferation induced by YGG was 
about 20-30% greater than of the control. In addition, the stimulatory effect of YGG on cell 
proliferation was abolished at higher peptide concentrations (10-4 - 10-5 mol/l). Laffineur et 
al. (1996) showed that unfermented and Lactobacillus helveticus 5089 fermented cow milk 
(at protein concentration of 2.5 to 2500 µg/ml) had higher proliferation response at lower 
protein concentration and this effect was decreased with the increase in protein concentration. 
Digested deer milk at 160 µg/ml protein concentration even without Con A (Fig.5.3.a), which 
is a proliferation stimulant, significantly (P < 0.05) enhanced lymphocyte proliferation. None 
of the protein concentrations of unfermented cow milk digest enhanced the lymphocyte 
proliferation without Con A (P > 0.05).   
As shown in figures 5.1, 5.2 and 5.3, the sensitivity of lymphocyte proliferation to protein 
concentration was significantly greater (P < 0.001) for cow milk than deer milk. When the 
protein concentration increased from 0.125 mg/ml to 0.5 mg/ml, cow milk digests (fermented 
and unfermented) showed a more rapid decline in proliferation than cells treated with deer 
milk digests. Milk digestions are mixtures of peptides which might have both immune 
stimulating and immunosuppressive properties (Gauthier et al., 2006). It could be suggested 
that cow milk digests might have more immunosuppressive peptides than deer milk digests. 
This may leads to have more immunosupresive peptides than immunostimulative peptides in 
cow milk digests when the protein concentration increases. Alternatively deer digest might 
have more immunostimulatory peptides than cow digest. So the net balance of peptides 
appears to be immunostimulatory in digested deer milk.  
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Deer peptides enhanced lymphocyte proliferation even without mitogen and thereby may 
show the same immunostimulating properties in vivo. Immunomodulatory peptides have 
potential application in the maintenance of immune health to protect against infections 
involving bacterial, viral and parasitic infections (Gauthier et al., 2006; Szwajkowska et al., 
2011) and may suppress tumours (Matsuzaki, 1998; Xu et al., 2011). Therefore,it can be 
suggested that there is potential to use deer milk protein for immune health.     
Cell Viability 
A trypan blue viability test was carried out to determine whether the observed effects could 
be due to the protein samples being toxic to the cells. The results of this test are shown in 
Table5.2. Only deer and cow digests at 0.5 mg/mL and cow digest at 0.25 mg/ml appeared to 
decrease the number of viable lymphocytes after 72 hr of incubation (P < 0.05). This could be 
explained by the toxic effect of protein to cells at higher protein concentrations (Phelan et al., 
2009). Jacquot et al. (2010) showed that hydrophobic peptides generated from trypsin and 
chymotrypsin digestion of milk proteins were toxic to murine splenocytes.  On the other 
hand, there was no significant effect on the cell viability for any concentration of both deer 
and cow milk digests during the 48 hr incubation for proliferation or cytokine assays.   
 
Table 5.2.  Proportion of viable cells compares to control sample after up to three days 
incubation with different protein concentrations. Control cells were incubated without milk 
protein samples. 
  
  % Viable cells   
  
Protein 
concentration 
(mg/mL) 
After 24 hr 
incubation 
After 48 hr 
incubation 
After 72 hr 
incubation 
Deer 
digest 0.125 92 ± 1 90 ± 2 88 ± 2 
 
0.250 90 ± 2 88 ± 4 84 ± 1 
 
0.500 90 ± 2 86 ± 2   82 ± 3* 
 
    
Cow digest 0.125 91 ± 1 90 ± 5          85 ± 1 
 
0.250 91 ± 2 89 ± 2  83 ± 1* 
 
0.500 91 ± 1 87 ± 1  80 ± 1* 
 
    
Control 0 89 ± 1 90 ± 2          86 ± 1 
 
*Significantly different compared to control (P < 0.05). Data are means± S.D.  (n = 3) 
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Cytokine production 
To develop a better understanding of the immune response, cytokine production by human 
PBMC treated with milk proteins was investigated (Barth et al., 2000; Phelan et al., 2009). T 
helper -1 (Th1) cells produce IL-2 and IFNγ and TNF-α cytokines resulting in enhanced cell-
mediated or cytotoxic responses, whereas T helper -2 (Th2) cells produce IL-4, IL-6, IL-5 
and IL-10 which generate a humoral or antibody-mediated immune response (Phelan et al., 
2009). 
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Figure 5.5. Interleukin-2 (IL-2) production by human peripheral blood mononuclear cells 
(PBMC) at different protein concentrations of deer (D) and cow (C) milk digestions and 
fermented milk digestions; Lactobacillus delbrueckiisubsp bulgaricus digest of deer (DL) and 
cow (CL), Streptococcus salivarius subsp thermophilus digest of deer (DS) and cow (CS), 
Lactobacillus casei strain Shirota digest of deer (Dsh) and cow (Csh). PBMCs were 
stimulated by Con A. Control cells stimulated by Con A without addition of proteins. 
Detection limit 4 pg/ml. 
٭ Significantly different compared to control P < 0.05   
٭٭ Significantly different compared to control P < 0.001   
٭ 
٭٭  ٭٭  
٭ 
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Figure 5.6. IFNγ production by human peripheral blood mononuclear cells (PBMC) at 
different protein concentration of deer (D) and cow (C) milk digest and fermented milk 
digests; Lactobacillus delbrueckiisubsp bulgaricus digest of deer (DL) and cow (CL), 
Streptococcus salivarius subsp thermophilus digest of deer (DS) and cow (CS), Lactobacillus 
casei strain Shirota digest of deer (Dsh) and cow (Csh). PBMC, were stimulated by Con A. 
Control cells stimulated by Con A without addition of proteins. Detection limit 4 pg/ml. 
 
٭ Significantly different compared to control P<0.05   
٭٭ Significantly different compared to control P<0.001   
 
Production of IL-2 by PBMC (105 cells/mL) supplemented with 10 µg/ml Con A and without 
milk digestion acted as a control and is shown in Figure 5.5. All deer milk digests at 0.125 
mg/ml protein produce significantly (Figure 5.5.) higher IL-2 levels than control. At the same 
time IL-2 production was significantly higher (P < 0.001) with deer milk than cow milk and 
showed significantly higher (P < 0.001) production at lower protein concentration (0.125 
٭ ٭ 
٭ 
٭ 
٭٭  ٭٭  
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mg/ml) than higher protein concentration (Fig. 5.5). Phelan et al., (2009) also reported that 
cow milk protein hydrolysates had generated a Th1 response by enhancing Con A-induced 
IL-2 production and Jacquot et al., (2010) showed three peptides from cow milk protein (β 
lactoglobulin and α lactalbumin) induced cytokine production (including IL-2 (9.9 pg/ml) and 
IFNγ (63.9 to 717.5 pg/ml) ) using murine splenocyte.      
At 0.125 mg/ml protein, digested ferments produced significantly higher (P < 0.05) IL-2 
levels than unfermented milk digest for both deer and cow milk (Fig. 5.5). This is in 
accordance with results of Vinderola et al. (2007), which showed Lactobacillus helveticus 
R389 fermented cow milk regulated immune response by IL-2 production. Galdeano et al., 
(2011) observed that fermented cow milk increased the number of IL-2 producing cells in the 
small intestine of mice.  Digests of deer milk fermented with Lactobacillusdelbrueckiisubsp 
bulgaricus,Lactobacillus casei strain Shirota (P < 0.001) and Streptococcus salivarius subsp 
thermophilus and unfermented milk digest produced significantly higher IL-2 levels than the 
control (P < 0.05).  When comparing the three fermented digests of deer milk, Lactobacillus 
casei strain Shirota produced significantly higher (P < 0.001) IL-2 level than Streptococcus 
salivarius subsp thermophilus, but the IL-2 level was not different (P > 0.05) from ferments 
with Lactobacillusdelbrueckiisubsp bulgaricus. Cow milk fermented with Lactobacillus casei 
strain Shirota produced significantly higher IL-2 levels than Streptococcus salivarius subsp 
thermophilus (P < 0.001). These results showed the same pattern of high IL-2 production at 
0.125 mg/ml protein concentration (Fig.5.5) correspondent with high lymphocyte 
proliferation at the same protein concentration (Fig. 5.1). This is further evidence to support 
the finding that lactobacillus strains were more effective than streptococcus for production of 
immunomodulating peptides as shown earlier by the lymphocyte proliferation results. In vivo 
study of Vinderola et al., (2007) showed mice fed with fermented milk produce more IL-2 
cytokine by increasing IL-2 producing cell numbers.  
Deer milk digests produced significantly higher IFNγ in PBMC (P < 0.001) than cow milk 
digests and production was higher (P< 0.001) at 0.125 mg/ml protein concentration than the 
other two concentrations (Fig. 5.5). Similar to IL-2, deer digest (except Streptococcus 
salivarius subsp thermophilus ferment digest) produced significantly higher (P < 0.05) IFNγ 
levels compared to control.  
At low (0.125mg/ml) protein concentration unfermented deer milk digests significantly 
induced IL-2 and IFNγ production (P<0.05). This was further improved (P < 0.001) by 
fermentation with Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus casei strain 
Shirota prior to digestion (Fig. 5.4 and 5.5). Similarly Mao et al. (2007) reported that Yak 
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milk casein hydrolysate increased Con A induced IL-2 and IFNγ production in spleen cells.  
Our findings clearly indicate that digestion products (fermented or unfermented) act on the 
cytokine network, as illustrated by IFNγ and IL-2. Comparison of IFNγ and IL-2 production 
with the proliferation response of lymphocytes indicated evidence of parallelism. Cytokine 
production (Fig. 5.4 and 5.5) and proliferation response (Fig. 5.1) were maximal at 0.125 
mg/mL protein concentration. There was no significant difference (P > 0.05) compared to 
control at higher concentration of proteins. Similarly using Con A stimulated human PBMC, 
Laffineur et al., (1996) reported Lactobacillus helveticus 5089 fermented cow milk to have 
the highest IFNγ and IL-2 productions at protein concentrations of 19 and 9 µg/ml, 
respectively, and the production of the cytokines was decreased with increasing protein 
concentration.  IFNγ is a typical type 1 helper T cytokine, which enhances immune response. 
Matsuzaki, (1998) showed that Lactobacillus casei strain Shirota had a potent anti-tumour 
effect on transplanTable tumour cells by inducing production of several cytokines including 
IFNγ, resulting in the inhibition of tumour growth. IFNγ production has been considered as a 
key factor for anti-tumour activity of mushroom bioactives (Xu et al., 2011). Blattman et al., 
(2003) reported that the specific interaction of casein hydrolysates with IL-2 might prove 
useful in modulating dysregulated immune responses as well in the treatment of various 
immune processes such as chronic viral infections. Our finding suggests deer milk digests 
and digests of LAB fermentation can enhance Con A stimulated IL-2 and IFNγ secretion, 
which would potentially amplify a lymphocyte (T cell) mediated response and differentiate 
helper T cells into Th1 cells. Therefore, these immunomodulatory deer milk digests 
(unfermented and fermented) could serve as a potential immunotherapeutic agent by 
selectively increasing the pool of activated T lymphocytes.  
 
5.4. Conclusion 
The findings from the present study suggest that deer milk digests exhibit immunomodulatory 
effects on human PBMC cultures and this effect was further improved by LAB fermentation 
prior to digestion. Immunoregulatory activities were measured as the stimulation of 
lymphocyte proliferation and the production of IL-2 and IFNγ cytokines. Fermentation with 
lactobacillus strains was more effective at producing immunomodulatory peptides than with 
streptococcus.  To our knowledge, this is the first report of the immunomodulatory activity of 
unfermented and fermented deer milk digests although there are historical therapeutic uses of 
deer milk.  
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 Deer milk is a good source for purification of bioactive peptides as it has twice the protein 
content of cow milk (Chapter 3, Opatha Vithana et al., 2012) and the immunomodulatory 
activity of deer milk digests were higher than cow digests at the same protein concentration. 
New Zealand has 1.2 million farmed deer which is half of world farmed deer population. 
Their current use is mainly for venison and velvet (DINZ, 2009). Therefore, there is a good 
potential for isolating immunomodulatory peptides from deer milk for pharmaceuticals or 
nutraceuticals. This area requires further in vitro and in vivo research to the durability and 
sustainability of peptides during digestion and their mechanisms of action.  In future work 
deer milk digests will be fractionated to isolate specific immunomodulatory peptides.  
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Chapter 6 
Comparative Study of Deer Milk with Three Other 
Mammalian Milks 
6.1. Introduction 
The chemical composition of the milk of different species is designed by natural selection to 
provide the nutritional needs of the neonate of that species (Park, 2011). Within a given 
species, genetic factors and environment conditions such as climate, diet, number and stage 
of lactation influence the chemical composition (Blasi et al., 2008). Cow milk has been the 
major source of milk and dairy products in developed countries, especially in the Western 
world (Haenlein, 2001), although traditional consumption of milk from other mammals such 
as goat, sheep, reindeer, buffalo, camel and yak is common many parts of the world. 
Information on the milk of some of these species is not readily available, perhaps since the 
milk of these mammals is produced for human consumption only in certain regions of the 
world (Park, 2011). Milk is a good source of minerals, which are essential nutrients for 
human and animals (Osorio et al., 2007). These may be considered as two groups: the major 
elements (Ca, K, Mg and Na) and minor or trace elements (Fe, Cu, Mn and Zn) (Rincon et 
al., 1994). Milk protein mainly consists of caseins which include αs1-, αs2-, β- and κ-casein, 
and whey proteins which include β-lactoglobulin, α-lactalbumin, serum albumin, 
immunoglobulins, lactoferrin and lysozyme (Inglingstad et al., 2010).  
 Milk proteins are natural vehicles for bioactive peptides (Yoav, 2010). There are many 
studies and reviews of cow milk bioactives (Minervini et al., 2003; Gobbetti, 2007; 
Korhonen, 2009 and Picariello et al., 2010) while only a few study milk from different 
species such as sheep and goat (Silva et al., 2006; Papadimitriou et al., 2007; Hernandez-
Ledesma et al., 2011). The aim of this chapter is to compare the composition of deer, cow, 
sheep and goat milk and the immunomodulatory activity of their milk proteins after in vitro 
digestion.  
6.2. Material and Methods 
6.2.1. Materials 
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Deer milk was obtained from the deer farm at Lincoln University (Canterbury, NZ). Fresh 
milk was collected from 6 red deer hinds with an age range from 6 to 11 years. All hinds 
were calved between 7/09/2010 to 26/09/2010. The samples were collected as per chapter 
3.2.2. Fresh sheep milk samples from individual animals (n = 6) were a kind gift from Blue 
River Dairy (Southland, NZ). Fresh cow (n = 10) and goat (n = 6) milks were purchased from 
a local farm (Otago, NZ). 
A silicabased C-18 RP-HPLC column (250 mm length x 4.6 mm i.d., Microsorb MV C-18, 
particle size: 5 µm, pore size: 30 nm), was used for protein separation (Rainin Instruments, 
Woburn, MA). Acetonitrile (Fisher Scientific, Pittsburgh, PA) was of HPLC grade, and Bis-
Tris buffer, dithiothreitol (DTT), guanidine hydrochloride (GdnHCl), sodium citrate, 
trifluoroacetic acid (Sigma, St. Louis, MO) and cow milk protein standards were purchased 
from Sigma (St. Louis, MO).    
Tetramethylammonium Hydroxide (TMAH) 25% solution in water was purchased from 
Sigma-Aldrich, USA. All the milk samples obtained in this research are from mid-lactation 
(except analysis of minerals which used milk through lactation).  Other materials are as listed 
in chapters 3.2.1 and 5.2.1. 
 
6.2.2. Compositional Analysis 
Proximate analysis 
Protein content was measured by methods described in chapter 3.2.3. Milk fat, ash and 
lactose and moisture contents were determined according to standard procedures (AOAC, 
2000) and expressed as % of the sample wet weight. 
 
Quantification of milk protein from Deer, Cow, Goat and Sheep Milk 
Milk proteins were identified using cow milk protein standards as described by Bobe et al. 
(1998). A solution containing 0.1 M Bis-Tris buffer (pH 6.8), 6 M GdnHCl, 5.37 mM sodium 
citrate, and 19.5  mM DTT (pH 7) was added directly to 500 µl milk in a 1:1 ratio (v:v) and 
incubated for 1 hr at room temperature, then centrifuged for 5 min at 16 000g in a 
microcentrifuge. The fat layer was removed with a spatula. The remaining solubilized sample 
was diluted 1:3 (v:v) with a solution containing 4.5 M GdnHCl and solvent A, which 
consisted of acetonitrile, water, and trifluoroacetic acid in a ratio 100:900:1 (v:v:v; pH 2). 
The concentration of milk protein in the final diluted solution was approximately 4 mg/ml. 
75 
 
The standard proteins were prepared as per the manufacturer’s instructions. Milk samples of 
5-80 µl (usually 20 µl) and standard (20-100 µl) were chromotographed by Reversed-Phase 
HPLC (RP-HPLC). Standard curves were developed by measuring the peak areas of various 
known amounts of injected milk protein standards. The standard curves were used to 
calculate the amount of protein represented by peak areas from milk samples of unknown 
composition.  
 
Mineral analysis of Deer, Cow, Goat and Sheep Milk 
Mineral analysis was determined by Inductively Coupled Plasma Optical Emission 
Spectrophotometer (ICP-OES) as per Ribeiro et al. (2003). A 1 ml sample of milk was mixed 
with 1 ml of TMAH and heated for 800C before analysis by ICP-OES (model 720 ICP-OES, 
Varian Australia Pty Ltd, Australia). The sample, in an aerosol form, was introduced into 
high energy plasma that dissociates the sample into atoms and ions which emit 
electromagnetic radiation. The emitted light is spectrally resolved by diffractive optics, and 
the intensity of light is measured with a detector (Nolte, 2003). The instrument allows 
complete wavelength coverage from 167-785 nm with a resolution of 7 pm and all 
wavelengths are captured in one simultaneous reading. The concentration of a specific 
element in a sample is related to the intensity of lines in its optical spectrum.   
 
6.2.3. Determination of Buffering Capacity (BC) of  Deer, Cow, Goat and Sheep 
Milk 
Buffering capacity of milk samples were tested using the procedure of Park (1991). Initial pH 
values of all milk samples were determined. Aliquots (25 ml) of each sample were placed in 
50 ml beakers and titrated slowly with 0.5N hydrochloric acid (HCl) by adding 1 ml each 
time with thorough stirring. The pH was measured after completion of each addition and BC 
was determined mathematically using the buffering capacity (intensity) formula given below 
(Ismail, et al., 1973; Park, 1991). 
dB    =  (ml acid added) (normality of acid) 
dpH        (volume of milk) (pH change)  
 
BC values were plotted against pH (end pH) after each addition of HCl. 
 
6.2.4. In vitro Digestion of  Deer, Cow, Goat and Sheep Milk 
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In vitro protein digestion of milk was performed in two steps using Pepsin and CPP as 
described in chapter 3.2.5. 
 
6.2.5. Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) of  Deer, Cow, Goat and Sheep Milk 
SDS-PAGE was performed for milk before and after digestion to monitor the digestion 
according to a standard protocol (Laemmli, 1970) using NuPAGE 4-12% Bis-Trisgels 
(Chapter 3.2.5.2). Bio-Rad Precision Plus Protein TM standard was used as a molecular weight 
marker.   
6.2.6. Immunomodulatory Activityof  in vitro Digested Deer, Cow, Goat and 
Sheep Milk  
6.2.6.1. In vitroLymphocyte Proliferation Assay 
The effect of milk digests on in vitro lymphocyte proliferation was determined in triplicate 
using PBMC isolated from human blood by the method described in chapter 5.2.6. Three 
different protein concentrations (0.125, 0.25 and 0.5 mg/ml) were tested for each milk digest. 
Proliferation was expressed as percentage increase in fluorescence compared to the 
fluorescence of the control (no added protein).  
 
 
% Change in proliferation = Sample fluorescence reading – Control fluorescence reading   x 100 
                                                                       Control fluorescence reading  
 
6.2.6.2. Cytokine Production 
IL-2 and IFNγ production of PBMC treated with milk digests at three different protein 
concentrations (0.125, 0.25 and 0.5 mg/ml) were determined using ELISA as per chapter 
5.2.4. 
6.2.7. Statistical Analysis 
Data from proximate analysis and protein concentrations were analysed by Minitab 16 using 
one way ANOVA to test for species effect. Significant differences among the means were 
separated using Tukey’s test.  
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Mineral data from all the species were analysed by one way ANOVA followed by t-test. The 
deer mineral data for four different stages of lactation were analysed by canonical variates 
analysis (CVA) (Chope and Terry, 2008). In canonical variates analysis all measured 
variables (all minerals) were considered jointly to investigate differences between four 
milking times. Depending on the dimensionality required, the analysis calculates the linear 
composite (that separates different groups in one dimension) called canonical variates 1 and 
an orthogonal composite (that separate different group in another dimension) called canonical 
variates 2. The analysis generates the percentage of variation due to the linear and orthogonal 
components and latent vectors (called loadings) that indicate the contribution level of each 
variable to the linear and orthogonal components, thus the importance of each variable to the 
overall separation of different stages of lactation.         
Data for buffering capacity were fitted to a general linear model (GLM) using end pH as a 
covariate for linear and quadratic effects and species as a classificatory variable.  
Data for the biological activities were analysed using the REML routine and the significance 
of treatment terms and their interactions were determined by Wald statistical tests. In the 
REML analysis, species and protein concentration were set as fixed factors, whereas 
interaction between species and animals within the same species were set as random factors.  
All the sample analyses were performed in triplicates and statistical analyses were carried out 
using Genstat (GenStat Release 14.1, Lawes Agricultural Trust, VSN Int. Ltd., Rothamsted, 
U.K.). 
 
 
6.3.  Results 
Proximate analysis of Deer, Cow, Goat and Sheep Milk  
The chemical composition of deer milk compared with milk from cow, goat and sheep  is 
shown in Table 6.1. Moisture, dry matter, protein, fat and ash content of deer milk were 
significantly different (P<0.05) from cow and goat milk, while there were no significant 
differences (P>0.05) between cow and goat milk for the above constituents. Deer milk had 
approximately twice the concentration of protein as cow milk. The major protein in deer milk 
was β casein and its content was significantly higher (P<0.05) than cow and goat milk β 
casein content but not significantly different (P>0.05) from sheep milk. κ-casein-like and αs1-
casein-like content of deer milk was significantly lower (P<0.05) than the other three species. 
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Of the whey proteins, deer milk had significantly lower (P<0.05) concentration of α-
lactalbumin-like than all the other species. 
Table 6.1.  Mean of proximate composition for deer (n = 6), cow (n = 10), sheep (n = 6) and 
goat (n = 6) milks and concentration of milk proteins (mg/ml) of deer, cow, sheep and goat 
milks (n = 6 each).  Values are reported as means± standard deviation. 
Species Proximate 
composition Deer Cow Sheep Goat 
Moisture (%) 79.4 ± 1.5b 86.9 ± 0.6a 79.6 ± 0.8b 87.4 ± 1.2a 
Dry matter (%) 20.6 ± 1.5a 13.1 ± 0.6b 20.4 ± 0.8a 12.6 ± 1.2b 
Protein (%) 7.3 ± 0.4a 3.7 ± 0.3b 6.3 ± 0.7a 3.9 ± 0.3b 
Fat (%) 8.1 ± 1.7a 4.7 ± 0.4b 8.1 ± 0.2a 3.8 ± 1.2b 
Lactose (%) 3.9 ± 0.3b 3.9 ± 0.2b 5.0 ± 0.4a 4.1 ± 0.2a 
Ash (%) 1.2 ± 0.1a 0.7 ± 0.1b 0.9 ± 0.1b 0.9 ± 0.1b 
Protein profile 
κ-casein 4.99 ± 0.61c 9.76 ± 0.61b 12.23 ± 0.08a 9.4 ± 0.10b 
αs2-casein 0.76 ± 0.05c 2.56 ± 1.16b 13.3 ± 0.07a 0.74 ± 1.15bc 
αs1-casein 6.92 ± 0.22c 21.24 ± 0.34a 11.9 ± 1.06b 17.35 ± 2.95ab 
β-casein 32.87±1.01b 15.11 ± 0.15d 36.64 ± 0.81a 26.29 ± 1.13c 
α-Lactalbumin 2.13 ± 0.01c 2.99 ± 0.30b 4.02 ± 0.41a 3.49 ± 0.52ab 
β-Lactoglobulin A 8.95 ± 0.91b 8.58 ± 0.09b 10.58 ± 0.05a 9.57 ± 0.37a 
β-Lactoglobulin B 0.83 ± 0.05b 1.15 ± 0.06b 2.53 ± 0.19a Not delected 
β-Lactoglobulin C Not detected 0.60 ± 0.06 Not detected Not detected 
Mix (Ig~s + Serum 
albumin) 7.68 ± 0.20
c
 13.55 ± 0.24b 29.10 ± 0.78a 2.63 + 0.23d 
Lactoferrin 2.60 ± 0.60a 2.33 ± 0.54a 1.94 ± 0.32ab 1.38 ± 0.37b 
Lysozyme Not detected 9.76 ± 0.61b 0.11 ± 0.03b 1.24 ± 0.05a 
a-dValues within each row with different superscripts are significantly different (P < 0.05). 
Mineral composition of Deer, Cow, Goat and Sheep Milk  
Mineral composition of deer, cow, sheep and goat milks is shown in Table 6.2. The 
concentrations of Ca, P and S which are major elements and Zn which is a trace or minor 
element were significantly higher (P < 0.05) in deer milk than any of the other three milk 
types. Deer milk had significantly higher (P < 0.05) Mg level than cow and goat milk but less 
(P < 0.05) than sheep milk. There were no significant differences (P < 0.05) in Fe content 
among deer, cow and goat milk, while sheep milk had a significantly higher (P < 0.05) Fe 
content than milk from the other three species. Goat milk had significantly higher (P < 0.05) 
K, Mn and Cu levels than deer, cow and sheep milk.   
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Table 6.2. Major and minor mineral contents of deer (n=6) of four milking, cow (n=10), sheep (n=6) and goat (n=5) milk. Values are reported 
means± standard deviation. 
Elements Deer (µg/ml) Cow (µg/ml) Sheep (µg/ml) Goat (µg/ml) 
Recovery 
(%) 
Limits of 
detection 
       
Ca 2958a ± 101 1601c ± 180 2427b ±  140 1459c ± 206  98.6 1.62 
P 2219a ± 102 1209c ± 104 1966b ± 86 1343c ± 115 103 0.02 
K 1148b ± 79 1187b ± 85 1009b ± 49 1626a ± 227 105 0.14 
Na 271.6b ± 13 391.6a ±45 366.6a ± 14 277.8b ± 18 97 2.21 
Mg 182.7b ± 11 139c ± 20 229.3a ± 12 156.8b,c ± 22 108.1 0.28 
S 602.3a ± 23 354.9c ± 34 533.8b ± 27 349.5c ± 31  0.19 
Fe 1.23b ± 0.31 1.36b ± 0.71 2.09a ± 0.14 1.58a,b ± 0.23 105.6 0.003 
Mn 0.15b ± 0.023 0.11b ± 0.029 0.19b ± 0.011 0.54a ± 0.244 108.2 0.0003 
As 0.62 ± 0.020 0.60 ± 0.070 0.62 ± 0.06 0.60 ± 0.02 100 0.015 
Cr 0.04a ± 0.003 0.02b ± 0.003 0.04a ± 0.003 0.03b ± 0.002 104.8 0.0002 
Cu 0.11b ± 0.015 0.11b ± 0.04 0.14b ± 0.01 0.22a ± 0.14 104.9 0.003 
Mo 0 0.03a ± 0.01 0 0 106.8 0.0006 
Se 1.11a ± 0.02 1.00b ± 0.07 1.10a,b ± 0.14 1.04a,b ± 0.11 90 0.031 
Zn 12.09a ± 0.78 6.27c ± 0.65 8.39b ± 0.32 5.32c ± 0.65 106.1 0.023 
Al 6.14b ± 0.28 6.65b ± 0.74 8.02a ± 0.37 6.64b ± 0.46 103.6 0.246 
Pb 0.04± 0.03 0.06 ± 0.04 0.08 ± 0.10 0.12 ± 0.02   110 0.005 
Co, Ni and Cd were not detected in any of the milk 
Mo was detected in only one sample of sheep milk and other samples and deer and goat milk were below quantification limit. 
a-cValues within each row with different superscripts are significantly different (P < 0.05). 
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Table 6.3. Mineral composition (µg/ml) of red deer milk (n=6) early, middle and late lactation. Values are reported as means± standard 
deviation. 
Elements  Time 1  (µg/ml) Time 2 (µg/ml)  Time 3 (µg/ml) Time 4 (µg/ml) Recovery (%) Limits of detection(µg/ml) 
Ca 3100 ± 636 2955 ± 1056 2942 ± 338 2833 ± 396 98.6 1.62 
P 2370 ± 389 2182 ± 771 2176 ± 168 2146 ± 273 103 0.02 
K 1205 ± 201 1202 ± 424 1150 ± 80 1036 ± 141 105 0.14 
Na 289.4 ± 33  272.6 ± 100 258.6 ± 20 266.0 ± 32 97 2.21 
Mg 191.8 ± 30  192.4 ± 69 175.7 ± 20 170.9 ± 23 108.1 0.28 
S 621.9 ± 109  577.0 ± 194 587.7 ± 41 622.7 ± 85 - 0.19 
Fe 1.64a ± 0.66 1.32ab ± 0.29 1.06ab ± 0.17 0.921b ± 0.24 105.6 0.003 
Mn 0.176 ± 0.10 0.16 ± 0.04 0.12 ± 0.03 0.13 ± 0.06 108.2 0.0003 
As 0.64 ± 0.08 0.64 ± 0.23 0.60 ± 0.06 0.61 ± 0.11 100 0.015 
Cr 0.05 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 104.8 0.0002 
Cu 0.14 ± 0.05 0.11 ± 0.04 0.11 ± 0.03 0.10 ± 0.03 104.9 0.003 
Se 1.13 ± 0.07 1.10 ± 0.43 1.08 ± 0.08 1.13 ± 0.10 90 0.031 
Zn 13.24 ± 2.09 11.58 ± 3.93 11.64 ± 1.26 11.91 ± 2.09 106.1 0.023 
Al 6.47 ± 0.71 6.26 ± 2.27 6.00 ± 0.20 5.83 ± 0.47 103.6 0.246 
Pb 0.06 ± 0.01 0.03 ± 0.09 0.01± 0.01 0.07 ± 0.03 110 0.005 
Mo, Co, Ni and Cd not detected 
Time 1: 17/12/2010  Time 3: 21/01/2011 
Time 2: 07/01/2011  Time 4: 10/02/2011 
a-bValues within each row with different superscripts are significantly different (P < 0.05). 
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The changes in mineral composition of red deer milk across lactation were studied using four 
collection times and the results are shown in Table 6.3. Only Feshowed significant changes (P < 
0.05) during lactation. There was a steady decline in Fe content with the first date tested 
(17/12/2010) being significantly higher (P<0.05) than that at the end of lactation (10/02/2011). 
Canonical variate analysis is a powerful statistical technique that considers the measured variables 
(the concentrations of 15 minerals) jointly to separate milking (stage 1-4) into groups and illustrate 
the overall differences in mineral composition among the four groups (Fig. 6.1). Canonical variate 1 
reflects the linear component of the analysis and it can be seen that it contributes to the majority of 
segregation between stage (time) of lactation. Canonical variate 2 is the orthogonal component that 
had much more limited contribution to separating the lactation times (Table 6.4.).  Contributions of 
each mineral to the differentiate lactations are shown by loading values (Table 6.4.). K, Mg, Al and 
Fe seem to be the major contributors in differentiating (P<0.05) the milking times based on 
canonical variate 1.             
 
Figure 6.1.  Canonical analysis for 15 minerals at four milking times/stages (time 1: 17/10/2010, 
time 2: 07/01/2011, time 3: 21/01/2011, time 4: 10/02/2011)of 6 red deer hinds.   
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Table 6.4. Canonical variate analysis for the red deer minerals 
Elements   Variate 1 Variate 2  
Percentage variation  79.7 16.94 
Ca  0.205 -0.044 
K  0.409 0.24 
Mg  0.377 0.159 
Na  0.359 -0.193 
Al  0.506 0.017 
Fe  0.64 -0.083 
Mn  0.307 -0.077 
P  0.287 -0.195 
S  0.01 -0.347 
As  0.198 0.052 
Cr  -0.111 -0.417 
Cu  0.341 -0.136 
Pb  0.034 -0.342 
Se  0.047 -0.245 
Zn   0.286 -0.367 
 
The linear component of the analysis is represented by variate 1 and orthogonal component of the analysis is 
represented by variate 2. The value in the Table represented the contribution of variate 1 and variate 2 in the separation 
of the different minerals (percentage variation). The coefficient of mineral content contributes to separation (loadings). 
The loadings are treated as vector, which mean that they indicate a direction and have the same weight regardless of the 
+/- sign. 
 
Buffering Capacity (BC)  of  Deer, Cow, Goat and Sheep Milk  
Initial pHs of deer, cow, goat and sheep milks were 6.51, 6.56, 6.75 and 6.6 respectively. The 
buffering capacity and end pH among the four milks upon titration with 0.05 N HCl are presented in 
figure 6.2. Deer milk had significantly greater (P<0.05) BC than any of the other three milks. BC of 
sheep milk was significantly higher (P<0.05) than that of cow and goat milk. At the beginning of 
titration, buffering index was increased with the decrease of end pH for all four milk types. Then it 
reached a plateau at around pH 4 for cow,goat and sheep milk. Deer milk buffering index continued 
to increase even after the addition of 5 ml 0.5 N HCl.  
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Figure 6.2.  Buffering index (buffering capacity) of cow (n=6), sheep (n=2) and goat (n=5) milks 
compared with deer milk (n=6).  
 
SDS-PAGE of Deer, Cow, Goat and Sheep Milk 
Milk from four different species was digested in vitro and the intact proteins remaining in the 
digested milk samples were analysed by SDS-PAGE (Figure 6.3). The results revealed that the 
casein of all four milks was well digested, while β-lg was still intact. The intensity of β-lg bands of 
deer and cow milk digests were less than those of sheep and goat milk digests.     
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                                             M    D    C    S    G    Dd Cd   Sd  Gd 
Figure 6.3.  SDS- PAGE (4-12%) of Deer, Cow, Sheep and Goat milk before and after digestion 
with pepsin and CPP.  Major bands; immunoglobulins heavy chain (IgHC), lactoferrin (LF), serum 
albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la). Standard molecular 
weight markers are shown on left-hand side of the gel. The lanes: Molecular weight marker (M), 
Deer (D), Cow (C), Sheep (S), Goat (G) milk and in vitro digestion of Deer (Dd), Cow(Cd), 
Sheep(Sd), Goat(Gd) milk.Each contained had 2 mg/ µl protein. 
 
Immunomodulatory Activityof In vitro Digested Deer, Cow, Goat and Sheep Milk 
Lymphocyte proliferation 
Lymphocyte proliferation was significantly different (P<0.05) between species (Table 6.5). Positive 
values show increased proliferation while negative values demonstrate decrease of proliferation 
compared with the positive control. Lymphocyte proliferation was significantly higher at 0.125 
mg/ml protein concentration for deer (P<0.001), cow and sheep (P<0.01) than the control (Fig. 6.4). 
At the same protein concentration (0.125 mg/ml) deer milk digest showed significantly higher 
lymphocyte proliferation compared to cow, sheep (P<0.01) and goat (P<0.001) milk digestswhile 
there were no significant differences (P>0.05) among cow, sheep and goat milk digests.     
 
Table 6.5. ANOVA for % change in lymphocyte proliferation.  
Fixed term Wald statistic n.d.f. F statistic d.d.f. F pr 
Species 10.66 3 3.55 19.0    0.034 
Protein Concentration 60.13 2 30.07 176.0 >0.001 
Species. Protein Concentration 11.62 6 1.94 176.0    0.077 
MW: 
250 kDa 
150  
100 
75 
 
50 
 
37 
 
25 
20 
 
15 
 
10 
 
CN 
IgHC 
LF 
SA 
β-lg 
α-la 
85 
 
Lymphocyte proliferation was significantly different (P<0.001) at different protein concentrations 
(Table 6.5). Proliferation decreased with increasing concentration of protein for all four species 
(Fig. 6.4).          
 
Figure 6.4.Percentage change of lymphocyte proliferation at a) 0.125mg/ml, b) 0.25mg/ml and c) 
0.5mg/ml protein concentration for deer, cow, sheep and goat milk digests.Data are means± S.D.  (n = 
6 for deer, cow, sheep and n = 5 for goat). 
٭ Significantly different from control P<0.01   
٭٭ Significantly different from control P<0.001   
 
 
Cytokineproduction  
IL-2 production (Fig. 6.5) was affected by the type of milk digest from different species (P<0.001) 
and the protein concentration (P<0.001). Digested deer milk produced significantly higher IL-2 
levels than cow, and goat milk at 0.125 mg/ml protein concentration (P<0.05). At this protein 
concentration all milk types showed significantly higher (P<0.001) IL-2 levels than the control. IL-
2 production was reduced with increased protein concentration. IL-2 production was significantly 
lower than control (P<0.001) at 0.5 mg/ml protein concentration, except for lymphocytes treated 
with sheep milk digests.  
IFNγ production (Fig. 6.6) by PBMC was significantly different when treated with milk digests 
from different species and at different protein concentrations (P < 0.001). All samples produced 
significantly higher (P < 0.001) IFNγ levels than control. PBMC incubated with deer milk at 0.125 
mg/ml protein concentration produced significantly higher (P < 0.001) IFNγ levels than those 
treated similarly with cow and sheep milks, while there was no significant difference with goat milk 
(P > 0.05) treatment.        
٭٭ 
٭ 
٭ 
٭ 
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Figure 6.5. Interleukin-2 (IL-2) production by Con A stimulated human peripheral blood 
mononuclear cells (PBMCs).  Production of IL-2 by PBMCs with different protein concentrations 
of deer, cow, sheep (n=6) and goat (n=5) milk in vitro digestion. Control represents cells stimulated 
by Con A without addition of proteins.  Values are the means± S. D. Detection limit 4 pg/ml. 
٭ Significantly different from control P<0.01   
٭٭ Significantly different from control P<0.001   
 
 
 
 
Figure 6.6. IFNγ production by Con A stimulated human peripheral blood mononuclear cells 
(PBMCs).  Production of IFNγ by PBMCs with different protein concentrations of deer, cow, sheep 
(n=6) and goat (n=5) milk in vitro digestion. Control represents cells stimulated by Con A without 
addition of proteins. Detection limit 4 pg/ml. 
٭٭All samples are significantly different compared to control (P<0.001).   
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6.4.  Discussion 
Compositional Analysis 
Milk composition varies according to several factors, such as animal, feed and environment 
(Mackle et al., 1999).  The 20% dry matter content of deer milk was significantly higher (P<0.05) 
than cow and goat milks. Thus deer milk has the highest dry matter content among these four milks.  
Protein & fat which are constituents of milk dry matter and ash, were all significantly higher 
(P<0.05) in deer milk than cow and goat milk. The results for proximate analysis (protein, fat, ash 
and lactose) of cow, goat and sheep milks in this study were in accordance with literature (Raynal-
Ljutovac et al., 2008; Ceballos et al., 2009; End et al., 2009). Deer milk had about two times the 
protein content of cow milk and these results are consistent with our previous results (Chapter 3, 
Opatha Vithana et al., 2010). Similarly deer milk protein of 7.3%  in this study is consistent with 
Arman et al.,  (1974) which showed 7.39% protein in red deer milk using six hinds. There was no 
significant difference (P<0.05) in lactose content among deer, cow and goat milks. Deer milk had 
3.9% lactose in this study versus 5% in sheep milk. It has been reported that sheep milk contains 
4.88% lactose (Raynal-Ljutovac et al., 2008).  
Milk proteins were identified and quantified by HPLC using cow milk protein standards to get a 
general idea of different milk proteins in milk from each species. The β casein-like content of deer 
milk was significantly higher (P>0.05) than cow and goat milk and not significantly different 
(P>0.05) from sheep milk. Cow milk protein is one of the most common food allergen in 
children.Cow milk contains more than 20 proteins (allergens) that can cause allergic reactions (El-
Agamy, 2007). Casein and β-lg are the main allergens in cow milk (Natale et al., 2004) and of the 
caseins, α-s1 is the major allergen (Cocco et al., 2003). Jarvinen et al., (2002) found that five IgE-
binding epitopes (2 on αs1-casein, 1 on αs2-casein, and 2 on κ-casein) were recognized in patients 
with persistent allergy. Goat milk is less allergenic than cow milk and β-casein is the major fraction 
in goat casein, which is similar to human casein, while αs1-casein is the major fraction of cow casein 
(El-Agamy, 2007). The present results showed that the major casein in deer milk is β casein and 
that it is low in αs1-casein, which suggests that deer milk might be less allergenic than cow milk. 
Further studies should be done to investigate the potential use of deer milk proteins as an alternative 
for cow milk for allerginic patients.     
In milk, the casein exists as large colloidal particles, 50-600 nm in diameter called “casein micelles” 
that are composed of four main caseins: αs1-casein, αs2-casein, β-casein and κ-casein (Semo et al., 
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2006). Many of the technologically important properties of milk, e.g. its white colour, stability to 
heat or ethanol, and coagulation by rennet are due to the properties of the casein micelles (Fox 
&Brodkord, 2008). The milk of different species is more or less white due to light scattering for 
which the micelles are mainly responsible (Fox &Brodkord, 2008). Therefore our observation of 
different colour intensity of different species milk (visual observation) might be due to the 
differences of casein micelles based on their compositions. Deer milk was whiter than the milk from 
the other three species.  
κ-casein-likeprotein content of deer milk  was significantly lower (P>0.05) than the other three 
species. The size of casein micelle is inversely related to their κ-casein content (Inglingstad et al., 
2010). This suggests that deer milk may form bigger casein micelles than other species. Most 
importantly the micelles are coagulated in the stomach of the neonate by chymosin, a proteinase 
designed for this function, and coagulation delays the entry of milk into the small intestine, thereby 
improving digestibility (Fox &Brodkord, 2008). Inglingstad et al., (2010) studied the comparative 
in vitro digestion of cow, goat, horse and human milk proteins and found that horse milk casein had 
very rapid gastric digestion compared to the other species. They concluded that lower content of κ-
casein and larger size of casein micelles in horse milk than other species (cow, goat and human) 
may be the reason for the high susceptibility to hydrolysis by gastric enzymes. This suggests deer 
milk which showed low content of κ-casein may form bigger casein micelles than other species and 
ultimately show higher casein digestibility than other species. This requires further research to be 
confirmed.  
β-lactoglobulin-like protein, the major whey protein content of deer milk was not significantly 
different  (P<0.05) to cow milk, when β-lactoglobulin standard of cow milk was used (HPLC), and 
also SDS-PAGE results (Fig 6.3.) β-lactoglobulin band of deer milk can be clearly visualized. 
McDougall and Stewart, (1975) studied red deer whey proteins by chromatographic separation 
(Sephadex G-75 column) using cow milk markers and was able to detect a component which eluted 
similarly to cow β-lactoglobulin. Their results also indicate the concentration of β-lactoglobulin 
changes with lactation time. Although there are similarities of red deer and cow milk β-
lactoglobulin, McDougall and Stewart, (1975) reported that differences in the amino acid 
composition of β-lactoglobulin were found. Deer β-lactoglobulin contained one more residual of 
aspartic acid, alanine and methionine and one less glutamic acid and two less leucine residues than 
cow β-lactoglobulin. Another difference was deer β-lactoglobulin A and B genetic variation were 
more acidic than those of the corresponding cow β-lactoglobulin.  
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Deer milk had the lowest level of α-lactalbumin-like compared to the other three species. β-
lactoglobulin and α-lactalbumin are the major whey protein allergens (El-Ghaish et al.,  2011; Wal, 
1998). Therefore allergenicity caused by whey proteins might be less for deer milk than other milk 
types, but this will need to be confirmed in future work.     
In this study the mineral composition of deer milk was compared with three other milk types which 
are more commonly consumed. The Ca, P and S content of deer milk were higher than cow, goat 
and sheep milk. Minerals play an essential role in human health and wellbeing. It is well known that 
milk and dairy products are good dietary source of Ca and P (Birghila et al., 2008; Ceballos et al., 
2009). There was 2958 µg/ml Ca in deer milk while cow milk had only 1601 µg/ml. These findings 
are in agreement with Arman et al. (1974) who showed 2200 - 2500 µg/g Ca content in deer milk 
and Ceballos et al., (2009) who showed 1135.8 µg/g Ca content in cow milk. Sheep milk had 
second highest Ca content which was 2427 µg/ml. Similar to our findings, Rincon et al., (1994) 
reported sheep milk has significantly (P<0.05) higher Ca level (2056 µg/g) than cow or goat milk.  
Mineral results of cow, goat and sheep were in agreement with studies done by Rincon et al.  
(1994), Wendorff (2006), Birghila et al. (2008), Raynal-Ljutovac et al. (2008) and Haenlein and 
Ceballos et al. (2009). At the same time, red deer milk mineral results of this study generally did 
not vary from those of Arman et al. (1974). 
Zn was significantly (P<0.05) higher in deer milk than other milk types. Zinc is the trace element in 
milk that is present in the largest concentration and found in the milk fat globule. Zn is generally 
considered being a stabilizing agent of biological membranes (Linden et al., 2004). Wiking and 
Sehested, (2008) reported that the transfer of fat from diet to milk might facilitate transfer of Zn 
from diet to milk. This might be the reason that the highest fat containing deer milk has highest Zn 
content and was followed by sheep milk which has second highest Zn and fat contents amongthe 
four studied milk types. Sheep milk had significantly higher (P<0.05) Mg and Fe contents than any 
other species of milk in this study and this was in agreement with Rincon et al. (1994) who showed 
that sheep milk has more Mg and Fe contents than cow or goat milk. The level of Mg in red deer 
milk was consistent with that reported by Arman et al. (1974) and slightly higher than the results 
reported by Vergan et al., (2003). Goat milk had higher K level than deer, cow and sheep milks. 
Goat milk is reported to be distinguished by its high K and Cl contents (Raynal-Ljutovac et al., 
2008). Although mineral composition of milk may be affected by the nutrition of the animals, there 
are certain aspects that are characteristic for each species which enable the mineral composition of 
the milk to be used to identify the species (Rincon et al., 1994; Ceballos et al., 2009). 
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Changes in mineral composition of deer milk during four milking times were studied. Fe 
concentration declined during lactation while all other mineral showed no significant differences 
(P>0.05) over the four milking times. Fe content at first milking was significantly higher (P>0.05) 
than last milking. Feely et al., (1983) showed similar results in human milk where Fe content was 
significantly higher (P<0.05) in early lactation and decreased with lactation time. 
There was no consistent pattern according to which stage of lactation had highest and lowest 
concentration of each element (Table 6.3). However since ANOVA is a unvariable analysis which 
allows comparisons to be made between milking based on a single variate, it does not give an 
insight into how the milking times are grouped or which is the most important element in defining 
group. Canonical variates analysis allows these type of conclusions to be drown, and has previously 
been used in discrimination between ultrafiltered milk permeates (Hansen et al., 2010), to 
differentiate onion cultivars by mineral content (Chope &Terry, 2009) and jointly separated New 
Zealand fish products using five colour parameters (Bekhit et al.,  2009). Canonical variates results 
differentiate the four milking times considering all the minerals as a whole (Fig. 6.3). Among all the 
minerals K, Mg, Al and Fe seem to be major contributors in differentiating (P<0.05) milking times 
based on canonical varitae 1 (Table 6.4).               
Buffering Capacity of Deer, Cow, Goat and Sheep Milk  
The buffering capacity (BC) of milk is an important physico-chemical characteristic that 
corresponds to the ability of the milk product to be acidified or alkalinized. This value depends on 
several compositional factors such as inorganic phosphate, citrate, organic acids, salts and milk 
proteins (Salaun et al., 2005). BC results of this study showed that deer milk had significantly 
higher (P<0.001) BC than that of the milk from the other three species. BC of sheep milk was  
significantly higher (P<0.05) than that of cow and goat milks.There was no significant difference 
(P>0.05) between cow and goat milk BC. Cow and goat milk reached maximum BC between 5.5 – 
4.0 pH after addition of 3 ml HCl while sheep milk showed maximum BC after addition of 4 ml 
HCl (Fig. 6.2.). Deer milk BC was still increasing even after addition of 5 ml HCl (Fig. 6.2.). The 
BC of caseins and whey proteins are maximal at about pH 5.0 –5.5 and pH 3-4, respectively (Salaun 
et al., 2005). High protein and mineral contents in deer milk could be the reason for the higher 
buffering capacity than other milks. Cations (Ca+2, Mg+2) can modify the acid-base equilibrium of 
anions and hence their pKas (negative logarithm of acid dissociation constant) (Salaun et al., 2005). 
Deer milk had high P, Ca, Mg and protein levels which may explain its higherBC. Park (1992) 
showed that goat milk has higher BC than cow milk and his results supported the idea that goat 
91 
 
milk can be utilized in treatment of gastric ulcers. In this experiments deer milk had significantly 
higher (P<0.05) BC than cow, goat and sheep milks (Fig.6.2). Therefore deer milk might be a better 
source for treatment of gastric ulcers. The high BC may be one reason for the historical use of deer 
milk to cure digestive disorders (Park &Haenlein, 2006).       
 
In vitro Digestion 
SDS-PAGE showed that casein of all four species was digested completely after in vitro digestion 
designed to mimic human digestion in the stomach and intestine (Fig. 6.3). These results were 
consistent with the in vitro digestion study of Inglingstad et al. (2010) on cow, goat, horse and 
human milks and Almaas et al. (2006) on cow and goat milks. β-lg of all milk types was not 
completely digested during the  in vitro digestion. The intensity of the β-lg band after in vitro 
digestion was lower in deer and cow milk than sheep and goat milk, which suggests β-lg 
digestibility of deer and cow milk was greater than for sheep and goat β-lg. Inglingstad et al.,  
(2010) reported that cow β-lg was very resistant to in vitro digestion by human gastric and duodenal 
enzymes while horse milk β-lg showed better digestibility than cow and goat milk β-lg. Opatha 
Vithana et al.,  (2012) (Chapter 3) reported there was 54% and 55% intact β-lg after in vitro 
digestion of deer and cow milks, respectively.   
 
In vitro Lymphocyte Proliferation  
All tested milks which had been digested in vitro increased the human lymphocyte proliferation 
(positive value) except sheep milk digest at 0.5 mg/ml protein concentration. At 0.125 mg/ml 
protein concentration lymphocyte proliferation of deer (P<0.001), cow and sheep milks were 
significantly higher (P < 0.01) than the control, while goat milk did not show any significant 
difference of proliferation (Fig. 6.4). Cross and Gill (2000) results revealed both suppressive and 
stimulating effects on in vitro lymphocyte proliferation, by whole cow casein, α-, β-, κ-casein (and 
their derivatives), whole whey protein and lactoferrin. There is sufficient evidence to show digested 
cow milk casein and whey proteins stimulate the lymphocyte proliferation (Cross &Gill, 2000; 
Silva &Malcata, 2004; Gauither et al., 2006; Korhonen, 2009). The proliferation stimulation 
activity may be caused either by whole protein or a specific fraction of protein. Wong et al. (1996) 
showed that cow β-casein significantly enhanced the mitogen-induced proliferation of ovine T and 
B lymphocytes. Mercier et al. (2004) showed that in vitro proliferation of murine spleen 
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lymphocytes is stimulated by micro filtered cow whey protein isolates (hydrolysed and 
unhydrolysed). The immunomodulating potential of peptide fractions isolated from cow β-lg 
enzymatic hydrolyzates has also been demonstrated (Prioult et al., 2004). Likewise, peptides 
corresponding to cow β-lg fragments f(15–20), f(55–60), f(84–91), f(92–105), f(139–148), and 
f(142–148) have been reported to stimulate murine splenocytes proliferation through the 
modulation of cytokine secretion (Jacquote et al., 2010). This can suggest immunostimulation 
property shown by deer milk digestions in this study may not limited to one protein but majority of 
effect may be due to β-casein, since it is the most abundant protein in deer milk.       
There was a significant difference (P<0.05) among milks from the four different species in terms of 
lymphocyte proliferation (Table 6.4). At 0.125mg/ml protein concentration deer milk digest showed 
significantly higher lymphocyte proliferation compared to cow, sheep (P<0.01) and goat (P<0.001) 
milks while there are no significant differences (P>0.05) among cow, sheep and goat milk (Fig. 
6.4.). While there is sufficient evidence to show cow milk digest stimulate the lymphocyte 
proliferation as shown before, very little work has compared the activity to milk from other species. 
This is the first reported study on lymphocyte proliferation of deer milk. A few studies have 
reported the release of immunostimulating peptides from sheep and goat milk proteins (Hernandez-
Ledesma et al., 2011). Peptic hydrolyzates of sheep α-la and β-lg has been demonstrated by El-
Zahar et al. (2004) to inhibit the growth of Escherichia coli HB101, Bacillus subtilis Cip5262 and 
Staphylococcus aureus 9973 in a dose dependent manner, but the peptides responsible for this 
activity were not identified. Also Haza et al. (1995) reported immunological characterization of 
goat casein by an indirect ELISA procedure. 
The results presented in this chapter confirm those reported in chapter 5 which showed higher 
lymphocyte proliferation of deer digests than cow digests. Goat milk digestion stimulated the least 
lymphocyte proliferation. This could be due to low level of immunstimulating peptides or more 
immunosuppressive peptides in goat milk digests than digests of other species since milk protein 
hydrolysatesare a mixture of immunostimulating and immunosuppressive peptides.Both inhibition 
and stimulation of the immune system could be useful (Cross and Gill, 2000; Gauthier et al., 2006). 
Suppressive effect of lymphocyte proliferation might be of great importance when ensuring a state 
of tolerance toward non-self-substances such as food molecules entering the body (Eriksen et al., 
2008). By enhancing the proliferation of immune cells, the body may be defended more quickly 
from infection (Meisel and Bockelmann, 1999; Gauthier et al., 2006; Szwajkowska et al., 2011) and 
suppress tumour growth (Matsuzaki, 1998; Xu et al., 2011). Different milk protein derived 
immunomodulating peptides somehow exhibit a regulatory effect on each other to avoid an 
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unfavourable activation or suppression of the neonatal immune system (Cross and Gill, 2000). Both 
immunostimulating and immunosuppressive peptides of cow α1-casein have been observed (Gill et 
al., 2000). On the other hand, goat milk (which has α1-casein as main protein) is considered to be 
less allergenic than cow milk (Eriksen et al., 2008). Results of this study show goat milk protein did 
not stimulate (P>0.05) human PBMC at any tested concentrations and exhibited significantly lower 
(P<0.001) lymphocyte proliferation at 0.125 mg/ml protein concentration than the other three 
species (Fig. 6.3). This could be due to low allergenic protein in goat milk compare to other species. 
Further studies should be carried out to explore the mechanisms that regulate these effects.  
Protein concentration had a significant (P<0.001) effect on proliferation (Table 6.3). At the lowest 
protein concentration (0.125 mg/ml) all milk protein samples showed higher proliferation than at 
0.25 mg/ml and 0.5 mg/ml protein concentration (Fig. 6.4). The results in chapter 5 showed 
concentration effect on deer and cow milk digest (10 – 360 µg/ml protein) and showed lymphocyte 
proliferation increased with increasing protein concentration at first phase and then started to 
decrease with the increase in protein concentration. Similar to that all milk digests from four species 
showed higher proliferation at lower concentration (0.125 mg/ml) and the proliferation activity 
decreased with the increase in protein concentration. This may due to toxic effect of protein to cells 
at high concentrations (Phelan et al., 2009). Similar results of lymphocyte proliferation effect with 
different concentration was shown by Sizemore et al. (1991), and Kayser and Meisel (1996) using 
immunomodulatory di- and tri-peptides. Jacquote et al. (2010) studied seven immunomodulatory 
peptides, namely β-lg f15–20 VAGTWY, f55–60 EILLQK, f84–91 IDALNENK, f92–105 
VLVLDTDYKKYLLF, f139–148 ALKALPMHIR, f142–148 ALPMHIR and α-la f10–16 
RELKDLK, and found they stimulated cell proliferation to varying degrees depending on their 
concentration. Some peptides showed decreased lymphocyte proliferation (murine splenocyte) with 
increased peptide concentration (10 – 2000 µg/ml) as in the current study. Sheep milk protein at 0.5 
mg/ml showed inhibition of Con A stimulation of PBMC (Fig. 6.4) which could be due to a toxic 
effect. 
 
Cytokine Production 
The present study demonstrated potential immunomodulatory effects of peptides (encrypted in the 
milk protein) from milk of four species. Cytokines are involved in the regulation of many biological 
systems, including the immune system (Friberg et al., 1994). IL-2, IFNγ and TNF-α are T helper-1 
(Th1) related cytokines and IL-4, IL-6, IL-5 and IL-10 are T helper -2 (Th2) related cytokines 
(Phelan et al., 2009; Jacquote et al., 2010). At low protein concentration (0.125mg/ml) deer milk 
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peptides treated PBMCs produced significantly higher IL-2 level than cow and goat peptides 
(P<0.05). Similarly IFNγ levels were significantly higher for deer milk digest than other milk 
digestions except for lymphocytes treated with goat milk digest which showed no significant 
difference to deer milk digest at same protein concentration. Jacquote et al., (2010) showed that 
cow peptide (β-lg fragment 139–148) exhibited high lymphocyte proliferation of Con A stimulated 
murine splenocyte and also showed significantly higher (P<0.01) IFNγ secretion (63.9 to 717.5 pg / 
ml) compared to control. The authors reported another immunomodulatory peptide (β-lg fragments 
55–60) with higher lymphocyte proliferation and IL-2 production compared to control. The present 
study showed deer milk digests at 0.125 mg/ml protein concentration exhibit higher lymphocyte 
proliferation and higher IL-2 and IFNγ production compared to control.  
Cytokine expression is a complex mechanism and several cytokines could be responsible for the 
proliferation response and it could be by increased or decreased level of cytokines (Laffineur et al., 
1996). Laffineur et al. (1996) showed the stimulation of proliferation was modulated by more 
cytokines other than IL-2 and IFNγ. Cytokines such as IFNα or IL-12 can stimulate IFNγ 
production by natural killer (NK) cells and lymphocytes (Chan et al., 1991). In general IL-2 induces 
proliferation and differentiation of T and B cells (Belardelli and Ferrantini, 2002). But in this study 
at high protein concentration (0.5 mg/ml) sheep milk digest with less proliferation than the control 
value exhibited better production of IL-2, which is unusual compared to other results. IL-2 
stimulates the growth of NK cells and enhances the cytolytic function of these cells, producing 
lymphokine-activated killer cells (Belardelli &Ferrantini, 2002). Therefore it may suggest that there 
might be a cytotoxic effect of sheep digest at the higher concentration and result incell death. In 
accordance with our results,a similar effect was shown by Laffineur et al.(1996) for cow β casein 
fermented by lactic acid bacteria.          
 
There are cow milk derived immunomodulatory peptides which stimulate lymphocyte proliferations 
and at the same time reduce the secretion of IL-4 and IL-2 cytokines (Jacquote et al., 2010). PBMC 
of children with cow milk protein allergy produce significantly higher IL-10 (P<0.001) and 
significantly lower TNFα (P<0.05) levels with goat milk protein than cow milk proteins. Although 
there are many cytokines responsible for immunomodulation, in this study the digested deer milk 
significantly increased the production of IL-2 and IFNγ by human PBMC. The specific interaction 
of cow casein hydrolysates with IL-2 might prove useful in modulating in vivo immune response 
and treatment of chronic viral infections (Blattman et al., 2003). Therefore, there might be a 
potential for use of deer milk casein to treat chronic viral infection as well. Further investigation 
should be carried out to see in vivo immune responses on deer milk. Cow milk proteins can cause 
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immunological problems for human, such as allergy (El-Agamy, 2007). Mechanism of allergic 
reactions to milk protein fall into two categories which are IgE mediated allergy and non IgE 
mediated allergy (Crittenden &Bennett, 2005). A pathway of IgE regulation is essentially based on 
reciprocal activities of IL-4 and IFNγ (Ebner et al., 1997). In this study deer milk protein at 
0.125mg/ml induced lymphocytes to produced significantly (P<0.001) higher IFNγ levels than cow 
milk which contain more than 20 allergen proteins (EL-Agamy, 2007) and was not significantly 
different (P>0.05) from goat which is less allergenic than cow milk (Alvarez and Lombardero, 
2002; Muraro et al., 2002). Human T cells produced more IFNγ after immunotherapy with bee 
venom for grass pollen allergy (Jutel et al., 1995). This can suggest high level of IFNγ could exhibit 
less allergenic reactions and thereby deer milk might be a good alternative for cow milk 
allergicsubjects. But further in vivo studies with animal models should be carried out before coming 
to any conclusion.  
 
 
6.5. Conclusions 
The results of this study revealed that red deer milk is a good source of protein, fat and minerals 
(especially Ca, P, Zn and Se) compared with cow, sheep and goat milk. The higher buffering 
capacity of deer milk than that of milk from the other three species suggests deer milk may be 
useful to treat patient with gastric ulcers. Deer milk proteins were digested well during simulated 
stomach and duodenum digestion and these hydrolysed products (peptides) exhibited greater 
immunostimulating properties compared to cow, sheep and goat milks in terms of proliferation and 
IL-2 and IFNγ cytokines production by Con A stimulated human PBMC in vitro.   
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Chapter 7 
Fractionation of Immunomodulatory Bioactive Peptides of deer 
and Cow Milk Ferments and Digests 
7.1. Introduction 
One of the primary functions of milk is to protect the health of new born mammal (Korhonen 
&Pihlanto, 2006; Szwajkowska et al., 2011). Bioactive peptides including immunomodulatory 
peptides are encrypted in milk proteins and can be released by food processing or gastrointestinal 
digestion (LeBlanc et al., 2002). Thus the ingestion of milk and its subsequent digestion releases 
bioactive peptides from the milk proteins throughout the course of digestion. A spectrum of 
opportunities has been created by the formation of bioactive peptides through lactic fermentation 
(Szwajkowska et al., 2011). The immunomodulatory action of peptides is related to the stimulation 
of proliferation of human lymphocytes and phagocytic activity of macrophages (Clare et al., 2003).  
Generally, three strategies are used to identify and characterize biologically active peptides: (i) 
isolation from in vitro enzymatic digestion of precursor protein; (ii) isolation from in vivo 
gastrointestinal digestion of precursor protein; (iii) chemically synthesised peptides which have a 
structure identical to that of those known to be biologically active (Meisel, 2001; Minervini et al., 
2003). Fast protein liquid chromatography (FPLC), a technique developed for the purification of 
protein in their native state, has become an increasingly useful tool in the dairy sector and reversed 
phase chromatography is used for peptide separation (Gonzalez-Llano et al., 1990). 
Jolles et al., (1981) were the first to report that extracts of trypsin hydrolysed human milk possess 
immunostimulating activity. In particular, the hexapetide Val-Glu-Pro-Ile-Pro-Tyr, corresponding 
to f54-59 of human milk β casein, was isolated from its tryptic hydrolysate (Parker et al., 1984). 
Several other immunomodulatory peptides were later isolated, namely f63-68 and f191-193 from 
cow milk β casein and f194-199 from cow milk αs1 casein (Parker et al., 1984; Migliore-Samour & 
Jolles, 1988) and others from cow whey proteins (Prioult et al.,  2004; Gauthier et al.,  2006). Most 
of the studies isolating bioactive peptides have used  cow milk protein as a precursor (Gobbetti et 
al., 2002), and only a few have used milk from different species such as goat and sheep (Minervini 
et al., 2003; Silva et al., 2006; Papadimitriou et al., 2007; Hernandez-Ledesma et al., 2011). 
Chapter 5 showed whole deer milk was more immunostimulatory (increased human lymphocyte 
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proliferation and IL-2 and IFNγ production) than cow milk after in vitro digestion. LAB 
fermentation of deer and cow milk prior to in vitro digestion further improved the 
immunostimulating activity.  
The goal of this study was to fractionate deer and cow milk in vitro digestions (unfermented and 
fermented) by FPLC and test their immunomodulatory activity by Con A stimulated human PBMC 
proliferation. Then the most active immunostimulating and immunosuppressive fractions were 
selected for further studies by human lymphocyte proliferation and IL-2 and IFNγ production after 
adjusting the protein concentration to 0.125 mg/ml. Finally one immunostimulating fraction was 
tested for lymphocyte proliferation at different protein concentrations with and without Con A 
stimulation.  
 
7.2. Material and Methods 
7.2.1. Materials 
Deer and cow skimmed milk digestions were prepared as described in chapter 3.2.5 and digestions 
of Lactobacillusdelbrueckiisubsp bulgaricus,Streptococcus salivarius subsp thermophilus and 
Lactobacillus casei strain Shirota fermented deer and cow milks were as described in chapter 4.2.3 
(three independent unfermented and fermented digests from each). 
ResourceTM RPC 1 ml (ResourceTM reverse phase column, GE Healthcare, Sweden) was purchased 
from GE Healthcare Bio-Science AB, Sweden. Trifluoroacetic acid (TFA) and acetonitrile were 
purchased from Sigma (St. Louis, MO, USA).  
BCA protein assay (bicinchoninic acid assay) kit was from ThermoScience, USA.   
 
7.2.2. Fractionation of Peptides by FPLC 
Peptides were separated from deer and cow milk (unfermented and fermented) in vitro digests by 
reverse phase FPLC (RP-FPLC) (Biorad) as per Minervini et al. (2003). The absorbance of the 
eluate was monitored with a UV detector operating at 280 nm and also the absorbance of fractions 
was measured at 220 nm using a FLUOstar Omega (BMG LABTECH) plate reader.    
Aliquots (500 µl) of the digests were diluted 1: 4 with 0.05 % (vol/vol) TFA (buffer A) and 
centrifuged at 12,000 xg for 10 min, and 1 ml of the supernatant was loaded into the column. 
Elution was carried at a flow rate of 1 ml/min with a gradient of acetonitrile (5 to 100 %) in 0.05 % 
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TFA (buffer B). The concentration of acetonitrile was increased linearly from 5 to 46 % between 16 
and 62 ml and from 46 to 100 % between 62 and 72 ml. A total of 51 fractions (2 ml each) were 
collected and were assayed for immunoactivity using the lymphocyte proliferation assay. Then 
selected active fractions were freeze dried and protein concentrations were adjusted to 0.125 µg/ml 
by dissolving in water. A lymphocyte proliferation assay was carried out and the cytokine 
production was measured with human PBMC.  
7.2.3. In vitro Lymphocyte Proliferation Assay 
PBMCs were isolated from human blood and in vitro lymphocyte proliferation assay was carried 
out as in chapter 5.2.3 for FPLC fractions. Proliferation of each fraction was expressed as 
percentage increase of fluorescence compared to the fluorescence of the control (no added proteins).  
% Change in proliferation = Sample fluorescence reading – Control fluorescence reading   x 100 
                                                                       Control fluorescence reading  
 
7.2.4. Cytokine Production 
IL-2 and IFNγ production by PBMC after 24 hr incubation with selected FPLC fractions were 
measuredas described in section 5.2.5. 
7.2.5. BCA Protein Assay 
Protein concentration in each sample was determined using Bicinchoninic Acid reagent (Pierce, 
Rockford, Il., USA) according to manufactures instructions. 10 µl samples were assayed in 
triplicate and compared to a standard curve generated using dilutions of 2 mg/ml albumin Standard 
(Pierce, Rockford, Illinois, USA), to provide concentrations ranging from 0.0625 mg/ml to 1 
mg/ml. Samples were diluted before BCA assay where necessary.  
7.2. 6. Statistical Analysis 
Data are the means and standard deviations of three independent experiments in triplicate. The data 
were subjected to factorial analysis of variance (factors were deer and cow, unfermented and 
fermented and different protein concentrations), followed by t-test to determine the significant 
difference between means using GenStat 14.1. The level of statistical significance was taken as P < 
0.05.  
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7.3. Results 
Prior to fractionation by RP-FPLC, unfermented and LAB fermented deer milk in vitro digests  
showed significantly higher lymphocyte proliferation and cytokine production compared to cow 
unfermented and fermented digest (chapter 5).  
 Deer and cow digestions (unfermented and fermented) were separated using Reverse Phase-FPLC 
based on their hydrophobicity. The absorbance at 220 nm of the fractions is shown in Fig. 7.1. The 
absorbance profiles from deer milk digests were different to the corresponding cow digests peaks. 
The Con A stimulated lymphocyte proliferation caused by fractions of unfermented and fermented 
(three species of LAB) deer and cow milk digests is also shown in Fig. 7.1. Positive values 
indicated an increase in proliferation compared to controls, while negative values indicated 
decreased proliferation. Deer milk digests had more immunostimulating fractions than cow digests.  
All digests contained fractions with a considerable lymphocyte proliferation activity, which did not 
necessarily correspond to large absorbance peak area. Three fractions with the highest lymphocyte 
proliferation for most digests (11, 22 and 30) and three fractions which showed suppressive 
lymphocyte proliferation (13, 24 and 36) were selected for further studies.  The protein 
concentrations of these fractions were adjusted to 0.125 mg/ml.  
 
Immunostimulating fractions    
 The proliferation response of human PBMC (ConA stimulated) for positive fractions 11, 22 and 30 
for unfermented and fermented deer and cow digests is shown in Fig 7.2. All three peptide fractions 
from all the digests (unfermented and fermented) significantly stimulated (P < 0.001) lymphocyte 
proliferation compared to the control.  
There was significantly higher (P < 0.001) lymphocyte proliferation for all three fractions from 
unfermented deer milk than unfermented cow milk (Fig. 7.2 A, B, C). Fractions 11 and 30 of 
Lactobacillus casei strain Shirota ferment digests (Fig. 7.2 A and C), and fraction 11 of 
Streptococcus salivarius subsp thermophilus ferment digests (Fig. 7.2 A) exhibited significantly 
higher (P < 0.05) lymphocyte proliferation for deer than cow. However no fractions from the 
Lactobacillus delbrueckiisubsp bulgaricus ferment digests showed significant differences (P > 0.05) 
between deer and cow. 
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Figure 7.1. RP-FPLC chromatograms of the unfermented and fermented deer and cow milk after in 
vitro digest.Deer milk digests (A); cow milk digests (B); digests of Lactobacillus delbrueckiisubsp 
bulgaricus ferment of deer (C) and cow (D); digests of Streptococcus salivarius subsp thermophilus 
ferment deer (E) and cow (F); digests of Lactobacillus casei strain Shirota ferment of deer (G) and 
cow (H).  The dashed line refers to the % change of lymphocyte proliferation compared to positive 
control. Data are means of individual samples measured in triplicates, SD not shown for clarity of 
graph.  
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Fermentation with Lactobacillusdelbrueckiisubsp bulgaricus had no significant effect (P>0.05) on 
lymphocyte proliferation for any of the three fractions (11, 22 and 30) of either deer and cow, while 
fermentation with the other two strains significantly lowered (P<0.05) lymphocyte proliferation by 
deer and cow digests except for Streptococcus salivarius subsp thermophilus deer fractions11 and 
30 and cow 22 and Lactobacillus casei strain Shirota deer fraction 11 (Fig. 7.2.). There was no 
significant difference (P>0.05) between fractions (11, 22 and 30) in terms of proliferation.    
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Figure 7.2. Percentage (%) change in lymphocyte proliferation in 10 µg/ml Con A stimulated 
human PBMC (compared to positive control) of FPLC fraction 11 (A), 22 (B) and 30 (C) of 
unfermented and fermented deer (   ) and cow (   ) milk in vitro digests at 0.125mg/ml protein 
concentration . Fractions from deer and cow milk digests and digests of Lactobacillus 
delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp thermophilus (Sst)and  
Lactobacillus casei strain Shirota (Lcs) ferment. Data are means± S.D. (n = 3). Samples measured 
in triplicates.  
٭ Deer significantly different than cow P<0.05   
٭٭ Deer significantly different than cow P<0.001   
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The cytokine production by human PBMC, a metabolic event that preceded cell proliferation 
(Hopkins, 2003) was investigated to determine the mechanism of the immunomodulatory activity of 
the selected peptide fractions. All three selected fractions (11, 22 and 30) from all digests 
(unfermented and fermented) which showed high proliferation, exhibited significantly higher 
(P<0.01) IL-2 production by human PBMC compared to the control (Fig. 7.3). At the same time all 
three fractions (11, 22 and 30)  from both deer and cow produced significantly higher (P<0.05) 
IFNγ level when incubated with human PBMC except for fraction 22 of cow unfermented digest, 
Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus digests 
and fraction 30 of unfermented cow digest (Fig. 7.4).  
As shown in figure 7.3, human PBMC with fraction 11 of unfermented deer digest produced 
significantly higher (P<0.01) IL-2 level than with the same fraction of cow digest. Similarly IFNγ 
production by human PBMC was significantly higher (P<0.05) with all three (11, 22 and 30) deer 
fractions (except for fraction 11 of Streptococcus salivarius subsp thermophilus and fraction22 of 
Lactobacillus casei strain Shirota) than with same fractions from cow digests (Fig. 7.4).  
There was no significant difference (P>0.05) between fractions (11, 22 and 30) in terms of IL-2 
production while fractions 11 and 30 showed significantly higher (P<0.001) IFNγ production than 
fraction 22.  
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Figure 7.3. Interleukin-2 (IL-2) production by human peripheral blood mononuclear cells (PBMC) 
stimulated by Con A treated with FPLC fraction (after 24 hr) 11 (A), 22 (B) and 30 (C) of 
unfermented and fermented deer (   ) and cow (   ) milk in vitro digests (0.125mg/ml protein). 
Fractions from deer and cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus 
(Ldb), Streptococcus salivarius subsp thermophilus (Sst)and  Lactobacillus casei strain Shirota 
(Lcs) ferment. Control cells were stimulated by Con A without the addition of proteins. Data are 
means ± S.D. (n = 3). Samples measured in triplicates. Detection limit 4 pg/ml. 
٭ Deer significantly different than cow P<0.01   
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Figure 7.4. IFNγ production by human peripheral blood mononuclear cells (PBMC) stimulated by 
Con A treated with FPLC fraction (after 24 hr) 11 (A), 22 (B) and 30 (C) of unfermented and 
fermented deer (   ) and cow (   ) milk in vitro digests (0.125mg/ml protein).Fractions from deer and 
cow milk digests and digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus 
salivarius subsp thermophilus (Sst)and Lactobacillus casei strain Shirota (Lcs) ferment. Control 
cells were stimulated by Con A without the addition of proteins. Data are means ± S.D. (n = 3). 
Samples measured in triplicates. Detection limit 4 pg/ml. 
٭ Deer significantly different than cow P<0.05   
٭٭ Deer significantly different than cow P<0.001   
 
Another experiment was carried out using fraction 30 of unfermented deer digest to investigate the 
proliferation behaviour of human PBMC with and without Con A and to test a wider range of 
immunostimulating peptide concentrations (10 to 640 µg/ml). The same experiment was carried out 
with whole deer digests in chapter 5.  Fraction 30 was selected for further study because there were 
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no significant differences (P>0.05) between tested immunostimulating fractions of deer digests (11, 
22 and 30) on lymphocyte proliferation, and it had more protein (peptide) than the other two 
fractions (Fig. 7.1).  The proliferation response of human PBMC with different concentrations of 
peptides with and without Con A stimulation is shown in Figure 7.5.  All peptide concentrations 
with or without Con A, stimulation significantly induced (P<0.05) lymphocyte proliferation.  In the 
absence of Con A there was no significant difference (P>0.05) between different peptide 
concentrations. When the cells were stimulated with ConA the proliferation was higher at 20 to 80 
µg/ml protein concentration range than at other concentrations.              
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Figure 7.5. % change of lymphocyte proliferation with ConA ( )and without ConA(  ) 
for different protein concentrations of deer milk digests FPLC fraction 30. Data are means± S.D.  (n 
= 3). 
Different letters within each curve are significantly different (P < 0.05). 
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Immunosuppressing fractions  
Although deer and cow milk digests (unfermented and fermented) as a whole exhibited 
immunostimulating properties (Chapter 5), there were some immunosuppressing fractions (Fig. 
7.1).  Three fractions (13, 24 and 36) which suppressed proliferation in common for all deer and 
cow digests (fermented and unfermented) were further studied after adjusting the protein (peptides) 
concentration to 0.125 mg/ml. Table 7.1 summarises the statistical results from the lymphocyte 
proliferation. There was no overall significant difference (P>0.05) between deer and cow milk but 
they behaved differently (interaction) in different fractions (P<0.001). In fraction 13 all cow digests 
gave lower lymphocyte proliferation than corresponding deer fractions, while fraction 36 was 
higher for deer. At the same time there was no significant difference (P>0.05) for human PBMC 
proliferation by fermented digests compared to unfermented digests. There were significant 
differences (P<0.001) between fractions with fraction 24 inhibiting proliferation significantly more 
(P<0.001) than fraction 13 and 36.        
 
Table 7.1. ANOVA analysis for % change of lymphocyte proliferation (compared to positive 
control) for FPLC fractions 13, 24 and 36 of unfermented and fermented deer and cow milk digests 
at 0.125 mg/ml protein concentration. 
Source of variance d.f. s.s m.s. F Sig. 
Animals (deer and cow) 1 74.8 74.8 0.55 0.46 
Unfermented Vs Fermented 1 107.5 107.5 0.79 0.376 
Fractions (13, 24, 36) 2 9176.9 4588.5 33.6 <0.001 
Animal. Unfermented Vs Fermented 1 23.6 23.6 0.17 0.678 
Animal. Fractions 2 20523.8 10261.9 75.14 <0.001 
 
Fractions 13, 24 and 36 of both deer and cow digests (both unfermented and fermented) produced 
significantly less (P<0.05) IL-2 with human PBMC compared to the control. Fraction 24 results are 
shown in figure 7.6 (A). There was no significant difference (P>0.05) between deer and cow in 
terms of IL-2 production for fraction 24 and it is same for the other fractions too (Appendix C). 
Similarly there was no significant difference (P>0.05) between deer and cow in fraction 24 for IFNγ 
production by human PBMC (Fig 7.6 (B). 
In these negative proliferation fractions (13, 24 and 36) IL-2 and IFNγ production by human PBMC 
were less than control for both deer and cow digests (Fig. 7.6) while positive proliferation fractions 
(11, 22 and 30) produce higher IL-2 and IFNγ than control (Fig. 7.3 &  7.4).    
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Figure 7.6. IL-2 (A) and IFNγ (B) production by human peripheral blood mononuclear cells 
(PBMC) stimulated by Con A with FPLC fraction 24  of unfermented and fermented deer (   ) and 
cow (   ) milk in vitro digests (0.125mg/ml protein). Fractions from deer and cow milk digests and 
digests of Lactobacillus delbrueckiisubsp bulgaricus (Ldb), Streptococcus salivarius subsp 
thermophilus (Sst)and Lactobacilluscasei strain Shirota (Lcs) ferment. Control cells were 
stimulated by Con A without the addition of proteins. Data are means ± S.D. (n = 3). Samples 
measured in triplicates. Detection limit 4 pg/ml. 
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7.4. Discussion  
After in vitro digestion unfermented and fermented deer milk showed more immunomodulatory 
activity than cow milk (Chapter 5). These digests are a mixture of peptides originating from the 
different milk proteins. In order to investigate this further, these digests were separated into 
fractions.The fractions with the greatest immunomodulating effects were identified. As a general 
rule, the immunomodulatory effects of individual milk components become more clearly defined as 
they are progressively purified from the primary milk protein (Cross & Gill, 2000).  
RP-FPLC was used in this study to generate fifty one peptide fractions for each sample. Fast protein 
liquid chromatography (FPLC), a technique developed for the purification of protein and peptides in 
their native state, has become an increasingly useful tool in the dairy sector (Gonzalez-Liano et al., 
1990).  Absorbance detections were done at 280 nm (Appendix D) and 220 nm (Fig. 7.1.). 
Separation was not clearly seen from 280 nm absorbance readings as this depends on the content of 
tyrosine, tryptophan (aromatic ring) and cysteine (disulphide bond) (Pace et al., 1995). Amarowicz 
and Shahidi et al. (1997) reported that protein absorbance reading at 220 nm measured the peptide 
bond and therefore 220 nm reading was used in this study. At 280 nm absorbance reading one 
fraction had very high reading while other had very low readings. High branched-chain amino acid 
to aromatic amino acid ratio (Fischer’s ratio) is important to get good absorbance reading at 280 nm 
(Pederoche et al., 2004). The 280 nm measurement suggests that most of the fractions have peptides 
with less aromatic ring containing amino acids which could be due to smaller peptides (few amino 
acids) than big peptide chains (where the chance of having aromatic ring is high).  
As shown in figure 7.1 some high absorbance (peak) fractions did not produce big proliferation 
differences (stimulating or inhibiting), while some fractions exhibited the highest proliferation 
changes but showed very low absorbance readings (no big peak). This suggests some peptides 
present in small quantities contribute to the activity and may have very high immunomodulating 
activities.     
The lymphocyte proliferation activities of each fraction were shown in figure 7.1 for all digests. 
Some fractions stimulated lymphocyte proliferation while others inhibited proliferation activities. 
Fractions with a considerable lymphocyte proliferation activity did not necessarily correspond to 
peaks with higher absorbance (220 nm). Similarly Minervini et al. (2003) reported large peaks of 
RP-FPLC fractions of hydrolysed casein from six species (cow, goat, sheep, buffalo, pig and 
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human) did not necessarily have high ACE inhibitory activity, while fractions with small quantities 
of peptides had high ACE inhibitory activity. LeBlanc et al. (2002) showed an HPLC fraction with 
lower protein exhibited higher immunomodulating effect than two fractions which had very high 
protein content (as shown by high absorbance at 214 nm). There were more fractions exhibiting 
lymphocyte proliferation activity in deer than cow milk, while cow milk digests had more 
lymphocyte inhibitory fractions than deer milk digests (Fig. 7.1.).  
Immunostimulating fractions  
All three selected fractions (proliferation stimulating) from deer and cow milk digests (unfermented 
and fermented) showed significant (P<0.001) lymphocyte proliferation (Fig. 7.2.) of Con A 
stimulated human PBMC in vitro. Tested immunostimulating unfermented and fermented deer 
digests fractions showed significantly higher lymphocyte proliferation than cow digests 
(unfermented and fermented).  There is now a substantial body of evidence to suggest cow milk 
hydrolysates as a whole (Laffineur et al., 1996; Vinderola et al., 2006; Eriksen et al., 2008; Phelan 
et al., 2009), as well as purified individual constituents (Berthou et al., 1987; Zucht et al., 1995; 
Kayser & Meisel, 1996) or fractions (Cross and Gill, 2000; LeBlance et al., 2004; Prioult et al., 
2004), can regulate immune function. Otani et al. (1995) demonstrated different FPLC fractions of 
in vitro digests of cow κ-caseinoglycopeptide possess different immunomodulatory capabilities. 
Yun et al. (1996) isolated a sub fraction from cow κ-caseinoglycopeptide by size-exclusion 
chromatography which promotes proliferation of murine spleen cells. Therefore findings of cow 
digests immunostimulating fractions in this study are in accordance with the above studies. To our 
knowledge, this study is the first to fractionate the deer milk digests (unfermented and fermented) 
and investigate the lymphocyte proliferation activity on human PBMC.  
There was a significant difference of proliferation (P<0.05) between unfermented and 
Streptococcus salivarius subspthermophilusand Lactobacillus casei strain Shirota fermented digests 
of all three fractions (except Streptococcus salivarius subspthermophilusdeer fractions 11 and 30 
and cow 22 and Lactobacillus casei strain Shirota deer fractions 11) for both deer and cow (Fig. 
7.2.) Although ferment digests showed higher Con A stimulated lymphocyte proliferation than 
unfermented digests (chapter 5) as a whole, some purified fermented fractions showed lower 
lymphocyte proliferation than the same fraction of unfermented digests. This could be due to 
formation of different peptides after fermentation. There is evidence that immunomodulatory 
activity was different in purified fractions compared to original milk products (Otani et al., 1993; 
Wong et al., 1997;Cross &Gill, 1999).  
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One immunostimulating fraction (fraction 30) of deer (unfermented) was selected to investigate its 
proliferation response with and without Con A.   
RP-FPLC fraction 30 of unfermented deer digests showed stimulation of human PBMC with or 
without Con A (Fig.7.6). Con A is a mitogen that induces cell proliferation (Moller et al., 1986; 
Boilard et al.,  2001; Zhang et al.,  2002). A similar study by Saint-Sauveur et al. (2008) using 
fractions isolated (RP-HPLC) from cow whey digests showed enhanced proliferation of both Con A 
stimulated and un stimulated splenocytes. Proliferation was significantly higher (P<0.05) at 20 – 80 
µg/ml protein concentration than other concentrations for Con A stimulated PBMC, while there 
were no proliferation difference (P>0.05) observed between different protein concentrations for 
PBMC without Con A stimulation. Since our present results showed that fraction (30) stimulates 
human PBMC in vitro even without Con A.This may be due to peptides (or a peptide) present in 
this fraction which are responsible for cell proliferation. Therefore we can suggest the same 
immunostimuating effect may be exhibitedin vivoin the absence of mitogen.  
Stimulation of cytokine production on human PBMC was detected using the ELISA method 
(Burrells et al., 1999; Phelan et al., 2009) as a second measure of immunomodulatory activity. Both 
IL-2 and IFNγ productions by Con A stimulated human PBMC were increased together with all 
three fractions of deer and cow digests (unfermented and fermented). Cytokines are involved in the 
regulation of many biological systems including the immune system (Friberg et al., 1994). Cytokine 
IL-2 and IFNγ are produced by T helper-1 (Th1) cells and are responsible for enhancing cell 
mediated or cytotoxic immune response (together with cytokine TNFα which is produced by Th1) 
(Phelan et al., 2009). This suggests increased level of IL-2 and IFNγ cytokine produced by PBMC 
with peptide fractions, may be due to changes in immune response. Already there are some studies 
showing cow milk has peptides which modulate immune response via cytokine regulation 
(Laffineur et al., 1996; LeBlance et al., 2004; Prioult et al., 2004; Vinderola et al., 2006). Prioult et 
al. (2004) reported an acidic peptide fraction of cow β lactoglobulin exhibited increased 
lymphocyte proliferation and increased IFNγ production in mouse splenocytes.     
 
When comparing the IL-2 cytokine production there was no difference observed between 
unfermented and LAB fermented milk digests (for both deer and cow) (Fig. 7.3.).  But there were 
some differences for IFNγ production as shown in Fig. 7.4. Deer milk fermented with 
Lactobacillusdelbrueckiisubsp bulgaricus (except fraction 30)and Lactobacillus casei strain Shirota 
ferment digests fractions showed significantly greater (P<0.05) IFNγ production than unfermented 
fractions (Fig. 7.4).  Similarly all cow LAB ferment fractions showed significantly greater (P<0.05) 
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IFNγ production than the corresponding unfermented fractions (except fraction 22 of 
Lactobacillusdelbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus). 
Consistent with our findings Laffineure et al. (1996) reported LAB fermentation of cow milk 
significantly improved the IFNγ productionwhile no significant improvement can be observed in 
IL-2 levels. 
The stimulation of proliferation response (Fig. 7.2) of fractions has been associated with 
significantly higher level of IL-2 (Fig. 7.3), the major growth factor activated lymphocyte (Morgan 
et al.,  1976; Laffineur et al.,  1996; Ceyhan et al.,  2004) and IFNγ (Laffineur et al.,  1996; 
Meixner et al.,  2004) (except fraction 22 of cow unfermented digests, Lactobacillus 
delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp thermophilus digests and fraction 
30 of unfermented cow digests) compared to control (Fig. 7.4). This contrasting result of IFNγ in 
some fractions suggests the intervention of cytokines other than IL-2 and IFNγ in lymphocyte 
proliferation. Cytokines such as IL-12 (Meixner et al., 2004; Heinzel et al., 1993), IL-4 (Ebner et 
al., 1997; Meixner et al., 2004; Jacquot et al., 2010) and IL-10 (Ceyhan et al., 2004; Meixner et al., 
2004; Jacquot et al., 2010) can regulate cell proliferation.    
 
Immunosuppressing fractions  
The immunomodulatory potential of peptides can be either enhancement (immunostimualtion) or 
suppression (immunosuppression) of immune system (Cross and Gill, 2000; Gauthier et al., 2006). 
The main focus of thisstudy was on immunostimulating peptides (since deer milk digestions 
showed immunostmulating effect as a whole (chapter 5), but to examine the presence of both 
immunostimualtion and immunosuppression type of peptides, three fractions, which suppressed 
lymphocyte proliferation for all milk digests (unfermented and fermented) were further studied after 
adjusting the protein concentration to 0.125 mg/ml.  
Although deer showed significantly higher proliferation than cow in immunostimulating peptide 
fractions (11, 22 and 30), there was no significant difference (P>0.05) between deer and cow for 
proliferation suppression fractions (Table 7.1). The presence of proliferation suppressive peptides 
has been reported in cow milk digests (Prioult et al., 2004; Eriksen et al., Cross &Gill, 2000) which 
explains the proliferation suppressive fractions of cow digestions in present study. Also LAB 
fermentation did not significantly affect (P>0.05) proliferation for these fractions from both deer 
and cow milk compare to unfermented milk (Table 7.1). Similarly Laffieur et al. (1996) reported 
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eight strains of LAB (out of 10 stains tested) did not have significant proliferation effect compared 
to unfermented milk.  
Similar to lymphocyte proliferation response there were no significant difference (P>0.05) between 
deer and cow in cytokine production (IL-2 and IFNγ) by human PBMC.  
The proliferation and cytokine production results of immunostimulating and immunosuppressive 
peptide fractions suggest it is more worthy to study immunostimulating peptides of deer milk than 
cow milk, since deer milk digest as a whole (Chapter 5, fig.5.1) showed immunostimulating effect 
than cow milk digest.  
 
7.5. Conclusion 
Both deer and cow digests (unfermented and fermented) had immunostimmulating and 
immunosuppressive peptide fractions, but deer digest had more proliferation stimulation fractions 
than cow digest. Selected high immunostimulating deer digests (unfermented and fermented) FPLC 
fractions (11, 22 and 30) showed higher lymphocyte proliferation and higher cytokine IL-2 and  
IFNγ production compared to corresponding fractions of cow digests when incubated in vitro with 
Con A stimulated human PBMC. Immunostimulating fraction 30 of unfermented deer digests was 
able to stimulate the human PBMC even without Con A. The findings of this research suggest that 
deer milk digests (and LAB ferment digests) have more immunostimulating activity than cow 
digests. Further investigation should be carried out to identify the specific peptide or peptide which 
is responsible for immune activity.         
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Chapter 8 
Identification of Peptides from Immunostimulating Fractions of 
Deer and Cow Milk Digestions 
8.1. Introduction 
Bioactive peptides of cow and other mammals (sheep, goat, buffalo, pig and human) milk have been 
studied previously after separation of proteolysis products by chromatography (FPLC or HPLC) 
and the identification of the peptides were carried out by biochemical methods (Minervini et al., 
2003; Jacquot et al., 2010). Mass spectrometry (MS) is commonly used to identify and sequence 
purified peptides (Juillard et al., 1995; Rohit et al., 2012; Hou et al., 2012). The use of liquid 
chromatography–mass spectrometry (LC-MS) makes it possible to determine the molecular weight 
of each peptide, even when testing fractions contain more than one peptide (Juillard et al., 1995). 
According to the literature there has been no investigation to identify bioactive peptides from deer 
milk protein hydrolysates. At present, deer milk protein sequence information is not available in any 
sequencing databases. Therefore in this study, database searching for deer peptides was done on 
Bovidae taxonomy; cow, sheep, goat and buffalo. 
The aim of this study was to identify the peptide or peptides present in the three most active 
immunostimulating fractions (11, 22 and 30)  isolated by reverse-phase FPLC(Chapter 7).In vitro 
digestions of unfermented and Lactobacillus delbrueckiisubsp bulgaricus fermented deer and cow 
milk proteins were used. 
 
8.2. Material and Methods 
8.2.1. Materials 
Immunostimulating fractions 11, 22 and 30 of deer and cow (unfermented and Lactobacillus 
delbrueckiisubsp bulgaricus fermented) digests (chapter 7) were isolated by reverse-phase FPLC. 
The fractions were freeze dried and used for analysis. 
Formic acid (FA) and acetonitrile were purchased from Sigma (St. Louis, MO, USA). Ultimate 
nanoflow HPLC equipment with Famos autosampler and Switchos column switching module were 
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from LC-Packings, The Netherlands. Nanospray needle was purchased from Proxeon, Denmark and 
QSTAR Pulsar I mass spectrometer was from AB Sciex, USA.     
8.2.2. Liquid Chromatography–Mass Spectrometry (LC-MS/MS) 
Freeze dried samples were reconstituted in 25 µl loading solvent (2% acetonitrile, 0.2% FA). LC-
MS/MS was carried out on an HPLC. A 10 µl of sample was loaded on a C18 precolumn (300 µm 
ID, 5 µm particles, 300 Å pore size) at a flow rate of 8 µl/min. The precolumn was then switched in 
line with the analytical column (C18, 20 cm, 75 µm ID, 5 µm particles, 300 Å pore size), and eluted 
at a flow rate of 150 nl/min, with a linear gradient from 2% to 55% solvent B in 50 min. Solvent A 
was HPLC-grade water with 0.2% FA, solvent B was LCMS-grade acetonitrile with 0.2% FA. 
Using a stainless steel nanospray needle, the column outlet was directly connected to a QSTAR 
Pulsar I mass spectrometer which was programmed to acquire MS/MS traces of the top three 1+, 
2+, 3+, 4+ and 5+ peptides (cycle time 6 seconds). 
8.2.3. Database searching 
Mascot Daemon (v2.2.2) was used to convert the data files to peak lists (Mascot Script for Analyst 
v1.6b25). Peak lists were imported in to ProteinScape V2.1 (Bruker) and submitted for searching to 
an in-house Mascot server (v2.2.0.6) (Matrix Science, UK). The following search parameters were 
used: No enzyme; MS tolerance 75 ppm; MS/MS tolerance 0.3 Da; database NCBInr 14/09/2011. 
Bos taurus and Bovidae taxonomy was used for cow and deer milk samples, respectively. Peptides 
and proteins with a Mascot score higher than 25 and 50, respectively, were accepted. 
 
8.3. Results and Discussion  
Peptides have been identified by coupling high-performance liquid chromatography (HPLC) and 
MS. All tested fractions had more than 15 different peptides and one fractions contained more than 
100 peptides (fraction 30 of cow milk unfermented and fermented digests) (Table 8.1). Even after 
further purification, RP-FPLC fractions of casein hydrolysates of cow, sheep, goat, pig, buffalo and 
human milk had mixture of different peptides (Minervini et al., 2003). Peptides present in 
immunostimulating RP-FPLC fractions (11, 22 and 30) of deer and cow milk were identified. The 
samples in the present work were hydrolysates of casein and whey protein which contribute to the 
presence of many different peptides. Mass spectrometric analysis done by Juillard et al. (1995) 
identified over 100 different β-casein-derived peptides from cow β casein after fermentation with 
Lactobacillus lactis subsp. lactis MG611.  
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Table 8.1. Total number of identified peptides contained and source of protein in FPLC fractions 
11, 22 and 30 from unfermented (Cow digests and Deer digests) and Lactobacillus delbrueckiisubsp 
bulgaricus fermented cow (CL) and deer (DL) in vitro digestions. 
Source Total number 
of peptides 
Source of protein Number of 
peptides 
Fraction 11    
Cow digests 32 β Casein    14 
  αs1 casein  10 
  αs2 casein  3 
  κ casein  4 
  β Lactoglobulin  1 
CL digests     49 β Casein   31 
  αs1 casein  15 
  αs2 casein  3 
Deer Digests 16 αs1 casein  10a 
  β Casein  5a 
  β Lactoglobulin  1a 
DL digests  36 β Casein  12a,h 
  αs1 casein 10a 
  αs2 casein  4b 
    β Lactoglobulin  10a 
Fraction 22    
Cow digests 79 β Casein  41 
  αs1 casein  22 
  αs2 casein  8 
  κ casein 6 
  β Lactoglobulin  2 
CL digests 73 αs1 casein  37 
   β Casein  23 
  αs2 casein  9 
  κ casein  4 
Deer Digests 51 β Casein  25a,b 
  αs1 casein  12a,b 
  αs2 casein  7a,c 
  κ casein  4a,d 
  β Lactoglobulin  3a 
DL 35 β Casein  14a 
  αs1 casein   13a,b,h 
  αs2 casein  2c 
  κ casein  2g 
    β Lactoglobulin  4a 
Fraction 30    
Cow digests 100 αs1 casein  39 
   β Casein  35 
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  αs2 casein  17 
  κ casein  9 
CL 104 β Casein  46 
  αs1 casein  40 
  αs2 casein  12 
  κ casein  6 
Deer Digests 51 β Casein  21b,h 
   
  αs2 casein  2c 
  κ casein  6e 
  β Lactoglobulin  4a 
DL 50 β Casein  22a,h 
  αs1 casein  13b,h 
  αs2 casein  8c 
  κ casein  2d 
  β Lactoglobulin  5a 
Below taxonomy was used for identification of peptides in deer milk samples  
a: Bos taurus    e: Ovis vignei bocharensis 
b: Capra hircus g: Ovis orientalis gmelini 
c: Ovis aries h: Bubalus bubalis 
d: Ovis vignei blanfordi 
 
In this study, identification of deer milk peptides was carried out by database search of cow, sheep, 
goat, buffalo milk proteins since there was no sequencing data available for deer milk proteins.        
The main protein source of identified peptides in most tested fractions was β casein. Therefore we 
can suggest that immunostimulating activity (chapter 7) in tested fraction was possibly from β 
casein originated peptides for both deer and cow milks. The immunomodulatory activities of β 
casein derived peptides have been well documented (Coste et al., 1992; Kitazawa et al., 2007; 
Phelan et al., 2009).      
Some differences in amino acid sequence of deer and cow milk proteins were identified (Table 8.2). 
There were four peptides of β casein origin (f 204-222, f 205-222, f 206–222 and f 207-222) present 
in fraction 22 of deer milk unfermented digests, which showed sequence differences with cow β 
casein where 207th position is leucine in deer as with goat milk versus isoleucine in cow protein 
(Table 8.2). Also fraction 11 of digest of Lactobacillus delbrueckiisubsp bulgaricus ferment of deer 
milk (11 DL) contained a peptide (β casein f 31–48) which showed a difference with cow β casein 
amino acid composition (Table 8.2). In 39th position Arginine (R) was found in deer milk similar to 
domestic water buffalo, while cow β casein has Glutamine (Q). A similar study by Masoodi and 
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Shafi (2010) showed the differences in amino acid composition of α1 casein and α2 casein of cow 
milk compared to those of sheep and goat milk.  
Bovidae (cow, sheep, goat and buffalo) taxonomy was used for identification of peptides in deer 
milk protein samples. There are no reported works on amino acid sequencing of deer milk protein 
but McDougall (1976) did compare the amino acid composition of red deer milk β lactoglobulin to 
that of cow milk. He found that deer milk β lactoglobulin contained one more residue of aspartic 
acid, alanine and methionine and one less glutamic acid residue and two less leucine residue than 
cow β-lactoglobulin composition. The results of this study show similarities (Fig. 8.1) and 
differences (Table 8.2) of deer milk proteins (especially casein) to homologous cow milk proteins 
which might lead to altered bioactive properties. As shown in figure 8.1 many of the peptides are 
identical in deer and cow fraction 30. This similarity of peptide sequence could be the reason why 
both deer and cow fraction showed immunostimulating activity (Chapter 7). At the same time, there 
are slight differences observed between deer and cow milk proteins (Table 8.2). This could lead to a 
difference of immunostimulating activity and might be the reason why deer milk fractions showed 
higher immunostimulating activity than the corresponding cow fraction (Chapter 7).                         
Table8.2. Comparison of amino acid residues in milk protein of deer with cow giving its specific 
position based on results of peptides found in FPLC fractions 11, 22 and 30 of unfermented and  
Lactobacillus delbrueckiisubsp bulgaricusfermented cow and deer milkin vitro digestions. 
Amino acid 
position 
Amino acid in cow milk Amino acid in deer milk 
β casein  39 Glutamine (Q) Arginine ( R) - Similar to goat milk 
β casein  207 Isoleucine (I) Leucine (L) - Similar to domestic water buffalo milk  
α1 casein 163 Glutamic acid (E ) Glutamine (Q) - Similar to goat and sheep milk 
α2 casein 215 Lysine (K) Asparagine (N) - Similar to goat and sheep milk 
 
Most abundant peptides identified from each fraction with a mascot value > 70 are shown in Table 
8.3. Mascot score is a measure of effectiveness of peptide identification. The fragment β casein 57-
66 (fraction 22 of cow digests) contained (Table 8.3) the sequence of β casomorphine-7 (β casein 
60-66), which has been previously identified as an immunomodulating cow milk peptide (Kayser & 
Meisel, 1996).  The authors showed β-casomorphin-7 stimulated human lymphocyte proliferation. 
β-casomorphin-7 may also affect the human mucosal immune system, possibly via opiate receptors 
in lamina propria lymphocytes (Elitsur et al., 1991). The β casein 184-209 fragment present in 
fraction 11 of cow digests (Table 8.3) contained another known cow immunostimulating peptide (β 
casein 192-209) which enhanced the proliferation of rat lymphocytes (Coste et al., 1992). Similarly 
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the β-cascochemotide (f114-118) an immunomodulating peptide (Kitazawa et al., 2007) exists 
within the range of β casein 114-128 peptide (Table 8.3, Fig. 8.1) present in fraction 30 of cow 
digest fermented with Lactobacillus delbrueckiisubsp bulgaricus. Cow β casein residues 63-68 and 
191-193 have been shown to stimulate phagocytosis of sheep red blood cells by murine peritoneal 
macrophages, and to exert a protective effect against Klebsiella pneumoniae infection in mice after 
intravenous treatment (Migliore-Samour & Jollès 1988) and these two amino acid sequences can be 
seen in peptides detected in cow β casein 57-66 and β casein 184-209, respectively (Table 8.3). 
Therefore, it can be suggested that cow milk fractions (11, 22 and 30) which showed high 
immunostimulating activity (Chapter 7) may partially have resulted from some of above mentioned 
peptide fragments which have been identified in literature. There might be other peptides 
contributing to the activity, which have not been identified before.  
Although each of the deer milk FPLC fractions exhibited higher lymphocyte proliferation than the 
corresponding cow milk fraction (Chapter 7), we did not identify any previously known 
immunomodulating peptides in deer samples. Deer fractions had higher activity compared with cow 
fractions suggesting new sequences may potentially contributeto this. Also immunostimulating 
activity of each fraction may be due to interaction of peptides present in each fraction or few 
peptides and their concentration.   
Further experiments should be carriedout to identify these peptidesafter purification as well as 
testing the immunostimulating activity of each peptide which should be confirmed by synthetic 
peptides constructed with the same sequence.          
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Table 8.3. Sequences and corresponding milk protein fragment of peptides contained in FPLC 
fractions 11, 22 and 30 from unfermented (Cow digests and Deer digests) and Lactobacillus 
delbrueckiisubsp bulgaricus fermented cow (CL) and deer (DL) in vitro digestions.m/z represents  
measured mass-to-charge ratio and ∆ m/z represents mass error between the measured mass m/z and 
the theoretical m/z for that sequence 
Fraction Source Sequence position Sequencea m/z ∆ m/z z 
11 
Cow 
digests βCN 124-139 SLTLTDVENLHLPLPL 888.0039 3.12 2 
  βCN 184-209 DMPIQAFLLYQEPVLGPVRGPFPIIV 975.8757 6.10 3 
  β lg 92-100 VLVLDTDYK 533.2904 -8.58 2 
       
 CL     βCN 124-139 SLTLTDVENLHLPLPL 887.9974 -4.18 2 
  βCN 34-48 QQEEQQQTEDELQDK   938.4144 0.70 2 
       
 
Deer 
Digests 
αs1CN 119 - 134 
(Bos taurus) YKVPQLEIVPNSAEER 651.3319 14.66 3 
  
αs1CN 189 - 208 
(Bos taurus) TDAPSFSDIPNPIGSENSEK 1052.9881 0.99 2 
  
β lg 110-118 (Ovis 
aries) VLVLDTDYK 533.2990 7.49 2 
       
 DL  
βCN 124-139 (Bos 
taurus,Bubalus 
bubalis) SLTLTDVENLHLPLPL 887.9942 -7.77 2 
  
βCN 129-144 (Bos 
taurus,Bubalus 
bubalis) DVENLHLPLPLLQSWM 953.0054 5.10 2 
    
βCN 34-48 (Bos 
taurus) QQEEQQQTEDELQDK  938.4139 0.17 2 
       
22 
Cow 
digests βCN 33-52 FQSEEQQQTEDELQDKIHPF 852.6958 -7.72 3 
  βCN 57-66 SLVYPFPGPI 1089.6059 7.32 1 
  βCN 145-162 HQPHQPLPPTVMFPPQSV 679.6958 17.32 3 
  βCN 190-202 FLLYQEPVLGPVR 765.9394 2.33 2 
  αs1CN 15- 28 HQGLPQEVLNENLL 802.4236 -2.50 2 
  αs1CN 189- 208 TDAPSFSDIPNPIGSENSEK 1052.9829 -3.99 2 
  αs2CN 116- 128 QGPIVLNPWDQVK 747.3992 -13.29 2 
  β lg 10-29 SLAMAASDISLLDAQSAPLR 682.6950 8.21 3 
       
 CL αs1CN 119- 134 YKVPQLEIVPNSAEER 651.3189 -5.27 3 
  αs1CN 181- 200 TDAPSFSDIPNPIGSENSEK 1052.9829 -4.04 2 
       
 
Deer 
Digests 
αs1CN 140- 164 
(Bos taurus) EGIHAQQKEPMIGVNQELAYFYPEL 968.8255 13.20 3 
  αs1CN 140- 164 EGIHAQQKEPMIGVNQELAYFYPEL 974.1516 7.41 3 
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(Bos taurus) 
  
αs1CN 197- 208 
(Bos taurus, Capra 
hircus) IPNPIGSENSGK 606.8213 11.12 2 
  
β lg 92-100 (Bos 
taurus) VLVLDTDYK 533.2993 8.06 2 
       
  DL 
βCN 124-139 (Bos 
taurus) SLTLTDVENLHLPLPL 888.0153 16.00 2 
       
30 
Cow 
digests βCN 124-139 SLTLTDVENLHLPLPL 888.0093 9.22 2 
  αs1CN 50- 65 DIGSESTEDQAMEDIK 972.3567 10.06 2 
  αs1CN 50- 67 DIGSESTEDQAMEDIKQM 1109.8898 -3.67 2 
  αs1CN 132- 156 EGIHAQQKEPMIGVNQELAYFYPEL 974.1546 10.46 3 
       
 CL βCN 114-128 YPVEPFTESQSLTLT 856.4202 -5.48 2 
  βCN 124-139 SLTLTDVENLHLPLPL 888.0062 5.69 2 
  βCN 144-163 MHQPHQPLPPTVMFPPQSVL 761.0555 -4.41 3 
  βCN 145-162 HQPHQPLPPTVMFPPQSV 679.6815 -3.72 3 
  βCN 145-163 HQPHQPLPPTVMFPPQSVL 717.3756 -4.38 3 
  αs1CN 23- 36 HQGLPQEVLNENLL 802.4202 -6.67 2 
  αs1CN 172- 199 YVPLGTQYTDAPSFSDIPNPIGSENSEK 1009.4803 -0.02 3 
  αs2CN 125- 138 TPEVDDEALEKFDK 545.9335 6.72 3 
       
 
Deer 
Digests 
βCN 124-139 
(Bubalus bubalis) SLTLTDVENLHLPLPL 888.02 20.9 2 
  
βCN 126-144 
(Bubalus bubalis) TLTDVENLHLPLPLLQSWM 1118.5817 -5.42 2 
  
β lg 10-24(Bos 
taurus) SLAMAASDISLLDAQ 761.3813 5.76 2 
  
β lg 10-29 (Bos 
taurus) SLAMAASDISLLDAQSAPLR 682.7030 19.96 3 
  
β lg 92-100 (Bos 
taurus) VLVLDTDYK 533.3198 46.56 2 
       
 DL 
βCN 124-139 
(Bubalus bubalis) SLTLTDVENLHLPLPL 888.0030 2.16 2 
  
βCN 129-138 (Bos 
taurus) DVENLHLPLP 573.8124 1.89 2 
  
β lg 10-28 (Bos 
taurus) SLAMAASDISLLDAQSAPL 937.4762 -6.67 2 
a Single letter amino acid code is used 
Peptides with > 70 mascot score were shown  
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Figure 8.1. Localization of identified peptides in FPLC fraction 30 of unfermented cow (C) and deer (D) milk digests and digests of 
Lactobacillus delbrueckiisubsp bulgaricus ferment of cow (CL) and deer (DL) on cow β casein.   
Peptides with > 70 mascot score were shown    
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β casein 124–139 peptide was found in all tested fractions of both deer and cow milks (Table 
8.3). This unexpected result is fully unknown since separation is based on hydrophobicity of 
peptide. The mascot score for the 124–139 peptides is different in different fractions.  
Therefore it could be suggested that due to high abundance of this peptide, it diffused to more 
than one fraction. These results are similar to those reported by Minervini et al. (2003) which 
reported the appearance of the same peptides in different FPLC fractions which use 
hydrophobicity as separation principle.  
This study used three fractions (11, 22 and 30) out of fifty FPLC fractions, where a high 
immunostimulating activity was shown (Chapter 7) and β casein 124 – 139 peptide was 
found in most of these fractions (both deer and cow) abundantly. This suggests there might be 
immunostimulating property of this peptide and there could be really interesting findings of 
this particular peptide and further investigation is strongly recommended. Di- and tripeptides 
are too small to be reliably identified with this method and therefore another method should 
be used in future work.  
 
 
8.4. Conclusion 
Mixtures of different peptides with different protein origins have been identified in 
immunostimulating FPLC fractions from both deer and cow milk digests. The main protein 
source was found to be β casein. The results obtained in this study showed that there are 
differences in the amino acid sequence of deer and cow milk proteins. Some previously 
identified immunostimulating peptide sequences were found in tested FPLC fractions in cow 
digests whereas there were no previously identified immunostimulating peptides in deer 
digests. Further studies should be carried out to identify these unknown immunostimulating 
peptides after further purification and the activity confirmed by synthesis.           
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Chapter 9 
General Discussion, Conclusion and Future Work 
Digestion and fermentation of milk protein produces bioactive peptides and currently milk 
proteins are considered the most important commercial source of bioactive peptides 
(Korhonen, 2009). Using deer and cow milks obtained from Lincoln University deer and 
dairy farm, respectively, the present study has shown that deer milk has twice protein content 
of cow milk. Also deer milk produced more peptides than cow milk after in vitro digestion 
(Chapter 3). LAB fermentation (Lactobacillus delbrueckiisubsp bulgaricus, Streptococcus 
salivarius subsp thermophilus and Lactobacillus casei strain Shirota) prior to in vitro 
digestion improved the peptide production compared to unfermented milk digestion. There 
were more peptides generated after an in vitro digestion of deer milk ferment than cow milk 
after similar treatment (Chapter 4).  
Immunomodulating activities of the above unfermented and fermented milk digestions were 
tested using human PBMC and deer milk showed more immunostimulating properties than 
cow milk after in vitro digestion and this was further improved by LAB fermentation prior to 
digestion based on lymphocyte proliferation and cytokine production (IL-2 and INFγ). 
Immunostimulating activities were higher at lower protein concentration (0.125 mg/ml) than 
higher concentrations for both milk types which could be explained by cytotoxic effect at 
higher concentrations of protein (Phelan et al., 2009). Similar results of higher lymphocyte 
proliferation at lower protein concentration were shown by several authors (Sizemore et al., 
1991, Kayser & Meisel, 1996; Jacquote et al., 2010).  
In vitro assays,as used in this work, are useful for identification of potential bioactive 
peptides in food and the results of in vitro assays may  indicate what may happen when 
potentially immunomodulating peptides are consumed (Eriksen et al., 2008; Agyei & 
Danquah, 2012). The action of immunomodulatory peptides is relatively nonspecific and the 
exact mechanism of action as well as the in vivo fate of these peptides is largely unknown 
(Pihlanto, 2011; Agyei & Danquah, 2012). It is known some small peptides are easily 
absorbed in the intestine while little is known about the absorption of larger bioactive 
peptides (Pihlanto, 2011). When the bioactive peptides are not absorbed in the intestinal tract, 
their activity may result either directly in the intestinal tract or via receptors and cell 
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signalling in the gut (Pihlanto, 2011). Immunomodulatory peptides which are absorbed from 
the gut can either suppress or stimulate certain immune responses (Agyei & Danquah, 2012). 
Therefore it is of great importance to establish if a protein (or peptide/peptides) has the same 
biological function in vivo as it has in vitro before using for human.               
Variation in milks between animal species was considered in chapter 6 and 
immunomodulating activity of deer milk was compared with three other domestic species 
(cow, goat and sheep). The immunostimulatoryactivity of deer milk digests was not only 
higher than cow digestions, but also goat and sheep milk digestions (two other commonly 
used milk types).  
The peptides in unfermented and fermented digests of deer and cow milk were fractionated 
using FPLC technique and three high immunostimulating peptide fractions (11, 22 and 30) 
were identified (Chapter 7). Each of these deer milk digests FPLC fractions showed more 
immnostimulating activity than corresponding cow milk digest fractions.  
Identification of peptides present in above immunostimulating fractions was done using LC-
MS/MS. Mixtures of different peptides were found in each fraction and most of them were 
from β casein (Chapter 8). Some previously characterised immunostimulating peptides 
sequences were found within peptides present in unfermented and fermented cow digest 
fractions (β casomorphine-7, β-cascochemotide, β casein f 192-209, f 63-68 and f 191-193). 
There were no previously identified immunostimulating peptides found in deer fractions 
suggesting deer milk might have novel (unidentified) immunostimulating peptides which 
have very high activity.  Peptide identification was done only in three high 
immunostimulating fractions (11, 22 and 30) which we selected previously from 51 FPLC 
fractions.  There was a common peptide (β casein fraction 124 – 139) observed in most of the 
above immunostimulating fractions for both deer and cow. Also some differences of amino 
acid sequence of deer milk protein (β casein , α1 casein, α2 casein) to cow milk protein were 
identified, which could be another reason to have different level of immunostimulating 
activities by deer and cow milk proteins.     
As it is discussed and pointed out throughout this thesis there were so many previous studies 
on immunomodulating activity of cow milk and some on other domestic species like sheep, 
goat and camel and still the interest of milk from these species can be seen as there are 
sufficient amount of very recent studies and reviewed on bioactive peptides on above milk 
species (Tanabe, 2012; Nagpal et al., 2012; Choi et al., 2012 and Ebaid et al., 2012). There is 
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no reported work on bioactive peptides on red deer milk which could have potential 
immunobioactivity based on historical use of deer milk to cure some medical problems 
(Fondahl, 1989; Park &Haenlein, 2006). The present work was able to fulfil that gap by 
identifying immunostimulating activity of deer milk and showing higher immunostimulating 
activity than cow, goat and sheep milk.  
Although the main research area of this study is immunostimulating peptides of deer milk, 
some other observations during this research were very interesting and led to studying other 
properties of deer milk such as buffering capacity and mineral content. During the first 
experiment (Chapter 1) there was the observation of high tolerance of deer milk to pH 
changes with addition of acid (1M HCl) or base (1M NaOH) during in vitro digestion pH 
adjustment prior to enzyme addition. Also pH of deer milk did not drop below 4.6 after LAB 
fermentation while cow milk pH dropped below 4.3 where casein is precipitated (Chapter 4). 
These observations led to the measurement ofthe buffering capacity of deer milk compared to 
cow milk. In this study higher buffering capacity of deer milk than cow, sheep and goat milk 
was identified, which may have potential to treat patient with gastric ulcers (Chapter 6). But 
further studies should be carried out to confirm the suggested property. At the same time,it 
was found that deer milk is a better source of minerals (especially Ca, P and Zn) compared 
with cow, sheep and goat milk. 
New information generated through this research were that red deer milk is a better source of 
immunomodulating bioactive peptides than cow milk protein and LAB fermentation prior to 
digestion improved the formation of bioactive peptides in both deer and cow milks. This 
potentially could open commercial opportunities for the deer industry in New Zealand. New 
Zealand has 1.2 million farmed deer which is half of world farmed deer population.  They are 
farmed mainly for meat and velvet (DINZ, 2009). This present research is an initial indication 
of the potential of utilising milk as another deer product. Based on present results there is 
considerable potential to isolate immunomodulatory peptides from deer milk for 
pharmaceuticals and furtherresearch should be carried out. Also this work indicates deer milk 
is a usefulsource of novel bioactive peptides.       
Future work 
• Many different peptides have been identified in this study from three 
immunostimulating FPLC fractions from unfermented and fermented deer milk 
digestions. It will be important to determine which, if any, of these 
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areimmunostimulating peptides by further purification by appropriate 
chromatography techniques together with biological assays (lymphocyte proliferation 
and cytokine production).  It will also be important to develop genetic resources for 
deer either using genomic sequencing or expressed sequence tags as this will allow 
the identification of unique deer peptides. This would be helpful to identify one or 
several most active immunostimulating peptides in each active fraction. Then the 
activity of each peptide should be tested to confirm the immunostimulating property 
after synthesis and those peptides may have potential commercial value as cow milk 
derived commercial bioactive products (Ricci-Cabello et al., 2012).  
• It is also interesting to investigate the cytokine production with different time 
intervals (6hrs interval) for longer time (72 hr).  
• Once any particular immunomodulating peptide/ peptides were identified from deer 
milk protein, in final stages animal trials should be beneficial to identify optimum 
plasmatic concentration of these substances and identify the therapeutic potential of 
immunostimulating bioactive peptides. 
• Some observations in this research led to the interest to study in areas which not 
directly relevant to present topic, but could be potential use of deer milk. Low growth 
of LAB strains in deer milk than cow milk (Chapter 4) created a really interesting area 
to study on antibacterial properties of deer milk. 
• It is also interesting to investigate other bioactivities in deer milk like opiate-like, 
mineral binding, antioxidant, antithrombotic, hypocholesterolemic, and 
antihypertensive actions since many bioactive peptides are multifunctional and can 
exhibit more than one of the effects (Korhonen, 2009).  
• Also further studies of the buffering capacity of deer milk is beneficial to confirm the 
observed higher buffering capacity, find out what cause the high buffering capacity 
and finally to investigate potential use of deer milk to treat human gastric problems. 
• LAB fermentation of present work was carried out in aerobic condition without pH 
control. It is interesting to find behaviour of tested lab strains in different fermentative 
conditions such as anaerobic and with pH control for both deer and cow milks and test 
the differences in peptide formation and immunomodulating activity.                       
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Identification of deer milk proteins compare to cow milk 
proteins& selection of SDS-PAGE concentration 
 
 
Identification of deer milk proteins compare to cow milk proteins 
 
  
  
M  C1    C2     D1           C3     C4      D2     D3 
 
Figure 1.SDS- PAGE (4-12%) of skimmed cow and deer milk and milk digested with pepsin 
and CPP. High molecular weight marker is shown on left-hand side of the gel. The lanes are: 
M: High molecular marker,C1:  Cow milk (10 µl sample),C2:  Cow milk (20 µl sample),D1:  
Deer milk (10 µl sample),C3:  Cow milk hydrolysed (10 µl sample),C4:  Cow milk 
hydrolysed (20 µl sample),D2:  Deer milk hydrolysed (10 µl sample),D3:  Deer milk 
hydrolysed (20 µl sample). protein.Immunoglobulins heavy chain (IgHC), lactoferrin (LF), 
serum albumin (SA), casein (CN), β-lactoglobulin (β-lg) and α-lactalbumin (α-la).Each 
contained had 2 mg/ µl 
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The shown cow protein bands were identified accordance with Almaas et al., 2006 (20% 
SDS-PAGE) and Inglingstad et al., 2010 (12.5 % and 15 % SDS-PAGE) gel results.  Deer 
protein bands were identified based on similarity to cow milk protein bands. 
 
 
Selection of SDS – PAGE concentration  
 
  
 
               C   C30 C50  C60      D   D30  D50   D60 
Figure 2.SDS- PAGE (8-16%) of skimmed cow & deer milk, cow & deer milk digested, with 
pepsin and CPP. The lanes are: High molecular marker (M), Cow milk(C), Digest after30min 
(C30), 50min (C50), 60min (C60), Deer milk (D), Digest after30min (D30), 50min (D50), 
60min (D60). Each contained had 2 mg/ µl 
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Figure 3.SDS-PAGE (8-16%) of fermented cow and deer milks by Lactobacillus 
delbrueckiisubsp bulgaricus, Streptococcus salivarius subsp thermophilus and Lactobacillus 
casei strain Shirota at 37°C for 24 hr. The lanes are  Lactobacillus delbrueckiisubsp bulgaricus 
fermented cow (CL) and deer (DL) milk, Streptococcus salivarius subspthermophilusfermented 
cow (CS) and deer (DS) milk, Lactobacillus casei strain Shirota fermented cow (Csh) and 
deer (Dsh) milk, unfermented cow (C) and deer (D) milk. Each contained had 2 mg/ µl 
 
                         C    C60               D60              D    D      M 
 
Figure 4.SDS-PAGE (20%) of skimmed cow & deer milk, cow & deer milk digested, with 
pepsin and CPP. The lanes are: High molecular marker (M), Cow milk(C), Cow milk digest 
after 60min (C60), Deer milk (D), Deer milk digest after 60min (D60). Each contained had 2 
mg/ µl 
 
 
 
As preliminary studies different concentration of gels were tested base on literature. 
Vinderola et al., 2006 used 12 % SDS – PAGE for LAB fermented cow milk and Matar et 
al., 1995 used 12.5% seperating gel and 4% stacking gel. Almass et al., 2005 used 20% SDS-
PAGE for cow and goat milk and their digests. Inglingstad et al., 2010 was used 12.5 % and 
15 % gel to analyse cow, goat, horse, human milk and their digest. 
Milk, milk ferment and milk digests were run with 4-12% precast gel which used in 
experiment chapters (fig. 3.3, 3.4, 4.7, 6.3), 8-16% gel (Fig 2 and 3) and 20 % gel (fig. 4).  
 
As shown in figure 2 and 3 protein bands of milk and digests were not clear in 8-16% gel and protein 
did not run well in 20 % gel (fig. 4) while  4-14% gel (experiemental chapters) showed cleare band. 
Since this study aimed to analyse milk protein bands and digested protein bands together 4-12 
% gels were selected which gave clear bands in both case. 
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The release of peptides by in-vitro digestion of 
fermented red deer (Cervus elphus) and cow (Bos 
taurus) milk. 
N. L. OPATHA VITHANA1, S. L. MASON1, A. E. A. BEKHIT2, J. D. MORTON1 
1Lincoln University, New Zealand; 2Otago University, New Zealand   
 
ABSTRACT 
Fermentation and digestion release peptides from milk as a source of amino acid and energy, as well as a source 
of biofunctional peptides that may have health benefits. The aim of this study was to ferment deer and cow milk 
using three strains of Lactic acid bacteria (LAB) and to compare the release of peptides following in-vitro 
digestion of the fermented milks. The three strains were Lactobacillus belburueckii subspbulgaricus, 
Streptococcus salivarius subsp thermophilus and Lactobacillus casei strain Shirota and the fermentations were 
carried at 37 oC for 24 hours. The in-vitrodigestion was performed in two steps; imitating both the human 
stomach (Pepsin, pH 2.5) and the duodenum (Corolase PP, pH 7.5). Release of peptides during milk 
fermentation and subsequent digestion was quantified using OPA (o-phthaldialdehyde) assay. Changes in 
protein and peptide profiles were evaluated using sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) and quantified using ImageJ software. After 24 hours of fermentation, the pH of cow milk 
dropped below 4.6 and precipitated caseins while pH of deer milk remained above pH 4.6 for all three strains. 
Deer milk fermentations gave higher peptide production than cow milk fermentations. Following in-vitro 
digestion peptide production was significantly greater in deer milk than cow milk (P≤ 0.05). Lactobacillus casei 
strain Shirota showed the highest release of peptides. The main milk proteins were degraded during 
fermentation of both milks. Lactoferrin (LF) in cow milk was more resistant to fermentation than that in deer 
milk for all 3 strains. After 24 hours of fermentation by Lactobacillus casei strain Shirota, cow LF was still 
intact while 47% of the deer LF had degraded. Digestibility of β-lactoglobulin, α-lactalbumin of deer milk and 
immunoglobulin of cow milk was improved by fermentation.This study showed LAB fermentation prior to in-
vitro digestion increased the digestibility and release of peptides from both milks. This effect was greater in deer 
milk than cow milk.  
INTRODUCTION 
Fermented milk products, in addition to providing a source of energy and nutrients, are also a source of peptides 
with biological functions that may improve health when ingested. The health benefits of fermented milk have 
been recognized and documented (Gobbetti et al., 2006). Over the last decade a great number of peptide 
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sequences with different bioactivities (eg.  immunomodulatory, antihypertensive, antithrombotic, antibacterial, 
antioxidative and opioid activity) have been identified in various milk proteins (Korhonen, 2009).  Many 
commercial lactic acid bacteria (LAB) based starter cultures are highly proteolytic (Korhonen, 2009). The in 
vitro study by Pihlanto-Leppala et al. (1998) demonstrated that fermentation of milk with starter cultures or 
enzymes derived from such cultures prior to treatment with digestive enzymes can enhance the release and alter 
the profile of bioactive peptides produced. Further, Matar et al. (1996) showed that fermentation of milk by 
LAB has a major impact on the release of novel low molecular mass peptides during in vitro digestion.  It is 
likely that peptides are also released during digestion in the gastrointestinal tract. Deer milk has 8.8 % protein 
which is twice as concentrated as cow milk (Opatha Vithana et al., 2010). This could be a good substrate for 
proteolytic activity of LAB stains and may produce more peptides which might have biological functions 
beneficial to health.    
The aim of this study was to compare deer and cow milk during fermentation using three LAB cultures in terms 
of peptide production before and after in vitro digestion and compare deer and cow milk protein digestibility. 
This is the first report studying the fermentation of deer milk followed by in vitro digestion and the information 
from the present work is potentially useful in understanding the release of peptides in animal nutrition and to 
evaluate the potential use of deer milk products for human use.  
 
METHODS 
Milk Fermentation 
Skim deer and cow milk were inoculated withLactobacillus delbrueckiisubsp bulgaricus, Streptococcus 
salivarius subsp thermophilus and Lactobacillus casei strain Shirota with 2% (vol/vol) inoculums separately and 
incubated at 37°C for 24 hr (Matar et al., 1996).  
In vitro Digestion 
In vitro digestion was performed for milk and fermented milk in two steps using Pepsin and Corolase PP 
(mixture of trypsin, chymotrypsin and several amino and carboxypeptidases) according to Eriksen et al. (2008). 
The release of peptides during milk fermentation and digestion was quantified using OPA (o-phthaldialdehyde) 
assay(Church et al., 1983). The changes in protein and peptide profiles were compared by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) as per Lammli (1970) and quantified using ImageJ 
software (rsbweb.nih.gov/ij/). 
Statistical analysis 
All experiments were carried out in triplicate and the reported values are mean ± standard deviation. The data 
were subjected to one way analysis of variance (ANOVA), followed by Tukey’s test to determine the significant 
difference between means at p˂0.05 level using Minitab (16 version).   
RESULTS 
The pH of deer milk was 6.1 prior to fermentation whereas it was 6.5 for cow milk. After 24 hr of fermentation; 
the pH of cow milk was significantly lower than deer milk ferments for all three stains of LAB;Lactobacillus 
casei strain Shirota, Lactobacillus delbrueckiisubsp bulgaricus and Streptococcus salivarius subsp 
thermophilus.  The pH fell below 4.6 for cow milk at which pH the casein is precipitated. Deer milk pH did not 
fall below 4.6 for any of the three LAB fermentations over 24 hr (Fig 1). 
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Figure 1.  pH during fermentation of deer (   ◦  ) and cow (  •  )  milk at 37°C. (a) Lactobacillus casei strain 
Shirota (Lcs), (b) Lactobacillus delbrueckiisubsp bulgaricus (Ldb), (c) Streptococcus salivarius subsp 
thermophilus (Sst). Data are mean of three independent fermentations ± S.D.   
 
The proteolytic activities of the studied strains (Fig.2) were significantly higher in deer milk than cow milk 
(p<0.05).  The highest production of peptides was generated by Lactobacillus casei strain Shirota (Fig.2) after 
24 hours of fermentation at 37°C. Once ferments were digested, significantly ( p<0.05) higher peptide 
production was observed in deer milk compared to cow milk for all three strains and the highest production was 
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found in digest of  Lactobacillus casei strain Shirota fermented deer milk. Fermented milk digests always have 
slightly higher peptide concentration than raw milk digest. When comparing the three stains in terms of peptide 
production there was no significant difference after in vitro digestion of both deer and cow milk ferment.  
 
Figure 2.  Peptide production following in vitro digest of raw milk and milk ferment for 24 hr as well as 
undigested ferment. Cow(   ) and deer (   )  milk fermented with (a) Lactobacillus casei strain Shirota (b) 
Lactobacillus delbrueckiisubspbulgaricus (c) Streptococcus salivarius subsp thermophilus. Data are means± SD 
(n = 3). 
 
The degradation of milk proteins was visualized using SDS gel electrophoresis. The main milk proteins started 
to degrade during fermentation of both milks (Fig 3). After in vitrodigestion, most of the milk protein bands 
completely disappeared and appearance of new lower molecular mass bands on the gel could be seen. 
Quantification of protein bands using ImageJ software is shown in Table 1. 
 
(i)                                          (ii)                                                    (iii) 
 
   M       C   Cf  Cfd            D  Df Dfd   C  Cf  Cfd                   D  Df  Dfd  C   Cf   Cfd                    D   Df   Dfd 
Figure 3. SDS-PAGE (4-12%) of deer and cow milk, ferment and digested ferment using(i) Lactobacillus casei 
strain Shirota, (ii) Lactobacillus delbrueckiisubsp bulgaricus and (iii) Streptococcus salivarius subsp 
thermophilus. The wells contains  (C) cow  milk, (Cf) cow  milk ferment, (Cfd) cow  milk ferment digest, (D) 
deer milk, (Df) deer milk ferment, (Dfd) deer milk ferment digest, (M) molecular weight marker. Each 
contained had 2 mg/ µl protein. 
Table 1.  Remaining protein content (%) in digest of milk,  Lactobacillus casei strain Shirota, Lactobacillus 
delbrueckiisubspbulgaricus and Streptococcus salivarius subsp thermophilusfermented (24 hr at37°C) milk 
before and after in vitro digested (30min simulated stomach + 30min simulated duodenum). Values are obtained 
by ImageJ. 
      Lactobacillus casei strain Shirota  
Lactobacillus delburueckii 
subsp bulgaricus 
Streptococcus salivarius subs 
thermophilus  
 Milk Digest  Ferment  
Ferment 
Digest Ferment  
Ferment 
Digest Ferments 
Ferment 
Digest 
  Deer Cow Deer Cow Deer Cow  Deer Cow Deer Cow  Deer Cow Deer Cow  
IgHC 1± 2 21±5  62±1 64±2 0±0  0±0  71±4 74±3 0±0  8±1 73±3 77±3 0±0  0±0  
LF 0±1  1±1  47±3 101±1 1±1 2±1 42±5 63±4 0±0  2±1 48±2 69±5 0±0  0±0  
SA 0±0  1±1  77±1 68±1 0±1 1±0 62±7 63±6 0±0  1±1 70±1 67±6 0±0  0±0  
IgHC 
CN 
LF 
SA 
βLG 
αLA 
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CN 0±0 1±1  83±2 85±1 0±0  0±1 76±8 82±4 1±0 1±1 85±2 84±1 2±0 2±0 
β-lg 54±5  55±8  87±1 86±1 52±1 57±1 85±2 91±7 51±1 57±4 83±4 78±2 51±1 68±1 
α-la 11±2  27±5  92±2 90±1 8±4 17±1 87±2 90±3 1±1 13±4 85±3 91±2 15±3 23±4 
Data are mean ± S.D. (n=3) 
 
Lactoferrin (LF) of cow milk is more resistant to degradation during fermentation by all three LAB strains than 
deer milk (Table 1). After 24 hours of fermentation by Lactobacillus casei strain Shirota, LF was still intact 
(100%) in cow milk while 47% LF remained intact after deer milk fermentation. Digestibility of α –lactalbumin 
(α –la) of deer milk was significantly (p< 0.05) improved by Lactobacillus delbrueckiisubsp 
bulgaricusfermentation. About 11% intact α –la was found after in vitro digestion of raw deer milk 
whileLactobacillus delbrueckiisubsp bulgaricus ferment digest only contained 1% intact α –la (Table 1).  The 
digestibility of β lactoglobulin in Streptococcus salivarius subsp thermophilus fermened deer milk was also 
significantly (p< 0.05) greater than β-lactoglobulin in cow milk ferment by the same culture. Deer milk 
fermented by the other two stains and digested showed slightly higher digestibility than cow ferment digest for 
β-lactoglobulin (β-lg).  There was a significant difference observed in immunoglobulin (IG) of cow milk. Intact 
protein level was 21% after in vitro digestion of raw milk and this decreased to 0 (no intact protein) after in vitro 
digestion of milk fermented by all three strains. These differences in digestibility of milk protein may lead to 
formation of novel peptides.  
DISCUSSION 
Deer milk was slightly more acidic than cow milk.  Differences in pH and buffering capacity of fresh milk 
reflect compositional variation (McCarthy, 2002). After 24 hour of fermentation, the deer milk ferment showed 
significantly higher pH (p<0.05) than cow milk which went below the casein iso electric point resulting in 
precipitation of casein for all three strains (Fig.1). The smaller pH drop of deer milk may be due to several 
factors such as low bacterial growth resulting in low lactic acid formation or a higher buffering capacity of deer 
milk than cow milk.The ultimate pH of cheese results from the lactic acid produced (from starter culture lactose 
metabolism) and moderated by the buffering capacity of the milk (Pendey et al., 2003). Principal buffer 
components in milk are soluble phosphate, colloidal calcium phosphate, citrate, bicarbonate, casein, salt and a 
number of minor constituents (McCarthy, 2002). Goat milk has high buffering capacity due to its high content 
of major buffering components  such as minerals and protein (Park, 1992). The mineral and casein content of 
red deer milk is about twice that of cow milk (Opatha Vithana et al., 2010). This high casein and minerals can 
lead to high buffering capacity of deer milk and could reduce the pH drop during fermentation when compared 
to cow milk. Further studies should be done to confirm the nature and the components contributing to the 
buffering capacity of deer milk. 
Lactobacillus delbrueckiisubsp bulgaricus and Lactobacillus casei strain Shirota fermentation of deer milk 
produced significantly (p<0.05) higher peptide concentration than the fermentation of cow milk (Fig 2). When 
all three strains ferments were digested, deer milk ferment produced significantly higher peptide concentration 
than cow milk ferment. Gobbetti et al. (2000) showed that during milk fermentation, probiotic strains may 
produce several oligopeptides which generate bioactive peptides only after subsequent digestion by pepsin and 
trypsin. Peptide bonds that are protected within the native protein structure might be exposed by the action of 
LAB enzymes, thereby allowing the release of new peptides.  According to Korhonen and Pilanto (2006), the 
use of both fermentation and digestion has been more effectiv in generating biofunctional peptides than 
fermentation or digestion alone.  Mata et al. (1996) reported that proteolysis during fermentation enhanced the 
release of peptides and may lead to the formation of novel peptides during gastrointestinal digestion. Overall 
deer milk digest produce more peptides than cow milk and this was further increased by fermentation prior to 
digestion.  
The ability to produce extracellular proteinases is a very important feature of LAB. They catalyse proteolysis of 
milk proteins, providing the amino acids essential for growth of LAB (Fira et al., 2001). LAB fermentation in 
yogurt is a desirable process improving milk digestibility and enhancing nutritional quality by protein 
degradation and hence, changes the texture, the taste and the aroma of fermented products (El-Ghaish et al., 
2011). In this study LAB fermentation improved the digestibility of β-lg of deer milk more than for cow milk 
(Table 1).  β-lg is the main cause of 80% of milk allergies in children and infants. β-lg is the major whey protein 
in milk and in dairy products and it is of particular interest since it is the only whey protein of cow milk absent 
in human milk (El-Ghaish et al., 2011). Kleber et al., 2006 studied the ability of some LAB strains to reduce the 
antigenicity of β-lg using skim milk and sweet whey by indirect competitive ELISA, using polyclonal 
antibodies. They observed the reduction of antigenicity of skim milk by 90% and sweet whey by 70% compared 
to the initial value. Our results suggest that less β-lg remained in the ferment digest of deer milk compared to 
cow ferment digest which may leads to less allergenicity of LAB fermented digest in deer milk than cow milk. 
α-Lactalbumin is another whey protein which is less allergenic than to β-lg (Wal, 1998). 11% intact α –la of 
deer milk was reduced to 1% by digestion with Lactobacillus delbrueckiisubsp bulgaricus and to 8% by 
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digestion with Lactobacillus casei strain Shirota ferments (Table 1). There was significantly lower concentration 
of intact α –la in digest of deer ferment than cow ferment for all three strains.   Bu et al. (2010) found that LAB 
fermentation reduced the antigenicity of cow α –la and β-lg by hydrolysis. Since our results showed less α –la 
and β-lg in deer ferment digest than cow ferment digest, fermented deer milk digest may be less allergen than 
fermented cow milk digest. Digestibility of cow IG was significantly improved after fermentation by all tested 
LAB strains (Table 3). Cow milk IGs are relatively resistant to proteolytic digestive enzymes in the 
gastrointestinal tract, but can be sensitive to microbial enzymes (Marnila and Korhone, 2011). In this study 
lactoferrrin (LF) in cow milk was significantly more resistant (P<0.05) to fermentation than that in deer milk for 
all three strains. Lactoferrin is an 80 kDa iron-binding glycoprotein of the transferrin family that is expressed in 
most biological fluids and is a major component of the mammalian innate immune system (Gonzalez-Chavez et 
al., 2009). In characterising the various peptides generated by LF hydrolysis, it was found that minimal 
variations in the amino acid sequence change the antimicrobial activity of the peptide. For example, LFampin 
268–284 and LFampin 265–284, chemically synthesised fragments from the N-terminal sequence of bLF, differ 
in only three amino acids (265Asp-Leu-267Ile) but exhibit different antibacterial activities  (Kraan van der et 
al., 2006). Therefore different levels of hydrolysis in deer and cow milk during fermentation may form different 
peptides which may have different strength of biological activity. Similar to our cow milk fermentation results, 
results of Franco et al. (2010) indicate that LF structure does not seem to be altered much by the activity of 
commercial LAB bacteria (yogurt). In contrast digestibility of deer milk is higher than cow milk and was further 
improved by LAB fermentation prior to digestion.   
CONCLUSION 
Fermentation prior to digestion increased the production of peptides from and the digestibility of major milk 
proteins from both deer and cow. Deer ferment digest produced more peptides than cow ferment digest. There 
was no significant difference in terms of peptide level produced after digestion among three LAB stains used in 
this experiment.  Digestibility of major milk proteins was higher in deer ferment than cow ferment. This study is 
a novel approach which might have a great impact in diversifying income stream for deer farmers and generate 
new information which will help in understanding fawn nutrition.  In future work deer and cow milk peptides 
will be fractionated using FPLC and immunomodulatory activity will be studied using human peripheral blood 
mononuclear cells (PBMC).  
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     Appendix C 
IL-2 production by human peripheral blood 
mononuclear cells (PBMC) stimulated by Con A with 
FPLC fraction 13 and 36 of unfermented and fermented 
deer and cow milk in vitro digests 
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Figure 1. IL-2 production by human peripheral blood mononuclear cells (PBMC) stimulated 
by Con A with FPLC fraction 13 and 36 of unfermented and fermented deer (   ) and cow (   ) 
milk in vitrodigests (0.125mg/ml protein). Fractions from deer and cow milk digests and 
digests of Lactobacillus delburueckii subsp bulgaricus (Ldb), Streptococcus salivarius subs 
thermophilus (Sst) and  Lactobacillus casi strain Shirota (Lcs) ferment. Control (   ) cells 
were stimulated by Con A without the addition of proteins. Data are mean ± S.D. (n = 3). 
Samples measured in triplicates. 
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Appendix D 
 
Deer and cow milk digests FPLC fractions absorbance at  
280 nm 
 
 
 
Figure 1.Absorbance at 280 nm of RP-FPLC chromatograms of the deer milk digests 
 
 
 
 
Figure 2. Absorbance at 280 nm of RP-FPLC chromatograms of the cow milk digests 
